{
 "cells": [
  {
   "cell_type": "markdown",
   "id": "9f83bea0-ed38-4464-8350-10e122406b87",
   "metadata": {},
   "source": [
    "## dummy swapping pmid and log"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 5,
   "id": "9f4a7363-2d12-425a-8b18-dda0a71c2670",
   "metadata": {
    "execution": {
     "iopub.execute_input": "2025-01-20T17:38:48.131377Z",
     "iopub.status.busy": "2025-01-20T17:38:48.130906Z",
     "iopub.status.idle": "2025-01-20T17:38:48.330855Z",
     "shell.execute_reply": "2025-01-20T17:38:48.329868Z",
     "shell.execute_reply.started": "2025-01-20T17:38:48.131334Z"
    }
   },
   "outputs": [],
   "source": [
    "%reload_ext autoreload\n",
    "%autoreload 2"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 1,
   "id": "abfa99f6-d264-486c-88a3-e7e03d407a75",
   "metadata": {
    "execution": {
     "iopub.execute_input": "2025-01-20T18:20:53.339112Z",
     "iopub.status.busy": "2025-01-20T18:20:53.338641Z",
     "iopub.status.idle": "2025-01-20T18:20:54.161634Z",
     "shell.execute_reply": "2025-01-20T18:20:54.160687Z",
     "shell.execute_reply.started": "2025-01-20T18:20:53.339063Z"
    }
   },
   "outputs": [],
   "source": [
    "import pandas as pd\n",
    "import os\n",
    "import logging\n",
    "import time\n",
    "import uuid\n",
    "import openai\n",
    "from pathlib import Path\n",
    "from llm_explainer.llm_explainer import vllm_get_response\n",
    "from hgcr_util.text_util import get_abstr_text\n",
    "from hgcr_util.lazy_json_kv_loader import LazyJsonlAbstractLoader\n",
    "from llm_context_processor_2 import LLMContextProcessor"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 3,
   "id": "81ff86ca-271f-4df8-9f52-6627b2ed5cbc",
   "metadata": {
    "execution": {
     "iopub.execute_input": "2025-01-20T18:21:02.109387Z",
     "iopub.status.busy": "2025-01-20T18:21:02.108908Z",
     "iopub.status.idle": "2025-01-20T18:21:02.204955Z",
     "shell.execute_reply": "2025-01-20T18:21:02.204346Z",
     "shell.execute_reply.started": "2025-01-20T18:21:02.109350Z"
    },
    "scrolled": true
   },
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>pair</th>\n",
       "      <th>subj_name</th>\n",
       "      <th>obj_name</th>\n",
       "      <th>pmid</th>\n",
       "      <th>pmid_text</th>\n",
       "      <th>source</th>\n",
       "      <th>first_year</th>\n",
       "      <th>label</th>\n",
       "      <th>context_pmids</th>\n",
       "      <th>path</th>\n",
       "      <th>context_pmids_space_edge</th>\n",
       "      <th>sorted_context_pmids</th>\n",
       "      <th>final_context_pmids</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>774</th>\n",
       "      <td>C0076080 C1530270</td>\n",
       "      <td>temozolomide</td>\n",
       "      <td>IRF1 protein, human</td>\n",
       "      <td>35274103</td>\n",
       "      <td>XAF1 directs glioma response to temozolomide t...</td>\n",
       "      <td>sr_pred_sent_7</td>\n",
       "      <td>2022</td>\n",
       "      <td>1</td>\n",
       "      <td>{('C0076080', 'C0069197'): ['19514084', '32901...</td>\n",
       "      <td>[C0076080, C0069197, C1530270]</td>\n",
       "      <td>{('C0076080', 'C0069197'): ['4300795', '210665...</td>\n",
       "      <td>{('C0076080', 'C0069197'): ['19514084', '32901...</td>\n",
       "      <td>{('C0076080', 'C0069197'): ['19514084', '32901...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>775</th>\n",
       "      <td>C0076080 C1530270</td>\n",
       "      <td>temozolomide</td>\n",
       "      <td>IRF1 protein, human</td>\n",
       "      <td>35274103</td>\n",
       "      <td>XAF1 directs glioma response to temozolomide t...</td>\n",
       "      <td>sr_pred_sent_7</td>\n",
       "      <td>2022</td>\n",
       "      <td>1</td>\n",
       "      <td>{('C0076080', 'C1337027'): ['31575897', '28122...</td>\n",
       "      <td>[C0076080, C1337027, C0069197, C1530270]</td>\n",
       "      <td>{('C0076080', 'C1337027'): ['24214988', '75263...</td>\n",
       "      <td>{('C0076080', 'C1337027'): ['31575897', '28122...</td>\n",
       "      <td>{('C0076080', 'C1337027'): ['31575897', '28122...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>776</th>\n",
       "      <td>C0076080 C1530270</td>\n",
       "      <td>temozolomide</td>\n",
       "      <td>IRF1 protein, human</td>\n",
       "      <td>35274103</td>\n",
       "      <td>XAF1 directs glioma response to temozolomide t...</td>\n",
       "      <td>sr_pred_sent_7</td>\n",
       "      <td>2022</td>\n",
       "      <td>1</td>\n",
       "      <td>{('C0076080', 'C1337027'): ['31575897', '28122...</td>\n",
       "      <td>[C0076080, C1337027, C1530270]</td>\n",
       "      <td>{('C0076080', 'C1337027'): ['24214988', '75263...</td>\n",
       "      <td>{('C0076080', 'C1337027'): ['31575897', '28122...</td>\n",
       "      <td>{('C0076080', 'C1337027'): ['31575897', '28122...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>777</th>\n",
       "      <td>C0076080 C1530270</td>\n",
       "      <td>temozolomide</td>\n",
       "      <td>IRF1 protein, human</td>\n",
       "      <td>35274103</td>\n",
       "      <td>XAF1 directs glioma response to temozolomide t...</td>\n",
       "      <td>sr_pred_sent_7</td>\n",
       "      <td>2022</td>\n",
       "      <td>0</td>\n",
       "      <td>{('C0076080', 'C2931926'): ['34700192', '32629...</td>\n",
       "      <td>[C0076080, C2931926, C1530270]</td>\n",
       "      <td>{('C0076080', 'C2931926'): ['29436151', '29049...</td>\n",
       "      <td>{('C0076080', 'C2931926'): ['32629176', '26981...</td>\n",
       "      <td>{('C0076080', 'C2931926'): ['32629176', '26981...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>778</th>\n",
       "      <td>C0076080 C1530270</td>\n",
       "      <td>temozolomide</td>\n",
       "      <td>IRF1 protein, human</td>\n",
       "      <td>35274103</td>\n",
       "      <td>XAF1 directs glioma response to temozolomide t...</td>\n",
       "      <td>sr_pred_sent_7</td>\n",
       "      <td>2022</td>\n",
       "      <td>0</td>\n",
       "      <td>{('C0076080', 'C1506592'): ['16908595', '33085...</td>\n",
       "      <td>[C0076080, C1506592, C2713871, C1530270]</td>\n",
       "      <td>{('C0076080', 'C1506592'): ['7364749', '268136...</td>\n",
       "      <td>{('C0076080', 'C1506592'): ['23243055', '33085...</td>\n",
       "      <td>{('C0076080', 'C1506592'): ['23243055', '33085...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>779</th>\n",
       "      <td>C0076080 C1530270</td>\n",
       "      <td>temozolomide</td>\n",
       "      <td>IRF1 protein, human</td>\n",
       "      <td>35274103</td>\n",
       "      <td>XAF1 directs glioma response to temozolomide t...</td>\n",
       "      <td>sr_pred_sent_7</td>\n",
       "      <td>2022</td>\n",
       "      <td>0</td>\n",
       "      <td>{('C0076080', 'C0123707'): ['25806680', '30562...</td>\n",
       "      <td>[C0076080, C0123707, C0033308, C1530270]</td>\n",
       "      <td>{('C0076080', 'C0123707'): ['33469032', '27696...</td>\n",
       "      <td>{('C0076080', 'C0123707'): ['29456350', '30562...</td>\n",
       "      <td>{('C0076080', 'C0123707'): ['29456350', '30562...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1386</th>\n",
       "      <td>C0011812 C0663241</td>\n",
       "      <td>dextroamphetamine</td>\n",
       "      <td>linezolid</td>\n",
       "      <td>37295073</td>\n",
       "      <td>A Case Series on Serotonin Syndrome from Conco...</td>\n",
       "      <td>title_cooc</td>\n",
       "      <td>2023</td>\n",
       "      <td>1</td>\n",
       "      <td>{('C0011812', 'C0010620'): ['414256', '139615'...</td>\n",
       "      <td>[C0011812, C0010620, C0024586, C0663241]</td>\n",
       "      <td>{('C0011812', 'C0010620'): ['805443', '1408460...</td>\n",
       "      <td>{('C0011812', 'C0010620'): ['7195140', '661046...</td>\n",
       "      <td>{('C0011812', 'C0010620'): ['7195140', '661046...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1387</th>\n",
       "      <td>C0011812 C0663241</td>\n",
       "      <td>dextroamphetamine</td>\n",
       "      <td>linezolid</td>\n",
       "      <td>37295073</td>\n",
       "      <td>A Case Series on Serotonin Syndrome from Conco...</td>\n",
       "      <td>title_cooc</td>\n",
       "      <td>2023</td>\n",
       "      <td>1</td>\n",
       "      <td>{('C0011812', 'C0024586'): ['6463096', '173646...</td>\n",
       "      <td>[C0011812, C0024586, C0663241]</td>\n",
       "      <td>{('C0011812', 'C0024586'): ['5786556', '764914...</td>\n",
       "      <td>{('C0011812', 'C0024586'): ['17364639', '96927...</td>\n",
       "      <td>{('C0011812', 'C0024586'): ['17364639', '96927...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1388</th>\n",
       "      <td>C0011812 C0663241</td>\n",
       "      <td>dextroamphetamine</td>\n",
       "      <td>linezolid</td>\n",
       "      <td>37295073</td>\n",
       "      <td>A Case Series on Serotonin Syndrome from Conco...</td>\n",
       "      <td>title_cooc</td>\n",
       "      <td>2023</td>\n",
       "      <td>1</td>\n",
       "      <td>{('C0011812', 'C0010620'): ['139615'], ('C0010...</td>\n",
       "      <td>[C0011812, C0010620, C0663241]</td>\n",
       "      <td>{('C0011812', 'C0010620'): ['805443', '1408460...</td>\n",
       "      <td>{('C0011812', 'C0010620'): ['139615'], ('C0010...</td>\n",
       "      <td>{('C0011812', 'C0010620'): ['139615', '805443'...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1389</th>\n",
       "      <td>C0011812 C0663241</td>\n",
       "      <td>dextroamphetamine</td>\n",
       "      <td>linezolid</td>\n",
       "      <td>37295073</td>\n",
       "      <td>A Case Series on Serotonin Syndrome from Conco...</td>\n",
       "      <td>title_cooc</td>\n",
       "      <td>2023</td>\n",
       "      <td>0</td>\n",
       "      <td>{('C0011812', 'C0004609'): ['24346808', '73674...</td>\n",
       "      <td>[C0011812, C0004609, C0663241]</td>\n",
       "      <td>{('C0011812', 'C0004609'): ['66577', '22704747...</td>\n",
       "      <td>{('C0011812', 'C0004609'): ['19042205', '11271...</td>\n",
       "      <td>{('C0011812', 'C0004609'): ['19042205', '11271...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1390</th>\n",
       "      <td>C0011812 C0663241</td>\n",
       "      <td>dextroamphetamine</td>\n",
       "      <td>linezolid</td>\n",
       "      <td>37295073</td>\n",
       "      <td>A Case Series on Serotonin Syndrome from Conco...</td>\n",
       "      <td>title_cooc</td>\n",
       "      <td>2023</td>\n",
       "      <td>0</td>\n",
       "      <td>{('C0011812', 'C0010592'): ['11869206'], ('C00...</td>\n",
       "      <td>[C0011812, C0010592, C0663241]</td>\n",
       "      <td>{('C0011812', 'C0010592'): ['22223272', '11399...</td>\n",
       "      <td>{('C0011812', 'C0010592'): ['11869206'], ('C00...</td>\n",
       "      <td>{('C0011812', 'C0010592'): ['11869206', '22223...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1391</th>\n",
       "      <td>C0011812 C0663241</td>\n",
       "      <td>dextroamphetamine</td>\n",
       "      <td>linezolid</td>\n",
       "      <td>37295073</td>\n",
       "      <td>A Case Series on Serotonin Syndrome from Conco...</td>\n",
       "      <td>title_cooc</td>\n",
       "      <td>2023</td>\n",
       "      <td>0</td>\n",
       "      <td>{('C0011812', 'C0003469'): ['24790199', '18029...</td>\n",
       "      <td>[C0011812, C0003469, C1565489, C0663241]</td>\n",
       "      <td>{('C0011812', 'C0003469'): ['5272990', '515477...</td>\n",
       "      <td>{('C0011812', 'C0003469'): ['16669726', '18029...</td>\n",
       "      <td>{('C0011812', 'C0003469'): ['16669726', '18029...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1584</th>\n",
       "      <td>C0002395 C1705607</td>\n",
       "      <td>F3 wt Allele</td>\n",
       "      <td>Alzheimer's Disease</td>\n",
       "      <td>35950105</td>\n",
       "      <td>Quality of dietary fat and risk of Alzheimer's...</td>\n",
       "      <td>sr_pred_sent_9</td>\n",
       "      <td>2022</td>\n",
       "      <td>1</td>\n",
       "      <td>{('C0002395', 'C1257879'): ['23635405', '22209...</td>\n",
       "      <td>[C0002395, C1257879, C1705607]</td>\n",
       "      <td>{('C0002395', 'C1257879'): ['16928999', '43932...</td>\n",
       "      <td>{('C0002395', 'C1257879'): ['19135506', '25809...</td>\n",
       "      <td>{('C0002395', 'C1257879'): ['19135506', '25809...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1585</th>\n",
       "      <td>C0002395 C1705607</td>\n",
       "      <td>F3 wt Allele</td>\n",
       "      <td>Alzheimer's Disease</td>\n",
       "      <td>35950105</td>\n",
       "      <td>Quality of dietary fat and risk of Alzheimer's...</td>\n",
       "      <td>sr_pred_sent_9</td>\n",
       "      <td>2022</td>\n",
       "      <td>1</td>\n",
       "      <td>{('C0002395', 'C0015687'): ['24970568', '20385...</td>\n",
       "      <td>[C0002395, C0015687, C1257879, C1705607]</td>\n",
       "      <td>{('C0002395', 'C0015687'): ['8689026', '295709...</td>\n",
       "      <td>{('C0002395', 'C0015687'): ['31130652', '33132...</td>\n",
       "      <td>{('C0002395', 'C0015687'): ['31130652', '33132...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1586</th>\n",
       "      <td>C0002395 C1705607</td>\n",
       "      <td>F3 wt Allele</td>\n",
       "      <td>Alzheimer's Disease</td>\n",
       "      <td>35950105</td>\n",
       "      <td>Quality of dietary fat and risk of Alzheimer's...</td>\n",
       "      <td>sr_pred_sent_9</td>\n",
       "      <td>2022</td>\n",
       "      <td>1</td>\n",
       "      <td>{('C0002395', 'C0015687'): ['1881238', '203037...</td>\n",
       "      <td>[C0002395, C0015687, C1705607]</td>\n",
       "      <td>{('C0002395', 'C0015687'): ['8689026', '295709...</td>\n",
       "      <td>{('C0002395', 'C0015687'): ['1881238', '196432...</td>\n",
       "      <td>{('C0002395', 'C0015687'): ['1881238', '196432...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1587</th>\n",
       "      <td>C0002395 C1705607</td>\n",
       "      <td>F3 wt Allele</td>\n",
       "      <td>Alzheimer's Disease</td>\n",
       "      <td>35950105</td>\n",
       "      <td>Quality of dietary fat and risk of Alzheimer's...</td>\n",
       "      <td>sr_pred_sent_9</td>\n",
       "      <td>2022</td>\n",
       "      <td>0</td>\n",
       "      <td>{('C0002395', 'C0022658'): ['11899079', '35385...</td>\n",
       "      <td>[C0002395, C0022658, C0025646, C1705607]</td>\n",
       "      <td>{('C0002395', 'C0022658'): ['25435401', '17117...</td>\n",
       "      <td>{('C0002395', 'C0022658'): ['19194887', '27497...</td>\n",
       "      <td>{('C0002395', 'C0022658'): ['19194887', '27497...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1588</th>\n",
       "      <td>C0002395 C1705607</td>\n",
       "      <td>F3 wt Allele</td>\n",
       "      <td>Alzheimer's Disease</td>\n",
       "      <td>35950105</td>\n",
       "      <td>Quality of dietary fat and risk of Alzheimer's...</td>\n",
       "      <td>sr_pred_sent_9</td>\n",
       "      <td>2022</td>\n",
       "      <td>0</td>\n",
       "      <td>{('C0002395', 'C1422519'): ['32706201', '25092...</td>\n",
       "      <td>[C0002395, C1422519, C0812234, C1705607]</td>\n",
       "      <td>{('C0002395', 'C1422519'): ['20103205', '17093...</td>\n",
       "      <td>{('C0002395', 'C1422519'): ['25092125', '31878...</td>\n",
       "      <td>{('C0002395', 'C1422519'): ['25092125', '31878...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1589</th>\n",
       "      <td>C0002395 C1705607</td>\n",
       "      <td>F3 wt Allele</td>\n",
       "      <td>Alzheimer's Disease</td>\n",
       "      <td>35950105</td>\n",
       "      <td>Quality of dietary fat and risk of Alzheimer's...</td>\n",
       "      <td>sr_pred_sent_9</td>\n",
       "      <td>2022</td>\n",
       "      <td>0</td>\n",
       "      <td>{('C0002395', 'C0202236'): ['31765631', '19504...</td>\n",
       "      <td>[C0002395, C0202236, C0025646, C1705607]</td>\n",
       "      <td>{('C0002395', 'C0202236'): ['29684792', '24977...</td>\n",
       "      <td>{('C0002395', 'C0202236'): ['19504347', '31765...</td>\n",
       "      <td>{('C0002395', 'C0202236'): ['19504347', '31765...</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "                   pair          subj_name             obj_name      pmid  \\\n",
       "774   C0076080 C1530270       temozolomide  IRF1 protein, human  35274103   \n",
       "775   C0076080 C1530270       temozolomide  IRF1 protein, human  35274103   \n",
       "776   C0076080 C1530270       temozolomide  IRF1 protein, human  35274103   \n",
       "777   C0076080 C1530270       temozolomide  IRF1 protein, human  35274103   \n",
       "778   C0076080 C1530270       temozolomide  IRF1 protein, human  35274103   \n",
       "779   C0076080 C1530270       temozolomide  IRF1 protein, human  35274103   \n",
       "1386  C0011812 C0663241  dextroamphetamine            linezolid  37295073   \n",
       "1387  C0011812 C0663241  dextroamphetamine            linezolid  37295073   \n",
       "1388  C0011812 C0663241  dextroamphetamine            linezolid  37295073   \n",
       "1389  C0011812 C0663241  dextroamphetamine            linezolid  37295073   \n",
       "1390  C0011812 C0663241  dextroamphetamine            linezolid  37295073   \n",
       "1391  C0011812 C0663241  dextroamphetamine            linezolid  37295073   \n",
       "1584  C0002395 C1705607       F3 wt Allele  Alzheimer's Disease  35950105   \n",
       "1585  C0002395 C1705607       F3 wt Allele  Alzheimer's Disease  35950105   \n",
       "1586  C0002395 C1705607       F3 wt Allele  Alzheimer's Disease  35950105   \n",
       "1587  C0002395 C1705607       F3 wt Allele  Alzheimer's Disease  35950105   \n",
       "1588  C0002395 C1705607       F3 wt Allele  Alzheimer's Disease  35950105   \n",
       "1589  C0002395 C1705607       F3 wt Allele  Alzheimer's Disease  35950105   \n",
       "\n",
       "                                              pmid_text          source  \\\n",
       "774   XAF1 directs glioma response to temozolomide t...  sr_pred_sent_7   \n",
       "775   XAF1 directs glioma response to temozolomide t...  sr_pred_sent_7   \n",
       "776   XAF1 directs glioma response to temozolomide t...  sr_pred_sent_7   \n",
       "777   XAF1 directs glioma response to temozolomide t...  sr_pred_sent_7   \n",
       "778   XAF1 directs glioma response to temozolomide t...  sr_pred_sent_7   \n",
       "779   XAF1 directs glioma response to temozolomide t...  sr_pred_sent_7   \n",
       "1386  A Case Series on Serotonin Syndrome from Conco...      title_cooc   \n",
       "1387  A Case Series on Serotonin Syndrome from Conco...      title_cooc   \n",
       "1388  A Case Series on Serotonin Syndrome from Conco...      title_cooc   \n",
       "1389  A Case Series on Serotonin Syndrome from Conco...      title_cooc   \n",
       "1390  A Case Series on Serotonin Syndrome from Conco...      title_cooc   \n",
       "1391  A Case Series on Serotonin Syndrome from Conco...      title_cooc   \n",
       "1584  Quality of dietary fat and risk of Alzheimer's...  sr_pred_sent_9   \n",
       "1585  Quality of dietary fat and risk of Alzheimer's...  sr_pred_sent_9   \n",
       "1586  Quality of dietary fat and risk of Alzheimer's...  sr_pred_sent_9   \n",
       "1587  Quality of dietary fat and risk of Alzheimer's...  sr_pred_sent_9   \n",
       "1588  Quality of dietary fat and risk of Alzheimer's...  sr_pred_sent_9   \n",
       "1589  Quality of dietary fat and risk of Alzheimer's...  sr_pred_sent_9   \n",
       "\n",
       "     first_year  label                                      context_pmids  \\\n",
       "774        2022      1  {('C0076080', 'C0069197'): ['19514084', '32901...   \n",
       "775        2022      1  {('C0076080', 'C1337027'): ['31575897', '28122...   \n",
       "776        2022      1  {('C0076080', 'C1337027'): ['31575897', '28122...   \n",
       "777        2022      0  {('C0076080', 'C2931926'): ['34700192', '32629...   \n",
       "778        2022      0  {('C0076080', 'C1506592'): ['16908595', '33085...   \n",
       "779        2022      0  {('C0076080', 'C0123707'): ['25806680', '30562...   \n",
       "1386       2023      1  {('C0011812', 'C0010620'): ['414256', '139615'...   \n",
       "1387       2023      1  {('C0011812', 'C0024586'): ['6463096', '173646...   \n",
       "1388       2023      1  {('C0011812', 'C0010620'): ['139615'], ('C0010...   \n",
       "1389       2023      0  {('C0011812', 'C0004609'): ['24346808', '73674...   \n",
       "1390       2023      0  {('C0011812', 'C0010592'): ['11869206'], ('C00...   \n",
       "1391       2023      0  {('C0011812', 'C0003469'): ['24790199', '18029...   \n",
       "1584       2022      1  {('C0002395', 'C1257879'): ['23635405', '22209...   \n",
       "1585       2022      1  {('C0002395', 'C0015687'): ['24970568', '20385...   \n",
       "1586       2022      1  {('C0002395', 'C0015687'): ['1881238', '203037...   \n",
       "1587       2022      0  {('C0002395', 'C0022658'): ['11899079', '35385...   \n",
       "1588       2022      0  {('C0002395', 'C1422519'): ['32706201', '25092...   \n",
       "1589       2022      0  {('C0002395', 'C0202236'): ['31765631', '19504...   \n",
       "\n",
       "                                          path  \\\n",
       "774             [C0076080, C0069197, C1530270]   \n",
       "775   [C0076080, C1337027, C0069197, C1530270]   \n",
       "776             [C0076080, C1337027, C1530270]   \n",
       "777             [C0076080, C2931926, C1530270]   \n",
       "778   [C0076080, C1506592, C2713871, C1530270]   \n",
       "779   [C0076080, C0123707, C0033308, C1530270]   \n",
       "1386  [C0011812, C0010620, C0024586, C0663241]   \n",
       "1387            [C0011812, C0024586, C0663241]   \n",
       "1388            [C0011812, C0010620, C0663241]   \n",
       "1389            [C0011812, C0004609, C0663241]   \n",
       "1390            [C0011812, C0010592, C0663241]   \n",
       "1391  [C0011812, C0003469, C1565489, C0663241]   \n",
       "1584            [C0002395, C1257879, C1705607]   \n",
       "1585  [C0002395, C0015687, C1257879, C1705607]   \n",
       "1586            [C0002395, C0015687, C1705607]   \n",
       "1587  [C0002395, C0022658, C0025646, C1705607]   \n",
       "1588  [C0002395, C1422519, C0812234, C1705607]   \n",
       "1589  [C0002395, C0202236, C0025646, C1705607]   \n",
       "\n",
       "                               context_pmids_space_edge  \\\n",
       "774   {('C0076080', 'C0069197'): ['4300795', '210665...   \n",
       "775   {('C0076080', 'C1337027'): ['24214988', '75263...   \n",
       "776   {('C0076080', 'C1337027'): ['24214988', '75263...   \n",
       "777   {('C0076080', 'C2931926'): ['29436151', '29049...   \n",
       "778   {('C0076080', 'C1506592'): ['7364749', '268136...   \n",
       "779   {('C0076080', 'C0123707'): ['33469032', '27696...   \n",
       "1386  {('C0011812', 'C0010620'): ['805443', '1408460...   \n",
       "1387  {('C0011812', 'C0024586'): ['5786556', '764914...   \n",
       "1388  {('C0011812', 'C0010620'): ['805443', '1408460...   \n",
       "1389  {('C0011812', 'C0004609'): ['66577', '22704747...   \n",
       "1390  {('C0011812', 'C0010592'): ['22223272', '11399...   \n",
       "1391  {('C0011812', 'C0003469'): ['5272990', '515477...   \n",
       "1584  {('C0002395', 'C1257879'): ['16928999', '43932...   \n",
       "1585  {('C0002395', 'C0015687'): ['8689026', '295709...   \n",
       "1586  {('C0002395', 'C0015687'): ['8689026', '295709...   \n",
       "1587  {('C0002395', 'C0022658'): ['25435401', '17117...   \n",
       "1588  {('C0002395', 'C1422519'): ['20103205', '17093...   \n",
       "1589  {('C0002395', 'C0202236'): ['29684792', '24977...   \n",
       "\n",
       "                                   sorted_context_pmids  \\\n",
       "774   {('C0076080', 'C0069197'): ['19514084', '32901...   \n",
       "775   {('C0076080', 'C1337027'): ['31575897', '28122...   \n",
       "776   {('C0076080', 'C1337027'): ['31575897', '28122...   \n",
       "777   {('C0076080', 'C2931926'): ['32629176', '26981...   \n",
       "778   {('C0076080', 'C1506592'): ['23243055', '33085...   \n",
       "779   {('C0076080', 'C0123707'): ['29456350', '30562...   \n",
       "1386  {('C0011812', 'C0010620'): ['7195140', '661046...   \n",
       "1387  {('C0011812', 'C0024586'): ['17364639', '96927...   \n",
       "1388  {('C0011812', 'C0010620'): ['139615'], ('C0010...   \n",
       "1389  {('C0011812', 'C0004609'): ['19042205', '11271...   \n",
       "1390  {('C0011812', 'C0010592'): ['11869206'], ('C00...   \n",
       "1391  {('C0011812', 'C0003469'): ['16669726', '18029...   \n",
       "1584  {('C0002395', 'C1257879'): ['19135506', '25809...   \n",
       "1585  {('C0002395', 'C0015687'): ['31130652', '33132...   \n",
       "1586  {('C0002395', 'C0015687'): ['1881238', '196432...   \n",
       "1587  {('C0002395', 'C0022658'): ['19194887', '27497...   \n",
       "1588  {('C0002395', 'C1422519'): ['25092125', '31878...   \n",
       "1589  {('C0002395', 'C0202236'): ['19504347', '31765...   \n",
       "\n",
       "                                    final_context_pmids  \n",
       "774   {('C0076080', 'C0069197'): ['19514084', '32901...  \n",
       "775   {('C0076080', 'C1337027'): ['31575897', '28122...  \n",
       "776   {('C0076080', 'C1337027'): ['31575897', '28122...  \n",
       "777   {('C0076080', 'C2931926'): ['32629176', '26981...  \n",
       "778   {('C0076080', 'C1506592'): ['23243055', '33085...  \n",
       "779   {('C0076080', 'C0123707'): ['29456350', '30562...  \n",
       "1386  {('C0011812', 'C0010620'): ['7195140', '661046...  \n",
       "1387  {('C0011812', 'C0024586'): ['17364639', '96927...  \n",
       "1388  {('C0011812', 'C0010620'): ['139615', '805443'...  \n",
       "1389  {('C0011812', 'C0004609'): ['19042205', '11271...  \n",
       "1390  {('C0011812', 'C0010592'): ['11869206', '22223...  \n",
       "1391  {('C0011812', 'C0003469'): ['16669726', '18029...  \n",
       "1584  {('C0002395', 'C1257879'): ['19135506', '25809...  \n",
       "1585  {('C0002395', 'C0015687'): ['31130652', '33132...  \n",
       "1586  {('C0002395', 'C0015687'): ['1881238', '196432...  \n",
       "1587  {('C0002395', 'C0022658'): ['19194887', '27497...  \n",
       "1588  {('C0002395', 'C1422519'): ['25092125', '31878...  \n",
       "1589  {('C0002395', 'C0202236'): ['19504347', '31765...  "
      ]
     },
     "execution_count": 3,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df = pd.read_pickle('./all_pkl_files/three_samples.pkl')\n",
    "df"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 5,
   "id": "fec634b6-e2b8-45d8-8f21-b3c9e9867a21",
   "metadata": {
    "execution": {
     "iopub.execute_input": "2025-01-20T18:22:04.554841Z",
     "iopub.status.busy": "2025-01-20T18:22:04.554375Z",
     "iopub.status.idle": "2025-01-20T18:22:04.564418Z",
     "shell.execute_reply": "2025-01-20T18:22:04.563312Z",
     "shell.execute_reply.started": "2025-01-20T18:22:04.554798Z"
    }
   },
   "outputs": [
    {
     "data": {
      "text/plain": [
       "18"
      ]
     },
     "execution_count": 5,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "len(df)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 4,
   "id": "2e321896-b8f4-4a4c-a2dd-08a76f6c12bd",
   "metadata": {
    "execution": {
     "iopub.execute_input": "2025-01-20T18:21:07.850672Z",
     "iopub.status.busy": "2025-01-20T18:21:07.850309Z",
     "iopub.status.idle": "2025-01-20T18:21:41.303499Z",
     "shell.execute_reply": "2025-01-20T18:21:41.302435Z",
     "shell.execute_reply.started": "2025-01-20T18:21:07.850637Z"
    }
   },
   "outputs": [
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Indexing jsonl files: 100%|███████████████████████████████████████████████████████████████████████████████████████████████████████████████████████| 109/109 [00:12<00:00,  8.48it/s]\n"
     ]
    }
   ],
   "source": [
    "sents_db = LazyJsonlAbstractLoader\n",
    "sent_jsonl_dir = Path(\n",
    "    \"/work/acslab/shared/Agatha_shared/\"\n",
    "    \"pmid_to_sent_id_w_text_kv_jsonl_lazy_chunks\"\n",
    ")\n",
    "\n",
    "sents_db = LazyJsonlAbstractLoader(\n",
    "    list(sent_jsonl_dir.glob(\"*.jsonl\"))\n",
    ")"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "642e0421-45f7-469d-a15c-44b3d27f3768",
   "metadata": {},
   "source": [
    "## NOTE: for 3 pair with 6 different path labeled 0 and 1 for llama3.3_70B it took 40 minutes max_iteration=4 number of pmid per edge=5:"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 6,
   "id": "443ac759-3eec-44ca-b4be-a45f9b5d4462",
   "metadata": {
    "execution": {
     "iopub.execute_input": "2025-01-20T18:22:41.353135Z",
     "iopub.status.busy": "2025-01-20T18:22:41.352702Z",
     "iopub.status.idle": "2025-01-20T19:03:02.115421Z",
     "shell.execute_reply": "2025-01-20T19:03:02.113846Z",
     "shell.execute_reply.started": "2025-01-20T18:22:41.353086Z"
    }
   },
   "outputs": [],
   "source": [
    "try:\n",
    "    processor = LLMContextProcessor(sents_db=sents_db)\n",
    "    updated_df = processor.process_df_with_llm(\n",
    "        df=df,\n",
    "        max_iterations=4,\n",
    "        k=5\n",
    "    )\n",
    "    updated_df.to_pickle(\"./all_pkl_files/mini_sample_3_pair_k_5_max_itr4_llama33_70B.pkl\")\n",
    "\n",
    "except RuntimeError as e:\n",
    "    print(f\"Critical error occurred: {e}\")\n",
    "    processor.logger.error(f\"Critical error occurred: {e}\")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 7,
   "id": "ffc02004-6a19-4bb5-89b9-bb7436328401",
   "metadata": {
    "execution": {
     "iopub.execute_input": "2025-01-20T20:19:51.990835Z",
     "iopub.status.busy": "2025-01-20T20:19:51.990284Z",
     "iopub.status.idle": "2025-01-20T20:19:52.845696Z",
     "shell.execute_reply": "2025-01-20T20:19:52.844698Z",
     "shell.execute_reply.started": "2025-01-20T20:19:51.990794Z"
    },
    "scrolled": true
   },
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>pair</th>\n",
       "      <th>subj_name</th>\n",
       "      <th>obj_name</th>\n",
       "      <th>pmid</th>\n",
       "      <th>pmid_text</th>\n",
       "      <th>source</th>\n",
       "      <th>first_year</th>\n",
       "      <th>label</th>\n",
       "      <th>context_pmids</th>\n",
       "      <th>path</th>\n",
       "      <th>context_pmids_space_edge</th>\n",
       "      <th>sorted_context_pmids</th>\n",
       "      <th>final_context_pmids</th>\n",
       "      <th>respond_llm</th>\n",
       "      <th>respond_time_llm</th>\n",
       "      <th>prompts_per_iteration</th>\n",
       "      <th>pmid_contexts_per_iteration</th>\n",
       "      <th>pmid_changes_per_iteration</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>774</th>\n",
       "      <td>C0076080 C1530270</td>\n",
       "      <td>temozolomide</td>\n",
       "      <td>IRF1 protein, human</td>\n",
       "      <td>35274103</td>\n",
       "      <td>XAF1 directs glioma response to temozolomide t...</td>\n",
       "      <td>sr_pred_sent_7</td>\n",
       "      <td>2022</td>\n",
       "      <td>1</td>\n",
       "      <td>{('C0076080', 'C0069197'): ['19514084', '32901...</td>\n",
       "      <td>[C0076080, C0069197, C1530270]</td>\n",
       "      <td>{('C0076080', 'C0069197'): ['4300795', '210665...</td>\n",
       "      <td>{('C0076080', 'C0069197'): ['19514084', '32901...</td>\n",
       "      <td>{('C0076080', 'C0069197'): ['19514084', '32901...</td>\n",
       "      <td>[{'iteration': 1, 'response': 'Based on the pr...</td>\n",
       "      <td>[33.195026874542236, 31.69631314277649, 35.408...</td>\n",
       "      <td>[Based on the following scientific abstracts, ...</td>\n",
       "      <td>[{('C0076080', 'C0069197'): ['19514084', '3290...</td>\n",
       "      <td>[{'edge': ('C0069197', 'C1530270'), 'dropped':...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>775</th>\n",
       "      <td>C0076080 C1530270</td>\n",
       "      <td>temozolomide</td>\n",
       "      <td>IRF1 protein, human</td>\n",
       "      <td>35274103</td>\n",
       "      <td>XAF1 directs glioma response to temozolomide t...</td>\n",
       "      <td>sr_pred_sent_7</td>\n",
       "      <td>2022</td>\n",
       "      <td>1</td>\n",
       "      <td>{('C0076080', 'C1337027'): ['31575897', '28122...</td>\n",
       "      <td>[C0076080, C1337027, C0069197, C1530270]</td>\n",
       "      <td>{('C0076080', 'C1337027'): ['24214988', '75263...</td>\n",
       "      <td>{('C0076080', 'C1337027'): ['31575897', '28122...</td>\n",
       "      <td>{('C0076080', 'C1337027'): ['31575897', '28122...</td>\n",
       "      <td>[{'iteration': 1, 'response': 'To describe an ...</td>\n",
       "      <td>[34.983481645584106, 36.60644602775574, 30.894...</td>\n",
       "      <td>[Based on the following scientific abstracts, ...</td>\n",
       "      <td>[{('C0076080', 'C1337027'): ['31575897', '2812...</td>\n",
       "      <td>[{'edge': ('C1337027', 'C0069197'), 'dropped':...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>776</th>\n",
       "      <td>C0076080 C1530270</td>\n",
       "      <td>temozolomide</td>\n",
       "      <td>IRF1 protein, human</td>\n",
       "      <td>35274103</td>\n",
       "      <td>XAF1 directs glioma response to temozolomide t...</td>\n",
       "      <td>sr_pred_sent_7</td>\n",
       "      <td>2022</td>\n",
       "      <td>1</td>\n",
       "      <td>{('C0076080', 'C1337027'): ['31575897', '28122...</td>\n",
       "      <td>[C0076080, C1337027, C1530270]</td>\n",
       "      <td>{('C0076080', 'C1337027'): ['24214988', '75263...</td>\n",
       "      <td>{('C0076080', 'C1337027'): ['31575897', '28122...</td>\n",
       "      <td>{('C0076080', 'C1337027'): ['31575897', '28122...</td>\n",
       "      <td>[{'iteration': 1, 'response': 'Based on the pr...</td>\n",
       "      <td>[26.065773248672485, 28.8979172706604, 33.3238...</td>\n",
       "      <td>[Based on the following scientific abstracts, ...</td>\n",
       "      <td>[{('C0076080', 'C1337027'): ['31575897', '2812...</td>\n",
       "      <td>[{'edge': ('C0076080', 'C1337027'), 'dropped':...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>777</th>\n",
       "      <td>C0076080 C1530270</td>\n",
       "      <td>temozolomide</td>\n",
       "      <td>IRF1 protein, human</td>\n",
       "      <td>35274103</td>\n",
       "      <td>XAF1 directs glioma response to temozolomide t...</td>\n",
       "      <td>sr_pred_sent_7</td>\n",
       "      <td>2022</td>\n",
       "      <td>0</td>\n",
       "      <td>{('C0076080', 'C2931926'): ['34700192', '32629...</td>\n",
       "      <td>[C0076080, C2931926, C1530270]</td>\n",
       "      <td>{('C0076080', 'C2931926'): ['29436151', '29049...</td>\n",
       "      <td>{('C0076080', 'C2931926'): ['32629176', '26981...</td>\n",
       "      <td>{('C0076080', 'C2931926'): ['32629176', '26981...</td>\n",
       "      <td>[{'iteration': 1, 'response': 'To describe an ...</td>\n",
       "      <td>[41.17671751976013, 28.509257316589355, 34.484...</td>\n",
       "      <td>[Based on the following scientific abstracts, ...</td>\n",
       "      <td>[{('C0076080', 'C2931926'): ['32629176', '2698...</td>\n",
       "      <td>[{'edge': ('C0076080', 'C2931926'), 'dropped':...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>778</th>\n",
       "      <td>C0076080 C1530270</td>\n",
       "      <td>temozolomide</td>\n",
       "      <td>IRF1 protein, human</td>\n",
       "      <td>35274103</td>\n",
       "      <td>XAF1 directs glioma response to temozolomide t...</td>\n",
       "      <td>sr_pred_sent_7</td>\n",
       "      <td>2022</td>\n",
       "      <td>0</td>\n",
       "      <td>{('C0076080', 'C1506592'): ['16908595', '33085...</td>\n",
       "      <td>[C0076080, C1506592, C2713871, C1530270]</td>\n",
       "      <td>{('C0076080', 'C1506592'): ['7364749', '268136...</td>\n",
       "      <td>{('C0076080', 'C1506592'): ['23243055', '33085...</td>\n",
       "      <td>{('C0076080', 'C1506592'): ['23243055', '33085...</td>\n",
       "      <td>[{'iteration': 1, 'response': 'Based on the pr...</td>\n",
       "      <td>[39.19556903839111, 42.19934821128845, 31.7485...</td>\n",
       "      <td>[Based on the following scientific abstracts, ...</td>\n",
       "      <td>[{('C0076080', 'C1506592'): ['23243055', '3308...</td>\n",
       "      <td>[{'edge': ('C0076080', 'C1506592'), 'dropped':...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>779</th>\n",
       "      <td>C0076080 C1530270</td>\n",
       "      <td>temozolomide</td>\n",
       "      <td>IRF1 protein, human</td>\n",
       "      <td>35274103</td>\n",
       "      <td>XAF1 directs glioma response to temozolomide t...</td>\n",
       "      <td>sr_pred_sent_7</td>\n",
       "      <td>2022</td>\n",
       "      <td>0</td>\n",
       "      <td>{('C0076080', 'C0123707'): ['25806680', '30562...</td>\n",
       "      <td>[C0076080, C0123707, C0033308, C1530270]</td>\n",
       "      <td>{('C0076080', 'C0123707'): ['33469032', '27696...</td>\n",
       "      <td>{('C0076080', 'C0123707'): ['29456350', '30562...</td>\n",
       "      <td>{('C0076080', 'C0123707'): ['29456350', '30562...</td>\n",
       "      <td>[{'iteration': 1, 'response': 'Based on the pr...</td>\n",
       "      <td>[34.53022503852844, 37.267558336257935, 34.992...</td>\n",
       "      <td>[Based on the following scientific abstracts, ...</td>\n",
       "      <td>[{('C0076080', 'C0123707'): ['29456350', '3056...</td>\n",
       "      <td>[{'edge': ('C0123707', 'C0033308'), 'dropped':...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1386</th>\n",
       "      <td>C0011812 C0663241</td>\n",
       "      <td>dextroamphetamine</td>\n",
       "      <td>linezolid</td>\n",
       "      <td>37295073</td>\n",
       "      <td>A Case Series on Serotonin Syndrome from Conco...</td>\n",
       "      <td>title_cooc</td>\n",
       "      <td>2023</td>\n",
       "      <td>1</td>\n",
       "      <td>{('C0011812', 'C0010620'): ['414256', '139615'...</td>\n",
       "      <td>[C0011812, C0010620, C0024586, C0663241]</td>\n",
       "      <td>{('C0011812', 'C0010620'): ['805443', '1408460...</td>\n",
       "      <td>{('C0011812', 'C0010620'): ['7195140', '661046...</td>\n",
       "      <td>{('C0011812', 'C0010620'): ['7195140', '661046...</td>\n",
       "      <td>[{'iteration': 1, 'response': 'Based on the pr...</td>\n",
       "      <td>[29.576554536819458, 35.0388925075531, 33.2695...</td>\n",
       "      <td>[Based on the following scientific abstracts, ...</td>\n",
       "      <td>[{('C0011812', 'C0010620'): ['7195140', '66104...</td>\n",
       "      <td>[{'edge': ('C0011812', 'C0010620'), 'dropped':...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1387</th>\n",
       "      <td>C0011812 C0663241</td>\n",
       "      <td>dextroamphetamine</td>\n",
       "      <td>linezolid</td>\n",
       "      <td>37295073</td>\n",
       "      <td>A Case Series on Serotonin Syndrome from Conco...</td>\n",
       "      <td>title_cooc</td>\n",
       "      <td>2023</td>\n",
       "      <td>1</td>\n",
       "      <td>{('C0011812', 'C0024586'): ['6463096', '173646...</td>\n",
       "      <td>[C0011812, C0024586, C0663241]</td>\n",
       "      <td>{('C0011812', 'C0024586'): ['5786556', '764914...</td>\n",
       "      <td>{('C0011812', 'C0024586'): ['17364639', '96927...</td>\n",
       "      <td>{('C0011812', 'C0024586'): ['17364639', '96927...</td>\n",
       "      <td>[{'iteration': 1, 'response': 'An indirect rel...</td>\n",
       "      <td>[29.309974670410156, 32.61806797981262, 32.936...</td>\n",
       "      <td>[Based on the following scientific abstracts, ...</td>\n",
       "      <td>[{('C0011812', 'C0024586'): ['17364639', '9692...</td>\n",
       "      <td>[{'edge': ('C0024586', 'C0663241'), 'dropped':...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1388</th>\n",
       "      <td>C0011812 C0663241</td>\n",
       "      <td>dextroamphetamine</td>\n",
       "      <td>linezolid</td>\n",
       "      <td>37295073</td>\n",
       "      <td>A Case Series on Serotonin Syndrome from Conco...</td>\n",
       "      <td>title_cooc</td>\n",
       "      <td>2023</td>\n",
       "      <td>1</td>\n",
       "      <td>{('C0011812', 'C0010620'): ['139615'], ('C0010...</td>\n",
       "      <td>[C0011812, C0010620, C0663241]</td>\n",
       "      <td>{('C0011812', 'C0010620'): ['805443', '1408460...</td>\n",
       "      <td>{('C0011812', 'C0010620'): ['139615'], ('C0010...</td>\n",
       "      <td>{('C0011812', 'C0010620'): ['139615', '805443'...</td>\n",
       "      <td>[{'iteration': 1, 'response': 'To describe an ...</td>\n",
       "      <td>[29.69477605819702, 30.643377780914307, 20.391...</td>\n",
       "      <td>[Based on the following scientific abstracts, ...</td>\n",
       "      <td>[{('C0011812', 'C0010620'): ['139615', '805443...</td>\n",
       "      <td>[{'edge': ('C0010620', 'C0663241'), 'dropped':...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1389</th>\n",
       "      <td>C0011812 C0663241</td>\n",
       "      <td>dextroamphetamine</td>\n",
       "      <td>linezolid</td>\n",
       "      <td>37295073</td>\n",
       "      <td>A Case Series on Serotonin Syndrome from Conco...</td>\n",
       "      <td>title_cooc</td>\n",
       "      <td>2023</td>\n",
       "      <td>0</td>\n",
       "      <td>{('C0011812', 'C0004609'): ['24346808', '73674...</td>\n",
       "      <td>[C0011812, C0004609, C0663241]</td>\n",
       "      <td>{('C0011812', 'C0004609'): ['66577', '22704747...</td>\n",
       "      <td>{('C0011812', 'C0004609'): ['19042205', '11271...</td>\n",
       "      <td>{('C0011812', 'C0004609'): ['19042205', '11271...</td>\n",
       "      <td>[{'iteration': 1, 'response': 'To describe an ...</td>\n",
       "      <td>[29.05800199508667, 31.147324800491333, 34.714...</td>\n",
       "      <td>[Based on the following scientific abstracts, ...</td>\n",
       "      <td>[{('C0011812', 'C0004609'): ['19042205', '1127...</td>\n",
       "      <td>[{'edge': ('C0011812', 'C0004609'), 'dropped':...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1390</th>\n",
       "      <td>C0011812 C0663241</td>\n",
       "      <td>dextroamphetamine</td>\n",
       "      <td>linezolid</td>\n",
       "      <td>37295073</td>\n",
       "      <td>A Case Series on Serotonin Syndrome from Conco...</td>\n",
       "      <td>title_cooc</td>\n",
       "      <td>2023</td>\n",
       "      <td>0</td>\n",
       "      <td>{('C0011812', 'C0010592'): ['11869206'], ('C00...</td>\n",
       "      <td>[C0011812, C0010592, C0663241]</td>\n",
       "      <td>{('C0011812', 'C0010592'): ['22223272', '11399...</td>\n",
       "      <td>{('C0011812', 'C0010592'): ['11869206'], ('C00...</td>\n",
       "      <td>{('C0011812', 'C0010592'): ['11869206', '22223...</td>\n",
       "      <td>[{'iteration': 1, 'response': 'To describe an ...</td>\n",
       "      <td>[28.954283952713013, 28.110923528671265, 22.23...</td>\n",
       "      <td>[Based on the following scientific abstracts, ...</td>\n",
       "      <td>[{('C0011812', 'C0010592'): ['11869206', '2222...</td>\n",
       "      <td>[{'edge': ('C0011812', 'C0010592'), 'dropped':...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1391</th>\n",
       "      <td>C0011812 C0663241</td>\n",
       "      <td>dextroamphetamine</td>\n",
       "      <td>linezolid</td>\n",
       "      <td>37295073</td>\n",
       "      <td>A Case Series on Serotonin Syndrome from Conco...</td>\n",
       "      <td>title_cooc</td>\n",
       "      <td>2023</td>\n",
       "      <td>0</td>\n",
       "      <td>{('C0011812', 'C0003469'): ['24790199', '18029...</td>\n",
       "      <td>[C0011812, C0003469, C1565489, C0663241]</td>\n",
       "      <td>{('C0011812', 'C0003469'): ['5272990', '515477...</td>\n",
       "      <td>{('C0011812', 'C0003469'): ['16669726', '18029...</td>\n",
       "      <td>{('C0011812', 'C0003469'): ['16669726', '18029...</td>\n",
       "      <td>[{'iteration': 1, 'response': 'Based on the pr...</td>\n",
       "      <td>[40.83695387840271, 35.757752895355225, 32.075...</td>\n",
       "      <td>[Based on the following scientific abstracts, ...</td>\n",
       "      <td>[{('C0011812', 'C0003469'): ['16669726', '1802...</td>\n",
       "      <td>[{'edge': ('C1565489', 'C0663241'), 'dropped':...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1584</th>\n",
       "      <td>C0002395 C1705607</td>\n",
       "      <td>F3 wt Allele</td>\n",
       "      <td>Alzheimer's Disease</td>\n",
       "      <td>35950105</td>\n",
       "      <td>Quality of dietary fat and risk of Alzheimer's...</td>\n",
       "      <td>sr_pred_sent_9</td>\n",
       "      <td>2022</td>\n",
       "      <td>1</td>\n",
       "      <td>{('C0002395', 'C1257879'): ['23635405', '22209...</td>\n",
       "      <td>[C0002395, C1257879, C1705607]</td>\n",
       "      <td>{('C0002395', 'C1257879'): ['16928999', '43932...</td>\n",
       "      <td>{('C0002395', 'C1257879'): ['19135506', '25809...</td>\n",
       "      <td>{('C0002395', 'C1257879'): ['19135506', '25809...</td>\n",
       "      <td>[{'iteration': 1, 'response': 'Based on the pr...</td>\n",
       "      <td>[39.65016222000122, 29.5916166305542, 34.49734...</td>\n",
       "      <td>[Based on the following scientific abstracts, ...</td>\n",
       "      <td>[{('C0002395', 'C1257879'): ['19135506', '2580...</td>\n",
       "      <td>[{'edge': ('C1257879', 'C1705607'), 'dropped':...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1585</th>\n",
       "      <td>C0002395 C1705607</td>\n",
       "      <td>F3 wt Allele</td>\n",
       "      <td>Alzheimer's Disease</td>\n",
       "      <td>35950105</td>\n",
       "      <td>Quality of dietary fat and risk of Alzheimer's...</td>\n",
       "      <td>sr_pred_sent_9</td>\n",
       "      <td>2022</td>\n",
       "      <td>1</td>\n",
       "      <td>{('C0002395', 'C0015687'): ['24970568', '20385...</td>\n",
       "      <td>[C0002395, C0015687, C1257879, C1705607]</td>\n",
       "      <td>{('C0002395', 'C0015687'): ['8689026', '295709...</td>\n",
       "      <td>{('C0002395', 'C0015687'): ['31130652', '33132...</td>\n",
       "      <td>{('C0002395', 'C0015687'): ['31130652', '33132...</td>\n",
       "      <td>[{'iteration': 1, 'response': 'Based on the pr...</td>\n",
       "      <td>[33.86064386367798, 36.308061838150024, 34.504...</td>\n",
       "      <td>[Based on the following scientific abstracts, ...</td>\n",
       "      <td>[{('C0002395', 'C0015687'): ['31130652', '3313...</td>\n",
       "      <td>[{'edge': ('C1257879', 'C1705607'), 'dropped':...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1586</th>\n",
       "      <td>C0002395 C1705607</td>\n",
       "      <td>F3 wt Allele</td>\n",
       "      <td>Alzheimer's Disease</td>\n",
       "      <td>35950105</td>\n",
       "      <td>Quality of dietary fat and risk of Alzheimer's...</td>\n",
       "      <td>sr_pred_sent_9</td>\n",
       "      <td>2022</td>\n",
       "      <td>1</td>\n",
       "      <td>{('C0002395', 'C0015687'): ['1881238', '203037...</td>\n",
       "      <td>[C0002395, C0015687, C1705607]</td>\n",
       "      <td>{('C0002395', 'C0015687'): ['8689026', '295709...</td>\n",
       "      <td>{('C0002395', 'C0015687'): ['1881238', '196432...</td>\n",
       "      <td>{('C0002395', 'C0015687'): ['1881238', '196432...</td>\n",
       "      <td>[{'iteration': 1, 'response': 'Based on the pr...</td>\n",
       "      <td>[31.940171003341675, 39.136714220047, 42.09142...</td>\n",
       "      <td>[Based on the following scientific abstracts, ...</td>\n",
       "      <td>[{('C0002395', 'C0015687'): ['1881238', '19643...</td>\n",
       "      <td>[{'edge': ('C0002395', 'C0015687'), 'dropped':...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1587</th>\n",
       "      <td>C0002395 C1705607</td>\n",
       "      <td>F3 wt Allele</td>\n",
       "      <td>Alzheimer's Disease</td>\n",
       "      <td>35950105</td>\n",
       "      <td>Quality of dietary fat and risk of Alzheimer's...</td>\n",
       "      <td>sr_pred_sent_9</td>\n",
       "      <td>2022</td>\n",
       "      <td>0</td>\n",
       "      <td>{('C0002395', 'C0022658'): ['11899079', '35385...</td>\n",
       "      <td>[C0002395, C0022658, C0025646, C1705607]</td>\n",
       "      <td>{('C0002395', 'C0022658'): ['25435401', '17117...</td>\n",
       "      <td>{('C0002395', 'C0022658'): ['19194887', '27497...</td>\n",
       "      <td>{('C0002395', 'C0022658'): ['19194887', '27497...</td>\n",
       "      <td>[{'iteration': 1, 'response': 'Based on the pr...</td>\n",
       "      <td>[34.50853896141052, 45.283775091171265, 36.399...</td>\n",
       "      <td>[Based on the following scientific abstracts, ...</td>\n",
       "      <td>[{('C0002395', 'C0022658'): ['19194887', '2749...</td>\n",
       "      <td>[{'edge': ('C0002395', 'C0022658'), 'dropped':...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1588</th>\n",
       "      <td>C0002395 C1705607</td>\n",
       "      <td>F3 wt Allele</td>\n",
       "      <td>Alzheimer's Disease</td>\n",
       "      <td>35950105</td>\n",
       "      <td>Quality of dietary fat and risk of Alzheimer's...</td>\n",
       "      <td>sr_pred_sent_9</td>\n",
       "      <td>2022</td>\n",
       "      <td>0</td>\n",
       "      <td>{('C0002395', 'C1422519'): ['32706201', '25092...</td>\n",
       "      <td>[C0002395, C1422519, C0812234, C1705607]</td>\n",
       "      <td>{('C0002395', 'C1422519'): ['20103205', '17093...</td>\n",
       "      <td>{('C0002395', 'C1422519'): ['25092125', '31878...</td>\n",
       "      <td>{('C0002395', 'C1422519'): ['25092125', '31878...</td>\n",
       "      <td>[{'iteration': 1, 'response': 'Based on the pr...</td>\n",
       "      <td>[33.97222948074341, 39.28410577774048, 34.6071...</td>\n",
       "      <td>[Based on the following scientific abstracts, ...</td>\n",
       "      <td>[{('C0002395', 'C1422519'): ['25092125', '3187...</td>\n",
       "      <td>[{'edge': ('C0002395', 'C1422519'), 'dropped':...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1589</th>\n",
       "      <td>C0002395 C1705607</td>\n",
       "      <td>F3 wt Allele</td>\n",
       "      <td>Alzheimer's Disease</td>\n",
       "      <td>35950105</td>\n",
       "      <td>Quality of dietary fat and risk of Alzheimer's...</td>\n",
       "      <td>sr_pred_sent_9</td>\n",
       "      <td>2022</td>\n",
       "      <td>0</td>\n",
       "      <td>{('C0002395', 'C0202236'): ['31765631', '19504...</td>\n",
       "      <td>[C0002395, C0202236, C0025646, C1705607]</td>\n",
       "      <td>{('C0002395', 'C0202236'): ['29684792', '24977...</td>\n",
       "      <td>{('C0002395', 'C0202236'): ['19504347', '31765...</td>\n",
       "      <td>{('C0002395', 'C0202236'): ['19504347', '31765...</td>\n",
       "      <td>[{'iteration': 1, 'response': 'To describe an ...</td>\n",
       "      <td>[39.29839301109314, 38.21434497833252, 31.9296...</td>\n",
       "      <td>[Based on the following scientific abstracts, ...</td>\n",
       "      <td>[{('C0002395', 'C0202236'): ['19504347', '3176...</td>\n",
       "      <td>[{'edge': ('C0025646', 'C1705607'), 'dropped':...</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "                   pair          subj_name             obj_name      pmid  \\\n",
       "774   C0076080 C1530270       temozolomide  IRF1 protein, human  35274103   \n",
       "775   C0076080 C1530270       temozolomide  IRF1 protein, human  35274103   \n",
       "776   C0076080 C1530270       temozolomide  IRF1 protein, human  35274103   \n",
       "777   C0076080 C1530270       temozolomide  IRF1 protein, human  35274103   \n",
       "778   C0076080 C1530270       temozolomide  IRF1 protein, human  35274103   \n",
       "779   C0076080 C1530270       temozolomide  IRF1 protein, human  35274103   \n",
       "1386  C0011812 C0663241  dextroamphetamine            linezolid  37295073   \n",
       "1387  C0011812 C0663241  dextroamphetamine            linezolid  37295073   \n",
       "1388  C0011812 C0663241  dextroamphetamine            linezolid  37295073   \n",
       "1389  C0011812 C0663241  dextroamphetamine            linezolid  37295073   \n",
       "1390  C0011812 C0663241  dextroamphetamine            linezolid  37295073   \n",
       "1391  C0011812 C0663241  dextroamphetamine            linezolid  37295073   \n",
       "1584  C0002395 C1705607       F3 wt Allele  Alzheimer's Disease  35950105   \n",
       "1585  C0002395 C1705607       F3 wt Allele  Alzheimer's Disease  35950105   \n",
       "1586  C0002395 C1705607       F3 wt Allele  Alzheimer's Disease  35950105   \n",
       "1587  C0002395 C1705607       F3 wt Allele  Alzheimer's Disease  35950105   \n",
       "1588  C0002395 C1705607       F3 wt Allele  Alzheimer's Disease  35950105   \n",
       "1589  C0002395 C1705607       F3 wt Allele  Alzheimer's Disease  35950105   \n",
       "\n",
       "                                              pmid_text          source  \\\n",
       "774   XAF1 directs glioma response to temozolomide t...  sr_pred_sent_7   \n",
       "775   XAF1 directs glioma response to temozolomide t...  sr_pred_sent_7   \n",
       "776   XAF1 directs glioma response to temozolomide t...  sr_pred_sent_7   \n",
       "777   XAF1 directs glioma response to temozolomide t...  sr_pred_sent_7   \n",
       "778   XAF1 directs glioma response to temozolomide t...  sr_pred_sent_7   \n",
       "779   XAF1 directs glioma response to temozolomide t...  sr_pred_sent_7   \n",
       "1386  A Case Series on Serotonin Syndrome from Conco...      title_cooc   \n",
       "1387  A Case Series on Serotonin Syndrome from Conco...      title_cooc   \n",
       "1388  A Case Series on Serotonin Syndrome from Conco...      title_cooc   \n",
       "1389  A Case Series on Serotonin Syndrome from Conco...      title_cooc   \n",
       "1390  A Case Series on Serotonin Syndrome from Conco...      title_cooc   \n",
       "1391  A Case Series on Serotonin Syndrome from Conco...      title_cooc   \n",
       "1584  Quality of dietary fat and risk of Alzheimer's...  sr_pred_sent_9   \n",
       "1585  Quality of dietary fat and risk of Alzheimer's...  sr_pred_sent_9   \n",
       "1586  Quality of dietary fat and risk of Alzheimer's...  sr_pred_sent_9   \n",
       "1587  Quality of dietary fat and risk of Alzheimer's...  sr_pred_sent_9   \n",
       "1588  Quality of dietary fat and risk of Alzheimer's...  sr_pred_sent_9   \n",
       "1589  Quality of dietary fat and risk of Alzheimer's...  sr_pred_sent_9   \n",
       "\n",
       "     first_year  label                                      context_pmids  \\\n",
       "774        2022      1  {('C0076080', 'C0069197'): ['19514084', '32901...   \n",
       "775        2022      1  {('C0076080', 'C1337027'): ['31575897', '28122...   \n",
       "776        2022      1  {('C0076080', 'C1337027'): ['31575897', '28122...   \n",
       "777        2022      0  {('C0076080', 'C2931926'): ['34700192', '32629...   \n",
       "778        2022      0  {('C0076080', 'C1506592'): ['16908595', '33085...   \n",
       "779        2022      0  {('C0076080', 'C0123707'): ['25806680', '30562...   \n",
       "1386       2023      1  {('C0011812', 'C0010620'): ['414256', '139615'...   \n",
       "1387       2023      1  {('C0011812', 'C0024586'): ['6463096', '173646...   \n",
       "1388       2023      1  {('C0011812', 'C0010620'): ['139615'], ('C0010...   \n",
       "1389       2023      0  {('C0011812', 'C0004609'): ['24346808', '73674...   \n",
       "1390       2023      0  {('C0011812', 'C0010592'): ['11869206'], ('C00...   \n",
       "1391       2023      0  {('C0011812', 'C0003469'): ['24790199', '18029...   \n",
       "1584       2022      1  {('C0002395', 'C1257879'): ['23635405', '22209...   \n",
       "1585       2022      1  {('C0002395', 'C0015687'): ['24970568', '20385...   \n",
       "1586       2022      1  {('C0002395', 'C0015687'): ['1881238', '203037...   \n",
       "1587       2022      0  {('C0002395', 'C0022658'): ['11899079', '35385...   \n",
       "1588       2022      0  {('C0002395', 'C1422519'): ['32706201', '25092...   \n",
       "1589       2022      0  {('C0002395', 'C0202236'): ['31765631', '19504...   \n",
       "\n",
       "                                          path  \\\n",
       "774             [C0076080, C0069197, C1530270]   \n",
       "775   [C0076080, C1337027, C0069197, C1530270]   \n",
       "776             [C0076080, C1337027, C1530270]   \n",
       "777             [C0076080, C2931926, C1530270]   \n",
       "778   [C0076080, C1506592, C2713871, C1530270]   \n",
       "779   [C0076080, C0123707, C0033308, C1530270]   \n",
       "1386  [C0011812, C0010620, C0024586, C0663241]   \n",
       "1387            [C0011812, C0024586, C0663241]   \n",
       "1388            [C0011812, C0010620, C0663241]   \n",
       "1389            [C0011812, C0004609, C0663241]   \n",
       "1390            [C0011812, C0010592, C0663241]   \n",
       "1391  [C0011812, C0003469, C1565489, C0663241]   \n",
       "1584            [C0002395, C1257879, C1705607]   \n",
       "1585  [C0002395, C0015687, C1257879, C1705607]   \n",
       "1586            [C0002395, C0015687, C1705607]   \n",
       "1587  [C0002395, C0022658, C0025646, C1705607]   \n",
       "1588  [C0002395, C1422519, C0812234, C1705607]   \n",
       "1589  [C0002395, C0202236, C0025646, C1705607]   \n",
       "\n",
       "                               context_pmids_space_edge  \\\n",
       "774   {('C0076080', 'C0069197'): ['4300795', '210665...   \n",
       "775   {('C0076080', 'C1337027'): ['24214988', '75263...   \n",
       "776   {('C0076080', 'C1337027'): ['24214988', '75263...   \n",
       "777   {('C0076080', 'C2931926'): ['29436151', '29049...   \n",
       "778   {('C0076080', 'C1506592'): ['7364749', '268136...   \n",
       "779   {('C0076080', 'C0123707'): ['33469032', '27696...   \n",
       "1386  {('C0011812', 'C0010620'): ['805443', '1408460...   \n",
       "1387  {('C0011812', 'C0024586'): ['5786556', '764914...   \n",
       "1388  {('C0011812', 'C0010620'): ['805443', '1408460...   \n",
       "1389  {('C0011812', 'C0004609'): ['66577', '22704747...   \n",
       "1390  {('C0011812', 'C0010592'): ['22223272', '11399...   \n",
       "1391  {('C0011812', 'C0003469'): ['5272990', '515477...   \n",
       "1584  {('C0002395', 'C1257879'): ['16928999', '43932...   \n",
       "1585  {('C0002395', 'C0015687'): ['8689026', '295709...   \n",
       "1586  {('C0002395', 'C0015687'): ['8689026', '295709...   \n",
       "1587  {('C0002395', 'C0022658'): ['25435401', '17117...   \n",
       "1588  {('C0002395', 'C1422519'): ['20103205', '17093...   \n",
       "1589  {('C0002395', 'C0202236'): ['29684792', '24977...   \n",
       "\n",
       "                                   sorted_context_pmids  \\\n",
       "774   {('C0076080', 'C0069197'): ['19514084', '32901...   \n",
       "775   {('C0076080', 'C1337027'): ['31575897', '28122...   \n",
       "776   {('C0076080', 'C1337027'): ['31575897', '28122...   \n",
       "777   {('C0076080', 'C2931926'): ['32629176', '26981...   \n",
       "778   {('C0076080', 'C1506592'): ['23243055', '33085...   \n",
       "779   {('C0076080', 'C0123707'): ['29456350', '30562...   \n",
       "1386  {('C0011812', 'C0010620'): ['7195140', '661046...   \n",
       "1387  {('C0011812', 'C0024586'): ['17364639', '96927...   \n",
       "1388  {('C0011812', 'C0010620'): ['139615'], ('C0010...   \n",
       "1389  {('C0011812', 'C0004609'): ['19042205', '11271...   \n",
       "1390  {('C0011812', 'C0010592'): ['11869206'], ('C00...   \n",
       "1391  {('C0011812', 'C0003469'): ['16669726', '18029...   \n",
       "1584  {('C0002395', 'C1257879'): ['19135506', '25809...   \n",
       "1585  {('C0002395', 'C0015687'): ['31130652', '33132...   \n",
       "1586  {('C0002395', 'C0015687'): ['1881238', '196432...   \n",
       "1587  {('C0002395', 'C0022658'): ['19194887', '27497...   \n",
       "1588  {('C0002395', 'C1422519'): ['25092125', '31878...   \n",
       "1589  {('C0002395', 'C0202236'): ['19504347', '31765...   \n",
       "\n",
       "                                    final_context_pmids  \\\n",
       "774   {('C0076080', 'C0069197'): ['19514084', '32901...   \n",
       "775   {('C0076080', 'C1337027'): ['31575897', '28122...   \n",
       "776   {('C0076080', 'C1337027'): ['31575897', '28122...   \n",
       "777   {('C0076080', 'C2931926'): ['32629176', '26981...   \n",
       "778   {('C0076080', 'C1506592'): ['23243055', '33085...   \n",
       "779   {('C0076080', 'C0123707'): ['29456350', '30562...   \n",
       "1386  {('C0011812', 'C0010620'): ['7195140', '661046...   \n",
       "1387  {('C0011812', 'C0024586'): ['17364639', '96927...   \n",
       "1388  {('C0011812', 'C0010620'): ['139615', '805443'...   \n",
       "1389  {('C0011812', 'C0004609'): ['19042205', '11271...   \n",
       "1390  {('C0011812', 'C0010592'): ['11869206', '22223...   \n",
       "1391  {('C0011812', 'C0003469'): ['16669726', '18029...   \n",
       "1584  {('C0002395', 'C1257879'): ['19135506', '25809...   \n",
       "1585  {('C0002395', 'C0015687'): ['31130652', '33132...   \n",
       "1586  {('C0002395', 'C0015687'): ['1881238', '196432...   \n",
       "1587  {('C0002395', 'C0022658'): ['19194887', '27497...   \n",
       "1588  {('C0002395', 'C1422519'): ['25092125', '31878...   \n",
       "1589  {('C0002395', 'C0202236'): ['19504347', '31765...   \n",
       "\n",
       "                                            respond_llm  \\\n",
       "774   [{'iteration': 1, 'response': 'Based on the pr...   \n",
       "775   [{'iteration': 1, 'response': 'To describe an ...   \n",
       "776   [{'iteration': 1, 'response': 'Based on the pr...   \n",
       "777   [{'iteration': 1, 'response': 'To describe an ...   \n",
       "778   [{'iteration': 1, 'response': 'Based on the pr...   \n",
       "779   [{'iteration': 1, 'response': 'Based on the pr...   \n",
       "1386  [{'iteration': 1, 'response': 'Based on the pr...   \n",
       "1387  [{'iteration': 1, 'response': 'An indirect rel...   \n",
       "1388  [{'iteration': 1, 'response': 'To describe an ...   \n",
       "1389  [{'iteration': 1, 'response': 'To describe an ...   \n",
       "1390  [{'iteration': 1, 'response': 'To describe an ...   \n",
       "1391  [{'iteration': 1, 'response': 'Based on the pr...   \n",
       "1584  [{'iteration': 1, 'response': 'Based on the pr...   \n",
       "1585  [{'iteration': 1, 'response': 'Based on the pr...   \n",
       "1586  [{'iteration': 1, 'response': 'Based on the pr...   \n",
       "1587  [{'iteration': 1, 'response': 'Based on the pr...   \n",
       "1588  [{'iteration': 1, 'response': 'Based on the pr...   \n",
       "1589  [{'iteration': 1, 'response': 'To describe an ...   \n",
       "\n",
       "                                       respond_time_llm  \\\n",
       "774   [33.195026874542236, 31.69631314277649, 35.408...   \n",
       "775   [34.983481645584106, 36.60644602775574, 30.894...   \n",
       "776   [26.065773248672485, 28.8979172706604, 33.3238...   \n",
       "777   [41.17671751976013, 28.509257316589355, 34.484...   \n",
       "778   [39.19556903839111, 42.19934821128845, 31.7485...   \n",
       "779   [34.53022503852844, 37.267558336257935, 34.992...   \n",
       "1386  [29.576554536819458, 35.0388925075531, 33.2695...   \n",
       "1387  [29.309974670410156, 32.61806797981262, 32.936...   \n",
       "1388  [29.69477605819702, 30.643377780914307, 20.391...   \n",
       "1389  [29.05800199508667, 31.147324800491333, 34.714...   \n",
       "1390  [28.954283952713013, 28.110923528671265, 22.23...   \n",
       "1391  [40.83695387840271, 35.757752895355225, 32.075...   \n",
       "1584  [39.65016222000122, 29.5916166305542, 34.49734...   \n",
       "1585  [33.86064386367798, 36.308061838150024, 34.504...   \n",
       "1586  [31.940171003341675, 39.136714220047, 42.09142...   \n",
       "1587  [34.50853896141052, 45.283775091171265, 36.399...   \n",
       "1588  [33.97222948074341, 39.28410577774048, 34.6071...   \n",
       "1589  [39.29839301109314, 38.21434497833252, 31.9296...   \n",
       "\n",
       "                                  prompts_per_iteration  \\\n",
       "774   [Based on the following scientific abstracts, ...   \n",
       "775   [Based on the following scientific abstracts, ...   \n",
       "776   [Based on the following scientific abstracts, ...   \n",
       "777   [Based on the following scientific abstracts, ...   \n",
       "778   [Based on the following scientific abstracts, ...   \n",
       "779   [Based on the following scientific abstracts, ...   \n",
       "1386  [Based on the following scientific abstracts, ...   \n",
       "1387  [Based on the following scientific abstracts, ...   \n",
       "1388  [Based on the following scientific abstracts, ...   \n",
       "1389  [Based on the following scientific abstracts, ...   \n",
       "1390  [Based on the following scientific abstracts, ...   \n",
       "1391  [Based on the following scientific abstracts, ...   \n",
       "1584  [Based on the following scientific abstracts, ...   \n",
       "1585  [Based on the following scientific abstracts, ...   \n",
       "1586  [Based on the following scientific abstracts, ...   \n",
       "1587  [Based on the following scientific abstracts, ...   \n",
       "1588  [Based on the following scientific abstracts, ...   \n",
       "1589  [Based on the following scientific abstracts, ...   \n",
       "\n",
       "                            pmid_contexts_per_iteration  \\\n",
       "774   [{('C0076080', 'C0069197'): ['19514084', '3290...   \n",
       "775   [{('C0076080', 'C1337027'): ['31575897', '2812...   \n",
       "776   [{('C0076080', 'C1337027'): ['31575897', '2812...   \n",
       "777   [{('C0076080', 'C2931926'): ['32629176', '2698...   \n",
       "778   [{('C0076080', 'C1506592'): ['23243055', '3308...   \n",
       "779   [{('C0076080', 'C0123707'): ['29456350', '3056...   \n",
       "1386  [{('C0011812', 'C0010620'): ['7195140', '66104...   \n",
       "1387  [{('C0011812', 'C0024586'): ['17364639', '9692...   \n",
       "1388  [{('C0011812', 'C0010620'): ['139615', '805443...   \n",
       "1389  [{('C0011812', 'C0004609'): ['19042205', '1127...   \n",
       "1390  [{('C0011812', 'C0010592'): ['11869206', '2222...   \n",
       "1391  [{('C0011812', 'C0003469'): ['16669726', '1802...   \n",
       "1584  [{('C0002395', 'C1257879'): ['19135506', '2580...   \n",
       "1585  [{('C0002395', 'C0015687'): ['31130652', '3313...   \n",
       "1586  [{('C0002395', 'C0015687'): ['1881238', '19643...   \n",
       "1587  [{('C0002395', 'C0022658'): ['19194887', '2749...   \n",
       "1588  [{('C0002395', 'C1422519'): ['25092125', '3187...   \n",
       "1589  [{('C0002395', 'C0202236'): ['19504347', '3176...   \n",
       "\n",
       "                             pmid_changes_per_iteration  \n",
       "774   [{'edge': ('C0069197', 'C1530270'), 'dropped':...  \n",
       "775   [{'edge': ('C1337027', 'C0069197'), 'dropped':...  \n",
       "776   [{'edge': ('C0076080', 'C1337027'), 'dropped':...  \n",
       "777   [{'edge': ('C0076080', 'C2931926'), 'dropped':...  \n",
       "778   [{'edge': ('C0076080', 'C1506592'), 'dropped':...  \n",
       "779   [{'edge': ('C0123707', 'C0033308'), 'dropped':...  \n",
       "1386  [{'edge': ('C0011812', 'C0010620'), 'dropped':...  \n",
       "1387  [{'edge': ('C0024586', 'C0663241'), 'dropped':...  \n",
       "1388  [{'edge': ('C0010620', 'C0663241'), 'dropped':...  \n",
       "1389  [{'edge': ('C0011812', 'C0004609'), 'dropped':...  \n",
       "1390  [{'edge': ('C0011812', 'C0010592'), 'dropped':...  \n",
       "1391  [{'edge': ('C1565489', 'C0663241'), 'dropped':...  \n",
       "1584  [{'edge': ('C1257879', 'C1705607'), 'dropped':...  \n",
       "1585  [{'edge': ('C1257879', 'C1705607'), 'dropped':...  \n",
       "1586  [{'edge': ('C0002395', 'C0015687'), 'dropped':...  \n",
       "1587  [{'edge': ('C0002395', 'C0022658'), 'dropped':...  \n",
       "1588  [{'edge': ('C0002395', 'C1422519'), 'dropped':...  \n",
       "1589  [{'edge': ('C0025646', 'C1705607'), 'dropped':...  "
      ]
     },
     "execution_count": 7,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "res_df_mini_sample_3_pair_k_5_max_itr4_llama33_70B = pd.read_pickle('./all_pkl_files/mini_sample_3_pair_k_5_max_itr4_llama33_70B.pkl')\n",
    "res_df_mini_sample_3_pair_k_5_max_itr4_llama33_70B"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 8,
   "id": "4d1e28af-8799-4a34-8d2a-46c7d55f21c0",
   "metadata": {
    "execution": {
     "iopub.execute_input": "2025-01-20T20:20:00.144363Z",
     "iopub.status.busy": "2025-01-20T20:20:00.143873Z",
     "iopub.status.idle": "2025-01-20T20:20:00.292072Z",
     "shell.execute_reply": "2025-01-20T20:20:00.291282Z",
     "shell.execute_reply.started": "2025-01-20T20:20:00.144322Z"
    }
   },
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>respond_llm</th>\n",
       "      <th>respond_time_llm</th>\n",
       "      <th>prompts_per_iteration</th>\n",
       "      <th>pmid_contexts_per_iteration</th>\n",
       "      <th>pmid_changes_per_iteration</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>774</th>\n",
       "      <td>[{'iteration': 1, 'response': 'Based on the pr...</td>\n",
       "      <td>[33.195026874542236, 31.69631314277649, 35.408...</td>\n",
       "      <td>[Based on the following scientific abstracts, ...</td>\n",
       "      <td>[{('C0076080', 'C0069197'): ['19514084', '3290...</td>\n",
       "      <td>[{'edge': ('C0069197', 'C1530270'), 'dropped':...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>775</th>\n",
       "      <td>[{'iteration': 1, 'response': 'To describe an ...</td>\n",
       "      <td>[34.983481645584106, 36.60644602775574, 30.894...</td>\n",
       "      <td>[Based on the following scientific abstracts, ...</td>\n",
       "      <td>[{('C0076080', 'C1337027'): ['31575897', '2812...</td>\n",
       "      <td>[{'edge': ('C1337027', 'C0069197'), 'dropped':...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>776</th>\n",
       "      <td>[{'iteration': 1, 'response': 'Based on the pr...</td>\n",
       "      <td>[26.065773248672485, 28.8979172706604, 33.3238...</td>\n",
       "      <td>[Based on the following scientific abstracts, ...</td>\n",
       "      <td>[{('C0076080', 'C1337027'): ['31575897', '2812...</td>\n",
       "      <td>[{'edge': ('C0076080', 'C1337027'), 'dropped':...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>777</th>\n",
       "      <td>[{'iteration': 1, 'response': 'To describe an ...</td>\n",
       "      <td>[41.17671751976013, 28.509257316589355, 34.484...</td>\n",
       "      <td>[Based on the following scientific abstracts, ...</td>\n",
       "      <td>[{('C0076080', 'C2931926'): ['32629176', '2698...</td>\n",
       "      <td>[{'edge': ('C0076080', 'C2931926'), 'dropped':...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>778</th>\n",
       "      <td>[{'iteration': 1, 'response': 'Based on the pr...</td>\n",
       "      <td>[39.19556903839111, 42.19934821128845, 31.7485...</td>\n",
       "      <td>[Based on the following scientific abstracts, ...</td>\n",
       "      <td>[{('C0076080', 'C1506592'): ['23243055', '3308...</td>\n",
       "      <td>[{'edge': ('C0076080', 'C1506592'), 'dropped':...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>779</th>\n",
       "      <td>[{'iteration': 1, 'response': 'Based on the pr...</td>\n",
       "      <td>[34.53022503852844, 37.267558336257935, 34.992...</td>\n",
       "      <td>[Based on the following scientific abstracts, ...</td>\n",
       "      <td>[{('C0076080', 'C0123707'): ['29456350', '3056...</td>\n",
       "      <td>[{'edge': ('C0123707', 'C0033308'), 'dropped':...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1386</th>\n",
       "      <td>[{'iteration': 1, 'response': 'Based on the pr...</td>\n",
       "      <td>[29.576554536819458, 35.0388925075531, 33.2695...</td>\n",
       "      <td>[Based on the following scientific abstracts, ...</td>\n",
       "      <td>[{('C0011812', 'C0010620'): ['7195140', '66104...</td>\n",
       "      <td>[{'edge': ('C0011812', 'C0010620'), 'dropped':...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1387</th>\n",
       "      <td>[{'iteration': 1, 'response': 'An indirect rel...</td>\n",
       "      <td>[29.309974670410156, 32.61806797981262, 32.936...</td>\n",
       "      <td>[Based on the following scientific abstracts, ...</td>\n",
       "      <td>[{('C0011812', 'C0024586'): ['17364639', '9692...</td>\n",
       "      <td>[{'edge': ('C0024586', 'C0663241'), 'dropped':...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1388</th>\n",
       "      <td>[{'iteration': 1, 'response': 'To describe an ...</td>\n",
       "      <td>[29.69477605819702, 30.643377780914307, 20.391...</td>\n",
       "      <td>[Based on the following scientific abstracts, ...</td>\n",
       "      <td>[{('C0011812', 'C0010620'): ['139615', '805443...</td>\n",
       "      <td>[{'edge': ('C0010620', 'C0663241'), 'dropped':...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1389</th>\n",
       "      <td>[{'iteration': 1, 'response': 'To describe an ...</td>\n",
       "      <td>[29.05800199508667, 31.147324800491333, 34.714...</td>\n",
       "      <td>[Based on the following scientific abstracts, ...</td>\n",
       "      <td>[{('C0011812', 'C0004609'): ['19042205', '1127...</td>\n",
       "      <td>[{'edge': ('C0011812', 'C0004609'), 'dropped':...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1390</th>\n",
       "      <td>[{'iteration': 1, 'response': 'To describe an ...</td>\n",
       "      <td>[28.954283952713013, 28.110923528671265, 22.23...</td>\n",
       "      <td>[Based on the following scientific abstracts, ...</td>\n",
       "      <td>[{('C0011812', 'C0010592'): ['11869206', '2222...</td>\n",
       "      <td>[{'edge': ('C0011812', 'C0010592'), 'dropped':...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1391</th>\n",
       "      <td>[{'iteration': 1, 'response': 'Based on the pr...</td>\n",
       "      <td>[40.83695387840271, 35.757752895355225, 32.075...</td>\n",
       "      <td>[Based on the following scientific abstracts, ...</td>\n",
       "      <td>[{('C0011812', 'C0003469'): ['16669726', '1802...</td>\n",
       "      <td>[{'edge': ('C1565489', 'C0663241'), 'dropped':...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1584</th>\n",
       "      <td>[{'iteration': 1, 'response': 'Based on the pr...</td>\n",
       "      <td>[39.65016222000122, 29.5916166305542, 34.49734...</td>\n",
       "      <td>[Based on the following scientific abstracts, ...</td>\n",
       "      <td>[{('C0002395', 'C1257879'): ['19135506', '2580...</td>\n",
       "      <td>[{'edge': ('C1257879', 'C1705607'), 'dropped':...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1585</th>\n",
       "      <td>[{'iteration': 1, 'response': 'Based on the pr...</td>\n",
       "      <td>[33.86064386367798, 36.308061838150024, 34.504...</td>\n",
       "      <td>[Based on the following scientific abstracts, ...</td>\n",
       "      <td>[{('C0002395', 'C0015687'): ['31130652', '3313...</td>\n",
       "      <td>[{'edge': ('C1257879', 'C1705607'), 'dropped':...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1586</th>\n",
       "      <td>[{'iteration': 1, 'response': 'Based on the pr...</td>\n",
       "      <td>[31.940171003341675, 39.136714220047, 42.09142...</td>\n",
       "      <td>[Based on the following scientific abstracts, ...</td>\n",
       "      <td>[{('C0002395', 'C0015687'): ['1881238', '19643...</td>\n",
       "      <td>[{'edge': ('C0002395', 'C0015687'), 'dropped':...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1587</th>\n",
       "      <td>[{'iteration': 1, 'response': 'Based on the pr...</td>\n",
       "      <td>[34.50853896141052, 45.283775091171265, 36.399...</td>\n",
       "      <td>[Based on the following scientific abstracts, ...</td>\n",
       "      <td>[{('C0002395', 'C0022658'): ['19194887', '2749...</td>\n",
       "      <td>[{'edge': ('C0002395', 'C0022658'), 'dropped':...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1588</th>\n",
       "      <td>[{'iteration': 1, 'response': 'Based on the pr...</td>\n",
       "      <td>[33.97222948074341, 39.28410577774048, 34.6071...</td>\n",
       "      <td>[Based on the following scientific abstracts, ...</td>\n",
       "      <td>[{('C0002395', 'C1422519'): ['25092125', '3187...</td>\n",
       "      <td>[{'edge': ('C0002395', 'C1422519'), 'dropped':...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1589</th>\n",
       "      <td>[{'iteration': 1, 'response': 'To describe an ...</td>\n",
       "      <td>[39.29839301109314, 38.21434497833252, 31.9296...</td>\n",
       "      <td>[Based on the following scientific abstracts, ...</td>\n",
       "      <td>[{('C0002395', 'C0202236'): ['19504347', '3176...</td>\n",
       "      <td>[{'edge': ('C0025646', 'C1705607'), 'dropped':...</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "                                            respond_llm  \\\n",
       "774   [{'iteration': 1, 'response': 'Based on the pr...   \n",
       "775   [{'iteration': 1, 'response': 'To describe an ...   \n",
       "776   [{'iteration': 1, 'response': 'Based on the pr...   \n",
       "777   [{'iteration': 1, 'response': 'To describe an ...   \n",
       "778   [{'iteration': 1, 'response': 'Based on the pr...   \n",
       "779   [{'iteration': 1, 'response': 'Based on the pr...   \n",
       "1386  [{'iteration': 1, 'response': 'Based on the pr...   \n",
       "1387  [{'iteration': 1, 'response': 'An indirect rel...   \n",
       "1388  [{'iteration': 1, 'response': 'To describe an ...   \n",
       "1389  [{'iteration': 1, 'response': 'To describe an ...   \n",
       "1390  [{'iteration': 1, 'response': 'To describe an ...   \n",
       "1391  [{'iteration': 1, 'response': 'Based on the pr...   \n",
       "1584  [{'iteration': 1, 'response': 'Based on the pr...   \n",
       "1585  [{'iteration': 1, 'response': 'Based on the pr...   \n",
       "1586  [{'iteration': 1, 'response': 'Based on the pr...   \n",
       "1587  [{'iteration': 1, 'response': 'Based on the pr...   \n",
       "1588  [{'iteration': 1, 'response': 'Based on the pr...   \n",
       "1589  [{'iteration': 1, 'response': 'To describe an ...   \n",
       "\n",
       "                                       respond_time_llm  \\\n",
       "774   [33.195026874542236, 31.69631314277649, 35.408...   \n",
       "775   [34.983481645584106, 36.60644602775574, 30.894...   \n",
       "776   [26.065773248672485, 28.8979172706604, 33.3238...   \n",
       "777   [41.17671751976013, 28.509257316589355, 34.484...   \n",
       "778   [39.19556903839111, 42.19934821128845, 31.7485...   \n",
       "779   [34.53022503852844, 37.267558336257935, 34.992...   \n",
       "1386  [29.576554536819458, 35.0388925075531, 33.2695...   \n",
       "1387  [29.309974670410156, 32.61806797981262, 32.936...   \n",
       "1388  [29.69477605819702, 30.643377780914307, 20.391...   \n",
       "1389  [29.05800199508667, 31.147324800491333, 34.714...   \n",
       "1390  [28.954283952713013, 28.110923528671265, 22.23...   \n",
       "1391  [40.83695387840271, 35.757752895355225, 32.075...   \n",
       "1584  [39.65016222000122, 29.5916166305542, 34.49734...   \n",
       "1585  [33.86064386367798, 36.308061838150024, 34.504...   \n",
       "1586  [31.940171003341675, 39.136714220047, 42.09142...   \n",
       "1587  [34.50853896141052, 45.283775091171265, 36.399...   \n",
       "1588  [33.97222948074341, 39.28410577774048, 34.6071...   \n",
       "1589  [39.29839301109314, 38.21434497833252, 31.9296...   \n",
       "\n",
       "                                  prompts_per_iteration  \\\n",
       "774   [Based on the following scientific abstracts, ...   \n",
       "775   [Based on the following scientific abstracts, ...   \n",
       "776   [Based on the following scientific abstracts, ...   \n",
       "777   [Based on the following scientific abstracts, ...   \n",
       "778   [Based on the following scientific abstracts, ...   \n",
       "779   [Based on the following scientific abstracts, ...   \n",
       "1386  [Based on the following scientific abstracts, ...   \n",
       "1387  [Based on the following scientific abstracts, ...   \n",
       "1388  [Based on the following scientific abstracts, ...   \n",
       "1389  [Based on the following scientific abstracts, ...   \n",
       "1390  [Based on the following scientific abstracts, ...   \n",
       "1391  [Based on the following scientific abstracts, ...   \n",
       "1584  [Based on the following scientific abstracts, ...   \n",
       "1585  [Based on the following scientific abstracts, ...   \n",
       "1586  [Based on the following scientific abstracts, ...   \n",
       "1587  [Based on the following scientific abstracts, ...   \n",
       "1588  [Based on the following scientific abstracts, ...   \n",
       "1589  [Based on the following scientific abstracts, ...   \n",
       "\n",
       "                            pmid_contexts_per_iteration  \\\n",
       "774   [{('C0076080', 'C0069197'): ['19514084', '3290...   \n",
       "775   [{('C0076080', 'C1337027'): ['31575897', '2812...   \n",
       "776   [{('C0076080', 'C1337027'): ['31575897', '2812...   \n",
       "777   [{('C0076080', 'C2931926'): ['32629176', '2698...   \n",
       "778   [{('C0076080', 'C1506592'): ['23243055', '3308...   \n",
       "779   [{('C0076080', 'C0123707'): ['29456350', '3056...   \n",
       "1386  [{('C0011812', 'C0010620'): ['7195140', '66104...   \n",
       "1387  [{('C0011812', 'C0024586'): ['17364639', '9692...   \n",
       "1388  [{('C0011812', 'C0010620'): ['139615', '805443...   \n",
       "1389  [{('C0011812', 'C0004609'): ['19042205', '1127...   \n",
       "1390  [{('C0011812', 'C0010592'): ['11869206', '2222...   \n",
       "1391  [{('C0011812', 'C0003469'): ['16669726', '1802...   \n",
       "1584  [{('C0002395', 'C1257879'): ['19135506', '2580...   \n",
       "1585  [{('C0002395', 'C0015687'): ['31130652', '3313...   \n",
       "1586  [{('C0002395', 'C0015687'): ['1881238', '19643...   \n",
       "1587  [{('C0002395', 'C0022658'): ['19194887', '2749...   \n",
       "1588  [{('C0002395', 'C1422519'): ['25092125', '3187...   \n",
       "1589  [{('C0002395', 'C0202236'): ['19504347', '3176...   \n",
       "\n",
       "                             pmid_changes_per_iteration  \n",
       "774   [{'edge': ('C0069197', 'C1530270'), 'dropped':...  \n",
       "775   [{'edge': ('C1337027', 'C0069197'), 'dropped':...  \n",
       "776   [{'edge': ('C0076080', 'C1337027'), 'dropped':...  \n",
       "777   [{'edge': ('C0076080', 'C2931926'), 'dropped':...  \n",
       "778   [{'edge': ('C0076080', 'C1506592'), 'dropped':...  \n",
       "779   [{'edge': ('C0123707', 'C0033308'), 'dropped':...  \n",
       "1386  [{'edge': ('C0011812', 'C0010620'), 'dropped':...  \n",
       "1387  [{'edge': ('C0024586', 'C0663241'), 'dropped':...  \n",
       "1388  [{'edge': ('C0010620', 'C0663241'), 'dropped':...  \n",
       "1389  [{'edge': ('C0011812', 'C0004609'), 'dropped':...  \n",
       "1390  [{'edge': ('C0011812', 'C0010592'), 'dropped':...  \n",
       "1391  [{'edge': ('C1565489', 'C0663241'), 'dropped':...  \n",
       "1584  [{'edge': ('C1257879', 'C1705607'), 'dropped':...  \n",
       "1585  [{'edge': ('C1257879', 'C1705607'), 'dropped':...  \n",
       "1586  [{'edge': ('C0002395', 'C0015687'), 'dropped':...  \n",
       "1587  [{'edge': ('C0002395', 'C0022658'), 'dropped':...  \n",
       "1588  [{'edge': ('C0002395', 'C1422519'), 'dropped':...  \n",
       "1589  [{'edge': ('C0025646', 'C1705607'), 'dropped':...  "
      ]
     },
     "execution_count": 8,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "res_df_mini_sample_3_pair_k_5_max_itr4_llama33_70B[['respond_llm',\t'respond_time_llm',\t'prompts_per_iteration',\t'pmid_contexts_per_iteration',\t'pmid_changes_per_iteration']]"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 11,
   "id": "c0cd9660-28c2-4223-981b-1f1d4ccd7690",
   "metadata": {
    "execution": {
     "iopub.execute_input": "2025-01-20T20:20:37.236996Z",
     "iopub.status.busy": "2025-01-20T20:20:37.236469Z",
     "iopub.status.idle": "2025-01-20T20:20:37.243976Z",
     "shell.execute_reply": "2025-01-20T20:20:37.243256Z",
     "shell.execute_reply.started": "2025-01-20T20:20:37.236956Z"
    }
   },
   "outputs": [
    {
     "data": {
      "text/plain": [
       "18"
      ]
     },
     "execution_count": 11,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "len(res_df_mini_sample_3_pair_k_5_max_itr4_llama33_70B)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 9,
   "id": "725529fb-6c09-4006-b5b9-c326a9f8f8e6",
   "metadata": {
    "execution": {
     "iopub.execute_input": "2025-01-20T20:20:03.652700Z",
     "iopub.status.busy": "2025-01-20T20:20:03.652243Z",
     "iopub.status.idle": "2025-01-20T20:20:03.667511Z",
     "shell.execute_reply": "2025-01-20T20:20:03.666476Z",
     "shell.execute_reply.started": "2025-01-20T20:20:03.652662Z"
    }
   },
   "outputs": [],
   "source": [
    "def extract_exploded_results_v3(processed_df, output_file=None):\n",
    "    \"\"\"\n",
    "    Extracts and explodes iterative results from the DataFrame generated by LLMContextProcessor.\n",
    "    Each iteration-related column is exploded to create a new row for each iteration,\n",
    "    while retaining the original index for easier tracking. Additionally, only the \"response\" field\n",
    "    is retained from the \"respond_llm\" column.\n",
    "\n",
    "    Args:\n",
    "        processed_df (pd.DataFrame): DataFrame generated by LLMContextProcessor.\n",
    "        output_file (str, optional): If provided, saves the exploded DataFrame to this file.\n",
    "\n",
    "    Returns:\n",
    "        pd.DataFrame: Exploded DataFrame with a new row for each iteration.\n",
    "    \"\"\"\n",
    "    # Step 1: Ensure all iteration-related columns are aligned\n",
    "    iteration_columns = [\n",
    "        \"respond_llm\", \"respond_time_llm\", \n",
    "        \"prompts_per_iteration\", \"pmid_contexts_per_iteration\", \"pmid_changes_per_iteration\"\n",
    "    ]\n",
    "    for col in iteration_columns:\n",
    "        assert processed_df[col].apply(len).nunique() == 1, f\"Column {col} has misaligned iteration lengths.\"\n",
    "\n",
    "    # Step 2: Explode iteration-related columns\n",
    "    exploded_df = processed_df.copy()\n",
    "    exploded_df = exploded_df.explode(\"respond_llm\").reset_index(names=\"original_index\")\n",
    "    exploded_df[\"respond_time_llm\"] = exploded_df[\"respond_time_llm\"].explode(ignore_index=True)\n",
    "    exploded_df[\"prompts_per_iteration\"] = exploded_df[\"prompts_per_iteration\"].explode(ignore_index=True)\n",
    "    exploded_df[\"pmid_contexts_per_iteration\"] = exploded_df[\"pmid_contexts_per_iteration\"].explode(ignore_index=True)\n",
    "    exploded_df[\"pmid_changes_per_iteration\"] = exploded_df[\"pmid_changes_per_iteration\"].explode(ignore_index=True)\n",
    "\n",
    "    # Retain only the \"response\" field from \"respond_llm\"\n",
    "    exploded_df[\"respond_llm\"] = exploded_df[\"respond_llm\"].apply(lambda x: x[\"response\"] if isinstance(x, dict) and \"response\" in x else None)\n",
    "\n",
    "    # Step 3: Add iteration number\n",
    "    exploded_df[\"iteration\"] = exploded_df.groupby(\"original_index\").cumcount() + 1\n",
    "\n",
    "    # Step 4: Extract detailed information for each iteration's PMIDs\n",
    "    exploded_df[\"edge_modified\"] = exploded_df[\"pmid_changes_per_iteration\"].apply(lambda x: x[\"edge\"] if pd.notnull(x) else None)\n",
    "    exploded_df[\"pmid_dropped\"] = exploded_df[\"pmid_changes_per_iteration\"].apply(lambda x: x[\"dropped\"] if pd.notnull(x) else None)\n",
    "    exploded_df[\"pmid_added\"] = exploded_df[\"pmid_changes_per_iteration\"].apply(lambda x: x[\"added\"] if pd.notnull(x) else None)\n",
    "\n",
    "    # Step 5: Save the DataFrame if an output file is specified\n",
    "    if output_file:\n",
    "        if output_file.endswith(\".pkl\"):\n",
    "            exploded_df.to_pickle(output_file)\n",
    "        elif output_file.endswith(\".xlsx\"):\n",
    "            exploded_df.to_excel(output_file, index=False)\n",
    "        elif output_file.endswith(\".csv\"):\n",
    "            exploded_df.to_csv(output_file, index=False)\n",
    "        else:\n",
    "            raise ValueError(\"Unsupported file format. Use '.pkl', '.xlsx', or '.csv'.\")\n",
    "\n",
    "    return exploded_df\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 10,
   "id": "40927926-86e5-4bcd-adc2-6d3090ee0773",
   "metadata": {
    "execution": {
     "iopub.execute_input": "2025-01-20T20:20:19.682989Z",
     "iopub.status.busy": "2025-01-20T20:20:19.682417Z",
     "iopub.status.idle": "2025-01-20T20:20:19.753498Z",
     "shell.execute_reply": "2025-01-20T20:20:19.752737Z",
     "shell.execute_reply.started": "2025-01-20T20:20:19.682948Z"
    }
   },
   "outputs": [
    {
     "data": {
      "text/plain": [
       "72"
      ]
     },
     "execution_count": 10,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "exploded_res_df_mini_sample_3_pair_k_5_max_itr4_llama33_70B = extract_exploded_results_v3(res_df_mini_sample_3_pair_k_5_max_itr4_llama33_70B, output_file=\"exploded_results_exploded_res_df_proc_779_samp_k_5_max_itr_3.csv\")\n",
    "len(exploded_res_df_mini_sample_3_pair_k_5_max_itr4_llama33_70B)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 12,
   "id": "d0871735-0ff9-46d2-8930-0a2a83941bec",
   "metadata": {
    "execution": {
     "iopub.execute_input": "2025-01-20T20:21:09.364637Z",
     "iopub.status.busy": "2025-01-20T20:21:09.364163Z",
     "iopub.status.idle": "2025-01-20T20:21:09.372168Z",
     "shell.execute_reply": "2025-01-20T20:21:09.371168Z",
     "shell.execute_reply.started": "2025-01-20T20:21:09.364599Z"
    }
   },
   "outputs": [
    {
     "data": {
      "text/plain": [
       "Index(['original_index', 'pair', 'subj_name', 'obj_name', 'pmid', 'pmid_text',\n",
       "       'source', 'first_year', 'label', 'context_pmids', 'path',\n",
       "       'context_pmids_space_edge', 'sorted_context_pmids',\n",
       "       'final_context_pmids', 'respond_llm', 'respond_time_llm',\n",
       "       'prompts_per_iteration', 'pmid_contexts_per_iteration',\n",
       "       'pmid_changes_per_iteration', 'iteration', 'edge_modified',\n",
       "       'pmid_dropped', 'pmid_added'],\n",
       "      dtype='object')"
      ]
     },
     "execution_count": 12,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "exploded_res_df_mini_sample_3_pair_k_5_max_itr4_llama33_70B.columns"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 13,
   "id": "7ea1b2b9-0805-486e-bcee-73ba23440670",
   "metadata": {
    "execution": {
     "iopub.execute_input": "2025-01-20T20:23:04.053247Z",
     "iopub.status.busy": "2025-01-20T20:23:04.052736Z",
     "iopub.status.idle": "2025-01-20T20:23:04.111998Z",
     "shell.execute_reply": "2025-01-20T20:23:04.111307Z",
     "shell.execute_reply.started": "2025-01-20T20:23:04.053209Z"
    },
    "scrolled": true
   },
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>original_index</th>\n",
       "      <th>pair</th>\n",
       "      <th>subj_name</th>\n",
       "      <th>obj_name</th>\n",
       "      <th>pmid</th>\n",
       "      <th>pmid_text</th>\n",
       "      <th>source</th>\n",
       "      <th>first_year</th>\n",
       "      <th>label</th>\n",
       "      <th>context_pmids</th>\n",
       "      <th>...</th>\n",
       "      <th>final_context_pmids</th>\n",
       "      <th>respond_llm</th>\n",
       "      <th>respond_time_llm</th>\n",
       "      <th>prompts_per_iteration</th>\n",
       "      <th>pmid_contexts_per_iteration</th>\n",
       "      <th>pmid_changes_per_iteration</th>\n",
       "      <th>iteration</th>\n",
       "      <th>edge_modified</th>\n",
       "      <th>pmid_dropped</th>\n",
       "      <th>pmid_added</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>774</td>\n",
       "      <td>C0076080 C1530270</td>\n",
       "      <td>temozolomide</td>\n",
       "      <td>IRF1 protein, human</td>\n",
       "      <td>35274103</td>\n",
       "      <td>XAF1 directs glioma response to temozolomide t...</td>\n",
       "      <td>sr_pred_sent_7</td>\n",
       "      <td>2022</td>\n",
       "      <td>1</td>\n",
       "      <td>{('C0076080', 'C0069197'): ['19514084', '32901...</td>\n",
       "      <td>...</td>\n",
       "      <td>{('C0076080', 'C0069197'): ['19514084', '32901...</td>\n",
       "      <td>Based on the provided abstracts, an indirect r...</td>\n",
       "      <td>33.195027</td>\n",
       "      <td>Based on the following scientific abstracts, p...</td>\n",
       "      <td>{('C0076080', 'C0069197'): ['19514084', '32901...</td>\n",
       "      <td>{'edge': ('C0069197', 'C1530270'), 'dropped': ...</td>\n",
       "      <td>1</td>\n",
       "      <td>(C0069197, C1530270)</td>\n",
       "      <td>17102778</td>\n",
       "      <td>2418942</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>774</td>\n",
       "      <td>C0076080 C1530270</td>\n",
       "      <td>temozolomide</td>\n",
       "      <td>IRF1 protein, human</td>\n",
       "      <td>35274103</td>\n",
       "      <td>XAF1 directs glioma response to temozolomide t...</td>\n",
       "      <td>sr_pred_sent_7</td>\n",
       "      <td>2022</td>\n",
       "      <td>1</td>\n",
       "      <td>{('C0076080', 'C0069197'): ['19514084', '32901...</td>\n",
       "      <td>...</td>\n",
       "      <td>{('C0076080', 'C0069197'): ['19514084', '32901...</td>\n",
       "      <td>Based on the provided abstracts, an indirect r...</td>\n",
       "      <td>31.696313</td>\n",
       "      <td>Based on the following scientific abstracts, p...</td>\n",
       "      <td>{('C0076080', 'C0069197'): ['19514084', '32901...</td>\n",
       "      <td>{'edge': ('C0076080', 'C0069197'), 'dropped': ...</td>\n",
       "      <td>2</td>\n",
       "      <td>(C0076080, C0069197)</td>\n",
       "      <td>20706757</td>\n",
       "      <td>17097370</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>774</td>\n",
       "      <td>C0076080 C1530270</td>\n",
       "      <td>temozolomide</td>\n",
       "      <td>IRF1 protein, human</td>\n",
       "      <td>35274103</td>\n",
       "      <td>XAF1 directs glioma response to temozolomide t...</td>\n",
       "      <td>sr_pred_sent_7</td>\n",
       "      <td>2022</td>\n",
       "      <td>1</td>\n",
       "      <td>{('C0076080', 'C0069197'): ['19514084', '32901...</td>\n",
       "      <td>...</td>\n",
       "      <td>{('C0076080', 'C0069197'): ['19514084', '32901...</td>\n",
       "      <td>Based on the provided abstracts, an indirect r...</td>\n",
       "      <td>35.408087</td>\n",
       "      <td>Based on the following scientific abstracts, p...</td>\n",
       "      <td>{('C0076080', 'C0069197'): ['19514084', '32901...</td>\n",
       "      <td>{'edge': ('C0076080', 'C0069197'), 'dropped': ...</td>\n",
       "      <td>3</td>\n",
       "      <td>(C0076080, C0069197)</td>\n",
       "      <td>32901889</td>\n",
       "      <td>16222105</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>774</td>\n",
       "      <td>C0076080 C1530270</td>\n",
       "      <td>temozolomide</td>\n",
       "      <td>IRF1 protein, human</td>\n",
       "      <td>35274103</td>\n",
       "      <td>XAF1 directs glioma response to temozolomide t...</td>\n",
       "      <td>sr_pred_sent_7</td>\n",
       "      <td>2022</td>\n",
       "      <td>1</td>\n",
       "      <td>{('C0076080', 'C0069197'): ['19514084', '32901...</td>\n",
       "      <td>...</td>\n",
       "      <td>{('C0076080', 'C0069197'): ['19514084', '32901...</td>\n",
       "      <td>Based on the provided abstracts, an indirect r...</td>\n",
       "      <td>28.589508</td>\n",
       "      <td>Based on the following scientific abstracts, p...</td>\n",
       "      <td>{('C0076080', 'C0069197'): ['19514084', '43007...</td>\n",
       "      <td>{'edge': 'max_iteration', 'dropped': 'max_iter...</td>\n",
       "      <td>4</td>\n",
       "      <td>max_iteration</td>\n",
       "      <td>max_iteration</td>\n",
       "      <td>max_iteration</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>775</td>\n",
       "      <td>C0076080 C1530270</td>\n",
       "      <td>temozolomide</td>\n",
       "      <td>IRF1 protein, human</td>\n",
       "      <td>35274103</td>\n",
       "      <td>XAF1 directs glioma response to temozolomide t...</td>\n",
       "      <td>sr_pred_sent_7</td>\n",
       "      <td>2022</td>\n",
       "      <td>1</td>\n",
       "      <td>{('C0076080', 'C1337027'): ['31575897', '28122...</td>\n",
       "      <td>...</td>\n",
       "      <td>{('C0076080', 'C1337027'): ['31575897', '28122...</td>\n",
       "      <td>To describe an indirect relationship between t...</td>\n",
       "      <td>33.195027</td>\n",
       "      <td>Based on the following scientific abstracts, p...</td>\n",
       "      <td>{('C0076080', 'C0069197'): ['19514084', '32901...</td>\n",
       "      <td>{'edge': ('C0069197', 'C1530270'), 'dropped': ...</td>\n",
       "      <td>1</td>\n",
       "      <td>(C0069197, C1530270)</td>\n",
       "      <td>17102778</td>\n",
       "      <td>2418942</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>...</th>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>67</th>\n",
       "      <td>1588</td>\n",
       "      <td>C0002395 C1705607</td>\n",
       "      <td>F3 wt Allele</td>\n",
       "      <td>Alzheimer's Disease</td>\n",
       "      <td>35950105</td>\n",
       "      <td>Quality of dietary fat and risk of Alzheimer's...</td>\n",
       "      <td>sr_pred_sent_9</td>\n",
       "      <td>2022</td>\n",
       "      <td>0</td>\n",
       "      <td>{('C0002395', 'C1422519'): ['32706201', '25092...</td>\n",
       "      <td>...</td>\n",
       "      <td>{('C0002395', 'C1422519'): ['25092125', '31878...</td>\n",
       "      <td>Based on the provided scientific abstracts, an...</td>\n",
       "      <td>39.023563</td>\n",
       "      <td>Based on the following scientific abstracts, p...</td>\n",
       "      <td>{('C0076080', 'C1506592'): ['23243055', '33085...</td>\n",
       "      <td>{'edge': 'max_iteration', 'dropped': 'max_iter...</td>\n",
       "      <td>4</td>\n",
       "      <td>max_iteration</td>\n",
       "      <td>max_iteration</td>\n",
       "      <td>max_iteration</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>68</th>\n",
       "      <td>1589</td>\n",
       "      <td>C0002395 C1705607</td>\n",
       "      <td>F3 wt Allele</td>\n",
       "      <td>Alzheimer's Disease</td>\n",
       "      <td>35950105</td>\n",
       "      <td>Quality of dietary fat and risk of Alzheimer's...</td>\n",
       "      <td>sr_pred_sent_9</td>\n",
       "      <td>2022</td>\n",
       "      <td>0</td>\n",
       "      <td>{('C0002395', 'C0202236'): ['31765631', '19504...</td>\n",
       "      <td>...</td>\n",
       "      <td>{('C0002395', 'C0202236'): ['19504347', '31765...</td>\n",
       "      <td>To describe an indirect relationship between t...</td>\n",
       "      <td>39.195569</td>\n",
       "      <td>Based on the following scientific abstracts, p...</td>\n",
       "      <td>{('C0076080', 'C1506592'): ['23243055', '33085...</td>\n",
       "      <td>{'edge': ('C0076080', 'C1506592'), 'dropped': ...</td>\n",
       "      <td>1</td>\n",
       "      <td>(C0076080, C1506592)</td>\n",
       "      <td>26813683</td>\n",
       "      <td>19251725</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>69</th>\n",
       "      <td>1589</td>\n",
       "      <td>C0002395 C1705607</td>\n",
       "      <td>F3 wt Allele</td>\n",
       "      <td>Alzheimer's Disease</td>\n",
       "      <td>35950105</td>\n",
       "      <td>Quality of dietary fat and risk of Alzheimer's...</td>\n",
       "      <td>sr_pred_sent_9</td>\n",
       "      <td>2022</td>\n",
       "      <td>0</td>\n",
       "      <td>{('C0002395', 'C0202236'): ['31765631', '19504...</td>\n",
       "      <td>...</td>\n",
       "      <td>{('C0002395', 'C0202236'): ['19504347', '31765...</td>\n",
       "      <td>To describe an indirect relationship between t...</td>\n",
       "      <td>42.199348</td>\n",
       "      <td>Based on the following scientific abstracts, p...</td>\n",
       "      <td>{('C0076080', 'C1506592'): ['23243055', '33085...</td>\n",
       "      <td>{'edge': ('C2713871', 'C1530270'), 'dropped': ...</td>\n",
       "      <td>2</td>\n",
       "      <td>(C2713871, C1530270)</td>\n",
       "      <td>15642129</td>\n",
       "      <td>11007054</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>70</th>\n",
       "      <td>1589</td>\n",
       "      <td>C0002395 C1705607</td>\n",
       "      <td>F3 wt Allele</td>\n",
       "      <td>Alzheimer's Disease</td>\n",
       "      <td>35950105</td>\n",
       "      <td>Quality of dietary fat and risk of Alzheimer's...</td>\n",
       "      <td>sr_pred_sent_9</td>\n",
       "      <td>2022</td>\n",
       "      <td>0</td>\n",
       "      <td>{('C0002395', 'C0202236'): ['31765631', '19504...</td>\n",
       "      <td>...</td>\n",
       "      <td>{('C0002395', 'C0202236'): ['19504347', '31765...</td>\n",
       "      <td>Based on the provided scientific abstracts, an...</td>\n",
       "      <td>31.748512</td>\n",
       "      <td>Based on the following scientific abstracts, p...</td>\n",
       "      <td>{('C0076080', 'C1506592'): ['23243055', '33085...</td>\n",
       "      <td>{'edge': ('C0076080', 'C1506592'), 'dropped': ...</td>\n",
       "      <td>3</td>\n",
       "      <td>(C0076080, C1506592)</td>\n",
       "      <td>7364749</td>\n",
       "      <td>17152096</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>71</th>\n",
       "      <td>1589</td>\n",
       "      <td>C0002395 C1705607</td>\n",
       "      <td>F3 wt Allele</td>\n",
       "      <td>Alzheimer's Disease</td>\n",
       "      <td>35950105</td>\n",
       "      <td>Quality of dietary fat and risk of Alzheimer's...</td>\n",
       "      <td>sr_pred_sent_9</td>\n",
       "      <td>2022</td>\n",
       "      <td>0</td>\n",
       "      <td>{('C0002395', 'C0202236'): ['31765631', '19504...</td>\n",
       "      <td>...</td>\n",
       "      <td>{('C0002395', 'C0202236'): ['19504347', '31765...</td>\n",
       "      <td>To describe an indirect relationship between t...</td>\n",
       "      <td>39.023563</td>\n",
       "      <td>Based on the following scientific abstracts, p...</td>\n",
       "      <td>{('C0076080', 'C1506592'): ['23243055', '33085...</td>\n",
       "      <td>{'edge': 'max_iteration', 'dropped': 'max_iter...</td>\n",
       "      <td>4</td>\n",
       "      <td>max_iteration</td>\n",
       "      <td>max_iteration</td>\n",
       "      <td>max_iteration</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "<p>72 rows × 23 columns</p>\n",
       "</div>"
      ],
      "text/plain": [
       "    original_index               pair     subj_name             obj_name  \\\n",
       "0              774  C0076080 C1530270  temozolomide  IRF1 protein, human   \n",
       "1              774  C0076080 C1530270  temozolomide  IRF1 protein, human   \n",
       "2              774  C0076080 C1530270  temozolomide  IRF1 protein, human   \n",
       "3              774  C0076080 C1530270  temozolomide  IRF1 protein, human   \n",
       "4              775  C0076080 C1530270  temozolomide  IRF1 protein, human   \n",
       "..             ...                ...           ...                  ...   \n",
       "67            1588  C0002395 C1705607  F3 wt Allele  Alzheimer's Disease   \n",
       "68            1589  C0002395 C1705607  F3 wt Allele  Alzheimer's Disease   \n",
       "69            1589  C0002395 C1705607  F3 wt Allele  Alzheimer's Disease   \n",
       "70            1589  C0002395 C1705607  F3 wt Allele  Alzheimer's Disease   \n",
       "71            1589  C0002395 C1705607  F3 wt Allele  Alzheimer's Disease   \n",
       "\n",
       "        pmid                                          pmid_text  \\\n",
       "0   35274103  XAF1 directs glioma response to temozolomide t...   \n",
       "1   35274103  XAF1 directs glioma response to temozolomide t...   \n",
       "2   35274103  XAF1 directs glioma response to temozolomide t...   \n",
       "3   35274103  XAF1 directs glioma response to temozolomide t...   \n",
       "4   35274103  XAF1 directs glioma response to temozolomide t...   \n",
       "..       ...                                                ...   \n",
       "67  35950105  Quality of dietary fat and risk of Alzheimer's...   \n",
       "68  35950105  Quality of dietary fat and risk of Alzheimer's...   \n",
       "69  35950105  Quality of dietary fat and risk of Alzheimer's...   \n",
       "70  35950105  Quality of dietary fat and risk of Alzheimer's...   \n",
       "71  35950105  Quality of dietary fat and risk of Alzheimer's...   \n",
       "\n",
       "            source first_year  label  \\\n",
       "0   sr_pred_sent_7       2022      1   \n",
       "1   sr_pred_sent_7       2022      1   \n",
       "2   sr_pred_sent_7       2022      1   \n",
       "3   sr_pred_sent_7       2022      1   \n",
       "4   sr_pred_sent_7       2022      1   \n",
       "..             ...        ...    ...   \n",
       "67  sr_pred_sent_9       2022      0   \n",
       "68  sr_pred_sent_9       2022      0   \n",
       "69  sr_pred_sent_9       2022      0   \n",
       "70  sr_pred_sent_9       2022      0   \n",
       "71  sr_pred_sent_9       2022      0   \n",
       "\n",
       "                                        context_pmids  ...  \\\n",
       "0   {('C0076080', 'C0069197'): ['19514084', '32901...  ...   \n",
       "1   {('C0076080', 'C0069197'): ['19514084', '32901...  ...   \n",
       "2   {('C0076080', 'C0069197'): ['19514084', '32901...  ...   \n",
       "3   {('C0076080', 'C0069197'): ['19514084', '32901...  ...   \n",
       "4   {('C0076080', 'C1337027'): ['31575897', '28122...  ...   \n",
       "..                                                ...  ...   \n",
       "67  {('C0002395', 'C1422519'): ['32706201', '25092...  ...   \n",
       "68  {('C0002395', 'C0202236'): ['31765631', '19504...  ...   \n",
       "69  {('C0002395', 'C0202236'): ['31765631', '19504...  ...   \n",
       "70  {('C0002395', 'C0202236'): ['31765631', '19504...  ...   \n",
       "71  {('C0002395', 'C0202236'): ['31765631', '19504...  ...   \n",
       "\n",
       "                                  final_context_pmids  \\\n",
       "0   {('C0076080', 'C0069197'): ['19514084', '32901...   \n",
       "1   {('C0076080', 'C0069197'): ['19514084', '32901...   \n",
       "2   {('C0076080', 'C0069197'): ['19514084', '32901...   \n",
       "3   {('C0076080', 'C0069197'): ['19514084', '32901...   \n",
       "4   {('C0076080', 'C1337027'): ['31575897', '28122...   \n",
       "..                                                ...   \n",
       "67  {('C0002395', 'C1422519'): ['25092125', '31878...   \n",
       "68  {('C0002395', 'C0202236'): ['19504347', '31765...   \n",
       "69  {('C0002395', 'C0202236'): ['19504347', '31765...   \n",
       "70  {('C0002395', 'C0202236'): ['19504347', '31765...   \n",
       "71  {('C0002395', 'C0202236'): ['19504347', '31765...   \n",
       "\n",
       "                                          respond_llm respond_time_llm  \\\n",
       "0   Based on the provided abstracts, an indirect r...        33.195027   \n",
       "1   Based on the provided abstracts, an indirect r...        31.696313   \n",
       "2   Based on the provided abstracts, an indirect r...        35.408087   \n",
       "3   Based on the provided abstracts, an indirect r...        28.589508   \n",
       "4   To describe an indirect relationship between t...        33.195027   \n",
       "..                                                ...              ...   \n",
       "67  Based on the provided scientific abstracts, an...        39.023563   \n",
       "68  To describe an indirect relationship between t...        39.195569   \n",
       "69  To describe an indirect relationship between t...        42.199348   \n",
       "70  Based on the provided scientific abstracts, an...        31.748512   \n",
       "71  To describe an indirect relationship between t...        39.023563   \n",
       "\n",
       "                                prompts_per_iteration  \\\n",
       "0   Based on the following scientific abstracts, p...   \n",
       "1   Based on the following scientific abstracts, p...   \n",
       "2   Based on the following scientific abstracts, p...   \n",
       "3   Based on the following scientific abstracts, p...   \n",
       "4   Based on the following scientific abstracts, p...   \n",
       "..                                                ...   \n",
       "67  Based on the following scientific abstracts, p...   \n",
       "68  Based on the following scientific abstracts, p...   \n",
       "69  Based on the following scientific abstracts, p...   \n",
       "70  Based on the following scientific abstracts, p...   \n",
       "71  Based on the following scientific abstracts, p...   \n",
       "\n",
       "                          pmid_contexts_per_iteration  \\\n",
       "0   {('C0076080', 'C0069197'): ['19514084', '32901...   \n",
       "1   {('C0076080', 'C0069197'): ['19514084', '32901...   \n",
       "2   {('C0076080', 'C0069197'): ['19514084', '32901...   \n",
       "3   {('C0076080', 'C0069197'): ['19514084', '43007...   \n",
       "4   {('C0076080', 'C0069197'): ['19514084', '32901...   \n",
       "..                                                ...   \n",
       "67  {('C0076080', 'C1506592'): ['23243055', '33085...   \n",
       "68  {('C0076080', 'C1506592'): ['23243055', '33085...   \n",
       "69  {('C0076080', 'C1506592'): ['23243055', '33085...   \n",
       "70  {('C0076080', 'C1506592'): ['23243055', '33085...   \n",
       "71  {('C0076080', 'C1506592'): ['23243055', '33085...   \n",
       "\n",
       "                           pmid_changes_per_iteration iteration  \\\n",
       "0   {'edge': ('C0069197', 'C1530270'), 'dropped': ...         1   \n",
       "1   {'edge': ('C0076080', 'C0069197'), 'dropped': ...         2   \n",
       "2   {'edge': ('C0076080', 'C0069197'), 'dropped': ...         3   \n",
       "3   {'edge': 'max_iteration', 'dropped': 'max_iter...         4   \n",
       "4   {'edge': ('C0069197', 'C1530270'), 'dropped': ...         1   \n",
       "..                                                ...       ...   \n",
       "67  {'edge': 'max_iteration', 'dropped': 'max_iter...         4   \n",
       "68  {'edge': ('C0076080', 'C1506592'), 'dropped': ...         1   \n",
       "69  {'edge': ('C2713871', 'C1530270'), 'dropped': ...         2   \n",
       "70  {'edge': ('C0076080', 'C1506592'), 'dropped': ...         3   \n",
       "71  {'edge': 'max_iteration', 'dropped': 'max_iter...         4   \n",
       "\n",
       "           edge_modified   pmid_dropped     pmid_added  \n",
       "0   (C0069197, C1530270)       17102778        2418942  \n",
       "1   (C0076080, C0069197)       20706757       17097370  \n",
       "2   (C0076080, C0069197)       32901889       16222105  \n",
       "3          max_iteration  max_iteration  max_iteration  \n",
       "4   (C0069197, C1530270)       17102778        2418942  \n",
       "..                   ...            ...            ...  \n",
       "67         max_iteration  max_iteration  max_iteration  \n",
       "68  (C0076080, C1506592)       26813683       19251725  \n",
       "69  (C2713871, C1530270)       15642129       11007054  \n",
       "70  (C0076080, C1506592)        7364749       17152096  \n",
       "71         max_iteration  max_iteration  max_iteration  \n",
       "\n",
       "[72 rows x 23 columns]"
      ]
     },
     "execution_count": 13,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "exploded_res_df_mini_sample_3_pair_k_5_max_itr4_llama33_70B"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 27,
   "id": "567924ea-fa03-406e-b228-88d0fcfe59aa",
   "metadata": {
    "execution": {
     "iopub.execute_input": "2025-01-20T20:45:23.321329Z",
     "iopub.status.busy": "2025-01-20T20:45:23.320422Z",
     "iopub.status.idle": "2025-01-20T20:45:23.344268Z",
     "shell.execute_reply": "2025-01-20T20:45:23.343548Z",
     "shell.execute_reply.started": "2025-01-20T20:45:23.321286Z"
    }
   },
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>final_context_pmids</th>\n",
       "      <th>respond_llm</th>\n",
       "      <th>pmid_contexts_per_iteration</th>\n",
       "      <th>pmid_changes_per_iteration</th>\n",
       "      <th>edge_modified</th>\n",
       "      <th>pmid_dropped</th>\n",
       "      <th>pmid_added</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>{('C0076080', 'C0069197'): ['19514084', '32901889', '20706757', '4300795', '21066565', '17097370', '16222105', '25928166', '9473363', '34100706', '24640399', '15358884', '34352381', '25939521', '33787276', '1783274', '35739713', '34553478', '33805730', '17981249', '3963214', '18850102', '3008899', '33564284', '14369208', '7624262', '6773721'], ('C0069197', 'C1530270'): ['16520149', '34932098', '33992628', '17102778', '7199054', '2418942', '14596898', '2683289', '2888564', '1591363', '6481535', '35604826', '2332516', '2480183', '34621426', '33511939', '34763534', '34759615', '7510792', '16599639', '2411414', '3471909']}</td>\n",
       "      <td>Based on the provided abstracts, an indirect relationship between temozolomide and IRF1 protein, human, can be proposed as follows:\\n\\n1. **Temozolomide's mechanism of action**: Temozolomide is a DNA alkylating agent that works by damaging the DNA of cancer cells, thereby inhibiting their growth and proliferation. The effectiveness of temozolomide is influenced by the activity of the O6-methylguanine-DNA methyltransferase (MGMT) enzyme, which can repair the DNA damage caused by temozolomide.\\n\\n2. **MGMT and IRF1 connection**: The abstract \"Methionine-stress: a pleiotropic approach in enhancing the efficacy of chemotherapy\" mentions that methionine stress can inhibit the growth of brain tumor xenografts and enhance the efficacy of DNA alkylating chemotherapeutic agents, including temozolomide. This is associated with the downregulation of MGMT expression. Additionally, methionine stress upregulates IRF-1, a transcription factor involved in cell cycle regulation, apoptosis, and immune responses.\\n\\n3. **IRF1's role in cell cycle regulation and apoptosis**: IRF1 is known to regulate the expression of genes involved in cell cycle arrest, apoptosis, and DNA repair. Its upregulation can lead to the inhibition of cell cycle progression and the induction of apoptosis in cancer cells.\\n\\n4. **Temozolomide's effect on IRF1**: Although there is no direct mention of temozolomide's effect on IRF1 in the provided abstracts, it can be inferred that temozolomide's ability to induce DNA damage and activate cell cycle checkpoints may lead to the upregulation of IRF1. This is because IRF1 is involved in the regulation of cell cycle and apoptosis in response to DNA damage.\\n\\n5. **Indirect relationship between temozolomide and IRF1**: Based on the above points, an indirect relationship between temozolomide and IRF1 can be proposed. Temozolomide's DNA damaging effects can lead to the upregulation of IRF1, either directly or through the activation of cell cycle checkpoints and DNA repair mechanisms. The upregulation of IRF1 can, in turn, contribute to the inhibition of cancer cell growth and proliferation, enhancing the efficacy of temozolomide.\\n\\nIn summary, the indirect relationship between temozolomide and IRF1 protein, human, involves the following steps:\\n\\nTemozolomide → DNA damage → Cell cycle checkpoint activation → IRF1 upregulation → Inhibition of cancer cell growth and proliferation\\n\\nThis proposed relationship highlights the potential for IRF1 to play a role in the mechanism of action of temozolomide, and further research is needed to fully elucidate this connection.</td>\n",
       "      <td>{('C0076080', 'C0069197'): ['19514084', '32901889', '20706757', '4300795', '21066565'], ('C0069197', 'C1530270'): ['16520149', '34932098', '33992628', '17102778', '7199054']}</td>\n",
       "      <td>{'edge': ('C0069197', 'C1530270'), 'dropped': '17102778', 'added': '2418942'}</td>\n",
       "      <td>(C0069197, C1530270)</td>\n",
       "      <td>17102778</td>\n",
       "      <td>2418942</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>{('C0076080', 'C0069197'): ['19514084', '32901889', '20706757', '4300795', '21066565', '17097370', '16222105', '25928166', '9473363', '34100706', '24640399', '15358884', '34352381', '25939521', '33787276', '1783274', '35739713', '34553478', '33805730', '17981249', '3963214', '18850102', '3008899', '33564284', '14369208', '7624262', '6773721'], ('C0069197', 'C1530270'): ['16520149', '34932098', '33992628', '17102778', '7199054', '2418942', '14596898', '2683289', '2888564', '1591363', '6481535', '35604826', '2332516', '2480183', '34621426', '33511939', '34763534', '34759615', '7510792', '16599639', '2411414', '3471909']}</td>\n",
       "      <td>Based on the provided abstracts, an indirect relationship between temozolomide and IRF1 protein, human, can be proposed as follows:\\n\\n1. **Temozolomide's mechanism of action**: Temozolomide is a DNA alkylating agent that works by damaging the DNA of cancer cells, thereby inhibiting their growth and proliferation. The effectiveness of temozolomide is influenced by the activity of the O6-methylguanine-DNA methyltransferase (MGMT) enzyme, which can repair the DNA damage caused by temozolomide.\\n\\n2. **MGMT and IRF1 connection**: The abstract \"Methionine-stress: a pleiotropic approach in enhancing the efficacy of chemotherapy\" mentions that methionine stress can inhibit the growth of brain tumor xenografts and enhance the efficacy of DNA alkylating chemotherapeutic agents, including temozolomide. This is associated with the upregulation of IRF-1 (Interferon Regulatory Factor 1) among other factors. IRF-1 is a transcription factor involved in the regulation of various cellular processes, including cell growth, differentiation, and apoptosis.\\n\\n3. **Indirect relationship**: While there is no direct mention of temozolomide inducing IRF1 expression, the connection between temozolomide's mechanism of action and IRF1 can be inferred through the MGMT enzyme. Temozolomide's effectiveness is reduced by MGMT activity. Methionine stress, which can be induced by dietary restriction and administration of methioninase, inhibits MGMT expression and enhances temozolomide's efficacy. This methionine stress also upregulates IRF-1, suggesting that the conditions under which temozolomide is more effective (i.e., low MGMT activity) are also conditions under which IRF-1 is upregulated.\\n\\n4. **Potential intermediate processes**: The upregulation of IRF-1 in response to methionine stress and its association with enhanced efficacy of temozolomide suggests that IRF-1 could play a role in sensitizing cancer cells to temozolomide. This could occur through various intermediate processes, such as modulation of cell cycle checkpoints, induction of apoptosis, or alteration of DNA repair mechanisms, which are all influenced by IRF-1.\\n\\nIn summary, the indirect relationship between temozolomide and IRF1 protein, human, is proposed through the common pathway of MGMT modulation and the effects of methionine stress on both temozolomide efficacy and IRF-1 expression. This relationship suggests that conditions or interventions that upregulate IRF-1 could potentially enhance the effectiveness of temozolomide in cancer treatment.</td>\n",
       "      <td>{('C0076080', 'C0069197'): ['19514084', '32901889', '20706757', '4300795', '21066565'], ('C0069197', 'C1530270'): ['16520149', '34932098', '33992628', '7199054', '2418942']}</td>\n",
       "      <td>{'edge': ('C0076080', 'C0069197'), 'dropped': '20706757', 'added': '17097370'}</td>\n",
       "      <td>(C0076080, C0069197)</td>\n",
       "      <td>20706757</td>\n",
       "      <td>17097370</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>{('C0076080', 'C0069197'): ['19514084', '32901889', '20706757', '4300795', '21066565', '17097370', '16222105', '25928166', '9473363', '34100706', '24640399', '15358884', '34352381', '25939521', '33787276', '1783274', '35739713', '34553478', '33805730', '17981249', '3963214', '18850102', '3008899', '33564284', '14369208', '7624262', '6773721'], ('C0069197', 'C1530270'): ['16520149', '34932098', '33992628', '17102778', '7199054', '2418942', '14596898', '2683289', '2888564', '1591363', '6481535', '35604826', '2332516', '2480183', '34621426', '33511939', '34763534', '34759615', '7510792', '16599639', '2411414', '3471909']}</td>\n",
       "      <td>Based on the provided abstracts, an indirect relationship between temozolomide and IRF1 protein, human, can be proposed through the following mechanism:\\n\\n1. **Temozolomide's mechanism of action**: Temozolomide is a DNA alkylating agent that induces cytotoxicity in cancer cells by forming O6-methylguanine adducts in DNA. The repair of these adducts is mediated by the enzyme O6-methylguanine-DNA methyltransferase (MGMT).\\n2. **MGMT promoter methylation status**: The abstract \"Temozolomide concomitant and adjuvant to radiotherapy in elderly patients with glioblastoma: correlation with MGMT promoter methylation status\" suggests that the MGMT promoter methylation status is a predictive biomarker for the response to temozolomide treatment. Patients with methylated MGMT promoters tend to have better outcomes with temozolomide treatment.\\n3. **Methionine stress and IRF1 upregulation**: The abstract \"Methionine-stress: a pleiotropic approach in enhancing the efficacy of chemotherapy\" describes a treatment strategy that involves reducing methionine levels to induce stress in cancer cells. This stress leads to the upregulation of various genes, including IRF1, which is involved in cell cycle regulation, apoptosis, and immune responses.\\n4. **IRF1's role in cancer cell response to temozolomide**: Although not directly mentioned in the abstracts, IRF1 has been implicated in the regulation of cell cycle and apoptosis in response to DNA damage. It is possible that IRF1 upregulation in response to methionine stress could enhance the sensitivity of cancer cells to temozolomide-induced DNA damage.\\n5. **PARP-1 inhibition and temozolomide synergy**: The abstract \"PARP-1 inhibition sensitizes temozolomide-treated glioblastoma cell lines and decreases drug resistance independent of MGMT activity and PTEN proficiency\" suggests that PARP-1 inhibition can enhance the efficacy of temozolomide treatment by inducing synthetic lethality in cancer cells. This synergy could be related to the upregulation of IRF1, as PARP-1 inhibition has been shown to regulate IRF1 expression in other contexts.\\n\\nIn summary, the indirect relationship between temozolomide and IRF1 protein, human, can be proposed as follows:\\n\\nTemozolomide treatment → MGMT promoter methylation status → Methionine stress → IRF1 upregulation → Enhanced sensitivity to temozolomide-induced DNA damage → Synergy with PARP-1 inhibition → Increased efficacy of temozolomide treatment\\n\\nThis proposed mechanism highlights the potential for IRF1 to play a role in the response of cancer cells to temozolomide treatment, particularly in the context of methionine stress and PARP-1 inhibition. However, further research is needed to fully elucidate the relationships between these entities and to explore the therapeutic potential of targeting IRF1 in combination with temozolomide treatment.</td>\n",
       "      <td>{('C0076080', 'C0069197'): ['19514084', '32901889', '4300795', '21066565', '17097370'], ('C0069197', 'C1530270'): ['16520149', '34932098', '33992628', '7199054', '2418942']}</td>\n",
       "      <td>{'edge': ('C0076080', 'C0069197'), 'dropped': '32901889', 'added': '16222105'}</td>\n",
       "      <td>(C0076080, C0069197)</td>\n",
       "      <td>32901889</td>\n",
       "      <td>16222105</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>{('C0076080', 'C0069197'): ['19514084', '32901889', '20706757', '4300795', '21066565', '17097370', '16222105', '25928166', '9473363', '34100706', '24640399', '15358884', '34352381', '25939521', '33787276', '1783274', '35739713', '34553478', '33805730', '17981249', '3963214', '18850102', '3008899', '33564284', '14369208', '7624262', '6773721'], ('C0069197', 'C1530270'): ['16520149', '34932098', '33992628', '17102778', '7199054', '2418942', '14596898', '2683289', '2888564', '1591363', '6481535', '35604826', '2332516', '2480183', '34621426', '33511939', '34763534', '34759615', '7510792', '16599639', '2411414', '3471909']}</td>\n",
       "      <td>Based on the provided abstracts, an indirect relationship between temozolomide and IRF1 protein, human, can be proposed through the following mechanism:\\n\\n1. **Temozolomide's mechanism of action**: Temozolomide is a DNA alkylating agent that works by damaging the DNA of cancer cells, thereby inhibiting their growth and proliferation. As mentioned in the first abstract, temozolomide is used in combination with radiotherapy to treat glioblastoma.\\n\\n2. **MGMT promoter methylation status**: The effectiveness of temozolomide is influenced by the O6-methylguanine-DNA methyltransferase (MGMT) promoter methylation status. Patients with methylated MGMT promoters tend to respond better to temozolomide treatment, as seen in the first abstract.\\n\\n3. **Methionine stress and IRF1 upregulation**: The fifth abstract discusses the concept of methionine stress, which involves reducing plasma methionine levels to inhibit the growth of malignant cells. This treatment approach leads to the upregulation of IRF1, among other genes, and enhances the efficacy of DNA alkylating chemotherapeutic agents like temozolomide.\\n\\n4. **IRF1's role in cell cycle regulation and apoptosis**: IRF1 is a transcription factor involved in regulating cell cycle progression and apoptosis. Its upregulation in response to methionine stress can contribute to the inhibition of cell cycle progression and the induction of apoptosis in cancer cells.\\n\\nBy connecting these elements, it can be proposed that temozolomide treatment may indirectly influence IRF1 protein expression through the following pathway:\\n\\n- Temozolomide treatment leads to DNA damage and the activation of cellular stress responses.\\n- The stress response may involve the downregulation of methionine metabolism, leading to a state of methionine stress.\\n- Methionine stress, in turn, upregulates IRF1 expression, which contributes to the inhibition of cell cycle progression and the induction of apoptosis in cancer cells.\\n- The upregulation of IRF1 may also enhance the efficacy of temozolomide treatment by increasing the sensitivity of cancer cells to DNA damage.\\n\\nThis proposed indirect relationship between temozolomide and IRF1 protein highlights the complex interplay between cellular stress responses, methionine metabolism, and the regulation of transcription factors involved in cell cycle control and apoptosis. Further research is needed to fully elucidate the mechanisms underlying this relationship and its potential implications for cancer therapy.</td>\n",
       "      <td>{('C0076080', 'C0069197'): ['19514084', '4300795', '21066565', '17097370', '16222105'], ('C0069197', 'C1530270'): ['16520149', '34932098', '33992628', '7199054', '2418942']}</td>\n",
       "      <td>{'edge': 'max_iteration', 'dropped': 'max_iteration', 'added': 'max_iteration'}</td>\n",
       "      <td>max_iteration</td>\n",
       "      <td>max_iteration</td>\n",
       "      <td>max_iteration</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  final_context_pmids  \\\n",
       "0  {('C0076080', 'C0069197'): ['19514084', '32901889', '20706757', '4300795', '21066565', '17097370', '16222105', '25928166', '9473363', '34100706', '24640399', '15358884', '34352381', '25939521', '33787276', '1783274', '35739713', '34553478', '33805730', '17981249', '3963214', '18850102', '3008899', '33564284', '14369208', '7624262', '6773721'], ('C0069197', 'C1530270'): ['16520149', '34932098', '33992628', '17102778', '7199054', '2418942', '14596898', '2683289', '2888564', '1591363', '6481535', '35604826', '2332516', '2480183', '34621426', '33511939', '34763534', '34759615', '7510792', '16599639', '2411414', '3471909']}   \n",
       "1  {('C0076080', 'C0069197'): ['19514084', '32901889', '20706757', '4300795', '21066565', '17097370', '16222105', '25928166', '9473363', '34100706', '24640399', '15358884', '34352381', '25939521', '33787276', '1783274', '35739713', '34553478', '33805730', '17981249', '3963214', '18850102', '3008899', '33564284', '14369208', '7624262', '6773721'], ('C0069197', 'C1530270'): ['16520149', '34932098', '33992628', '17102778', '7199054', '2418942', '14596898', '2683289', '2888564', '1591363', '6481535', '35604826', '2332516', '2480183', '34621426', '33511939', '34763534', '34759615', '7510792', '16599639', '2411414', '3471909']}   \n",
       "2  {('C0076080', 'C0069197'): ['19514084', '32901889', '20706757', '4300795', '21066565', '17097370', '16222105', '25928166', '9473363', '34100706', '24640399', '15358884', '34352381', '25939521', '33787276', '1783274', '35739713', '34553478', '33805730', '17981249', '3963214', '18850102', '3008899', '33564284', '14369208', '7624262', '6773721'], ('C0069197', 'C1530270'): ['16520149', '34932098', '33992628', '17102778', '7199054', '2418942', '14596898', '2683289', '2888564', '1591363', '6481535', '35604826', '2332516', '2480183', '34621426', '33511939', '34763534', '34759615', '7510792', '16599639', '2411414', '3471909']}   \n",
       "3  {('C0076080', 'C0069197'): ['19514084', '32901889', '20706757', '4300795', '21066565', '17097370', '16222105', '25928166', '9473363', '34100706', '24640399', '15358884', '34352381', '25939521', '33787276', '1783274', '35739713', '34553478', '33805730', '17981249', '3963214', '18850102', '3008899', '33564284', '14369208', '7624262', '6773721'], ('C0069197', 'C1530270'): ['16520149', '34932098', '33992628', '17102778', '7199054', '2418942', '14596898', '2683289', '2888564', '1591363', '6481535', '35604826', '2332516', '2480183', '34621426', '33511939', '34763534', '34759615', '7510792', '16599639', '2411414', '3471909']}   \n",
       "\n",
       "                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       respond_llm  \\\n",
       "0                                                                                                                                                                                                                                                                   Based on the provided abstracts, an indirect relationship between temozolomide and IRF1 protein, human, can be proposed as follows:\\n\\n1. **Temozolomide's mechanism of action**: Temozolomide is a DNA alkylating agent that works by damaging the DNA of cancer cells, thereby inhibiting their growth and proliferation. The effectiveness of temozolomide is influenced by the activity of the O6-methylguanine-DNA methyltransferase (MGMT) enzyme, which can repair the DNA damage caused by temozolomide.\\n\\n2. **MGMT and IRF1 connection**: The abstract \"Methionine-stress: a pleiotropic approach in enhancing the efficacy of chemotherapy\" mentions that methionine stress can inhibit the growth of brain tumor xenografts and enhance the efficacy of DNA alkylating chemotherapeutic agents, including temozolomide. This is associated with the downregulation of MGMT expression. Additionally, methionine stress upregulates IRF-1, a transcription factor involved in cell cycle regulation, apoptosis, and immune responses.\\n\\n3. **IRF1's role in cell cycle regulation and apoptosis**: IRF1 is known to regulate the expression of genes involved in cell cycle arrest, apoptosis, and DNA repair. Its upregulation can lead to the inhibition of cell cycle progression and the induction of apoptosis in cancer cells.\\n\\n4. **Temozolomide's effect on IRF1**: Although there is no direct mention of temozolomide's effect on IRF1 in the provided abstracts, it can be inferred that temozolomide's ability to induce DNA damage and activate cell cycle checkpoints may lead to the upregulation of IRF1. This is because IRF1 is involved in the regulation of cell cycle and apoptosis in response to DNA damage.\\n\\n5. **Indirect relationship between temozolomide and IRF1**: Based on the above points, an indirect relationship between temozolomide and IRF1 can be proposed. Temozolomide's DNA damaging effects can lead to the upregulation of IRF1, either directly or through the activation of cell cycle checkpoints and DNA repair mechanisms. The upregulation of IRF1 can, in turn, contribute to the inhibition of cancer cell growth and proliferation, enhancing the efficacy of temozolomide.\\n\\nIn summary, the indirect relationship between temozolomide and IRF1 protein, human, involves the following steps:\\n\\nTemozolomide → DNA damage → Cell cycle checkpoint activation → IRF1 upregulation → Inhibition of cancer cell growth and proliferation\\n\\nThis proposed relationship highlights the potential for IRF1 to play a role in the mechanism of action of temozolomide, and further research is needed to fully elucidate this connection.   \n",
       "1                                                                                                                                                                                                                                                                                                                                           Based on the provided abstracts, an indirect relationship between temozolomide and IRF1 protein, human, can be proposed as follows:\\n\\n1. **Temozolomide's mechanism of action**: Temozolomide is a DNA alkylating agent that works by damaging the DNA of cancer cells, thereby inhibiting their growth and proliferation. The effectiveness of temozolomide is influenced by the activity of the O6-methylguanine-DNA methyltransferase (MGMT) enzyme, which can repair the DNA damage caused by temozolomide.\\n\\n2. **MGMT and IRF1 connection**: The abstract \"Methionine-stress: a pleiotropic approach in enhancing the efficacy of chemotherapy\" mentions that methionine stress can inhibit the growth of brain tumor xenografts and enhance the efficacy of DNA alkylating chemotherapeutic agents, including temozolomide. This is associated with the upregulation of IRF-1 (Interferon Regulatory Factor 1) among other factors. IRF-1 is a transcription factor involved in the regulation of various cellular processes, including cell growth, differentiation, and apoptosis.\\n\\n3. **Indirect relationship**: While there is no direct mention of temozolomide inducing IRF1 expression, the connection between temozolomide's mechanism of action and IRF1 can be inferred through the MGMT enzyme. Temozolomide's effectiveness is reduced by MGMT activity. Methionine stress, which can be induced by dietary restriction and administration of methioninase, inhibits MGMT expression and enhances temozolomide's efficacy. This methionine stress also upregulates IRF-1, suggesting that the conditions under which temozolomide is more effective (i.e., low MGMT activity) are also conditions under which IRF-1 is upregulated.\\n\\n4. **Potential intermediate processes**: The upregulation of IRF-1 in response to methionine stress and its association with enhanced efficacy of temozolomide suggests that IRF-1 could play a role in sensitizing cancer cells to temozolomide. This could occur through various intermediate processes, such as modulation of cell cycle checkpoints, induction of apoptosis, or alteration of DNA repair mechanisms, which are all influenced by IRF-1.\\n\\nIn summary, the indirect relationship between temozolomide and IRF1 protein, human, is proposed through the common pathway of MGMT modulation and the effects of methionine stress on both temozolomide efficacy and IRF-1 expression. This relationship suggests that conditions or interventions that upregulate IRF-1 could potentially enhance the effectiveness of temozolomide in cancer treatment.   \n",
       "2  Based on the provided abstracts, an indirect relationship between temozolomide and IRF1 protein, human, can be proposed through the following mechanism:\\n\\n1. **Temozolomide's mechanism of action**: Temozolomide is a DNA alkylating agent that induces cytotoxicity in cancer cells by forming O6-methylguanine adducts in DNA. The repair of these adducts is mediated by the enzyme O6-methylguanine-DNA methyltransferase (MGMT).\\n2. **MGMT promoter methylation status**: The abstract \"Temozolomide concomitant and adjuvant to radiotherapy in elderly patients with glioblastoma: correlation with MGMT promoter methylation status\" suggests that the MGMT promoter methylation status is a predictive biomarker for the response to temozolomide treatment. Patients with methylated MGMT promoters tend to have better outcomes with temozolomide treatment.\\n3. **Methionine stress and IRF1 upregulation**: The abstract \"Methionine-stress: a pleiotropic approach in enhancing the efficacy of chemotherapy\" describes a treatment strategy that involves reducing methionine levels to induce stress in cancer cells. This stress leads to the upregulation of various genes, including IRF1, which is involved in cell cycle regulation, apoptosis, and immune responses.\\n4. **IRF1's role in cancer cell response to temozolomide**: Although not directly mentioned in the abstracts, IRF1 has been implicated in the regulation of cell cycle and apoptosis in response to DNA damage. It is possible that IRF1 upregulation in response to methionine stress could enhance the sensitivity of cancer cells to temozolomide-induced DNA damage.\\n5. **PARP-1 inhibition and temozolomide synergy**: The abstract \"PARP-1 inhibition sensitizes temozolomide-treated glioblastoma cell lines and decreases drug resistance independent of MGMT activity and PTEN proficiency\" suggests that PARP-1 inhibition can enhance the efficacy of temozolomide treatment by inducing synthetic lethality in cancer cells. This synergy could be related to the upregulation of IRF1, as PARP-1 inhibition has been shown to regulate IRF1 expression in other contexts.\\n\\nIn summary, the indirect relationship between temozolomide and IRF1 protein, human, can be proposed as follows:\\n\\nTemozolomide treatment → MGMT promoter methylation status → Methionine stress → IRF1 upregulation → Enhanced sensitivity to temozolomide-induced DNA damage → Synergy with PARP-1 inhibition → Increased efficacy of temozolomide treatment\\n\\nThis proposed mechanism highlights the potential for IRF1 to play a role in the response of cancer cells to temozolomide treatment, particularly in the context of methionine stress and PARP-1 inhibition. However, further research is needed to fully elucidate the relationships between these entities and to explore the therapeutic potential of targeting IRF1 in combination with temozolomide treatment.   \n",
       "3                                                                                                                                                                                                                                                                                                                                                            Based on the provided abstracts, an indirect relationship between temozolomide and IRF1 protein, human, can be proposed through the following mechanism:\\n\\n1. **Temozolomide's mechanism of action**: Temozolomide is a DNA alkylating agent that works by damaging the DNA of cancer cells, thereby inhibiting their growth and proliferation. As mentioned in the first abstract, temozolomide is used in combination with radiotherapy to treat glioblastoma.\\n\\n2. **MGMT promoter methylation status**: The effectiveness of temozolomide is influenced by the O6-methylguanine-DNA methyltransferase (MGMT) promoter methylation status. Patients with methylated MGMT promoters tend to respond better to temozolomide treatment, as seen in the first abstract.\\n\\n3. **Methionine stress and IRF1 upregulation**: The fifth abstract discusses the concept of methionine stress, which involves reducing plasma methionine levels to inhibit the growth of malignant cells. This treatment approach leads to the upregulation of IRF1, among other genes, and enhances the efficacy of DNA alkylating chemotherapeutic agents like temozolomide.\\n\\n4. **IRF1's role in cell cycle regulation and apoptosis**: IRF1 is a transcription factor involved in regulating cell cycle progression and apoptosis. Its upregulation in response to methionine stress can contribute to the inhibition of cell cycle progression and the induction of apoptosis in cancer cells.\\n\\nBy connecting these elements, it can be proposed that temozolomide treatment may indirectly influence IRF1 protein expression through the following pathway:\\n\\n- Temozolomide treatment leads to DNA damage and the activation of cellular stress responses.\\n- The stress response may involve the downregulation of methionine metabolism, leading to a state of methionine stress.\\n- Methionine stress, in turn, upregulates IRF1 expression, which contributes to the inhibition of cell cycle progression and the induction of apoptosis in cancer cells.\\n- The upregulation of IRF1 may also enhance the efficacy of temozolomide treatment by increasing the sensitivity of cancer cells to DNA damage.\\n\\nThis proposed indirect relationship between temozolomide and IRF1 protein highlights the complex interplay between cellular stress responses, methionine metabolism, and the regulation of transcription factors involved in cell cycle control and apoptosis. Further research is needed to fully elucidate the mechanisms underlying this relationship and its potential implications for cancer therapy.   \n",
       "\n",
       "                                                                                                                                                      pmid_contexts_per_iteration  \\\n",
       "0  {('C0076080', 'C0069197'): ['19514084', '32901889', '20706757', '4300795', '21066565'], ('C0069197', 'C1530270'): ['16520149', '34932098', '33992628', '17102778', '7199054']}   \n",
       "1   {('C0076080', 'C0069197'): ['19514084', '32901889', '20706757', '4300795', '21066565'], ('C0069197', 'C1530270'): ['16520149', '34932098', '33992628', '7199054', '2418942']}   \n",
       "2   {('C0076080', 'C0069197'): ['19514084', '32901889', '4300795', '21066565', '17097370'], ('C0069197', 'C1530270'): ['16520149', '34932098', '33992628', '7199054', '2418942']}   \n",
       "3   {('C0076080', 'C0069197'): ['19514084', '4300795', '21066565', '17097370', '16222105'], ('C0069197', 'C1530270'): ['16520149', '34932098', '33992628', '7199054', '2418942']}   \n",
       "\n",
       "                                                        pmid_changes_per_iteration  \\\n",
       "0    {'edge': ('C0069197', 'C1530270'), 'dropped': '17102778', 'added': '2418942'}   \n",
       "1   {'edge': ('C0076080', 'C0069197'), 'dropped': '20706757', 'added': '17097370'}   \n",
       "2   {'edge': ('C0076080', 'C0069197'), 'dropped': '32901889', 'added': '16222105'}   \n",
       "3  {'edge': 'max_iteration', 'dropped': 'max_iteration', 'added': 'max_iteration'}   \n",
       "\n",
       "          edge_modified   pmid_dropped     pmid_added  \n",
       "0  (C0069197, C1530270)       17102778        2418942  \n",
       "1  (C0076080, C0069197)       20706757       17097370  \n",
       "2  (C0076080, C0069197)       32901889       16222105  \n",
       "3         max_iteration  max_iteration  max_iteration  "
      ]
     },
     "execution_count": 27,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "filtered_df = exploded_res_df_mini_sample_3_pair_k_5_max_itr4_llama33_70B[exploded_res_df_mini_sample_3_pair_k_5_max_itr4_llama33_70B['original_index'] == 774]\n",
    "columns_to_view = ['final_context_pmids', 'respond_llm', 'pmid_contexts_per_iteration', 'pmid_changes_per_iteration', 'edge_modified','pmid_dropped','pmid_added']\n",
    "filtered_df = filtered_df[columns_to_view]\n",
    "filtered_df"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 17,
   "id": "cf5e3201-af77-4ed7-8702-0a62460904c5",
   "metadata": {
    "execution": {
     "iopub.execute_input": "2025-01-20T20:23:45.568274Z",
     "iopub.status.busy": "2025-01-20T20:23:45.567914Z",
     "iopub.status.idle": "2025-01-20T20:23:45.578258Z",
     "shell.execute_reply": "2025-01-20T20:23:45.577388Z",
     "shell.execute_reply.started": "2025-01-20T20:23:45.568239Z"
    }
   },
   "outputs": [
    {
     "data": {
      "text/plain": [
       "final_context_pmids                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        {('C0076080', 'C0069197'): ['19514084', '32901889', '20706757', '4300795', '21066565', '17097370', '16222105', '25928166', '9473363', '34100706', '24640399', '15358884', '34352381', '25939521', '33787276', '1783274', '35739713', '34553478', '33805730', '17981249', '3963214', '18850102', '3008899', '33564284', '14369208', '7624262', '6773721'], ('C0069197', 'C1530270'): ['16520149', '34932098', '33992628', '17102778', '7199054', '2418942', '14596898', '2683289', '2888564', '1591363', '6481535', '35604826', '2332516', '2480183', '34621426', '33511939', '34763534', '34759615', '7510792', '16599639', '2411414', '3471909']}\n",
       "respond_llm                    Based on the provided abstracts, an indirect relationship between temozolomide and IRF1 protein, human, can be proposed as follows:\\n\\n1. **Temozolomide's mechanism of action**: Temozolomide is a DNA alkylating agent that works by damaging the DNA of cancer cells, thereby inhibiting their growth and proliferation. The effectiveness of temozolomide is influenced by the activity of the O6-methylguanine-DNA methyltransferase (MGMT) enzyme, which can repair the DNA damage caused by temozolomide.\\n\\n2. **MGMT and IRF1 connection**: The abstract \"Methionine-stress: a pleiotropic approach in enhancing the efficacy of chemotherapy\" mentions that methionine stress can inhibit the growth of brain tumor xenografts and enhance the efficacy of DNA alkylating chemotherapeutic agents, including temozolomide. This is associated with the downregulation of MGMT expression. Additionally, methionine stress upregulates IRF-1, a transcription factor involved in cell cycle regulation, apoptosis, and immune responses.\\n\\n3. **IRF1's role in cell cycle regulation and apoptosis**: IRF1 is known to regulate the expression of genes involved in cell cycle arrest, apoptosis, and DNA repair. Its upregulation can lead to the inhibition of cell cycle progression and the induction of apoptosis in cancer cells.\\n\\n4. **Temozolomide's effect on IRF1**: Although there is no direct mention of temozolomide's effect on IRF1 in the provided abstracts, it can be inferred that temozolomide's ability to induce DNA damage and activate cell cycle checkpoints may lead to the upregulation of IRF1. This is because IRF1 is involved in the regulation of cell cycle and apoptosis in response to DNA damage.\\n\\n5. **Indirect relationship between temozolomide and IRF1**: Based on the above points, an indirect relationship between temozolomide and IRF1 can be proposed. Temozolomide's DNA damaging effects can lead to the upregulation of IRF1, either directly or through the activation of cell cycle checkpoints and DNA repair mechanisms. The upregulation of IRF1 can, in turn, contribute to the inhibition of cancer cell growth and proliferation, enhancing the efficacy of temozolomide.\\n\\nIn summary, the indirect relationship between temozolomide and IRF1 protein, human, involves the following steps:\\n\\nTemozolomide → DNA damage → Cell cycle checkpoint activation → IRF1 upregulation → Inhibition of cancer cell growth and proliferation\\n\\nThis proposed relationship highlights the potential for IRF1 to play a role in the mechanism of action of temozolomide, and further research is needed to fully elucidate this connection.\n",
       "pmid_contexts_per_iteration                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    {('C0076080', 'C0069197'): ['19514084', '32901889', '20706757', '4300795', '21066565'], ('C0069197', 'C1530270'): ['16520149', '34932098', '33992628', '17102778', '7199054']}\n",
       "pmid_changes_per_iteration                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      {'edge': ('C0069197', 'C1530270'), 'dropped': '17102778', 'added': '2418942'}\n",
       "Name: 0, dtype: object"
      ]
     },
     "execution_count": 17,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "exploded_res_df_mini_sample_3_pair_k_5_max_itr4_llama33_70B[['final_context_pmids', 'respond_llm', 'pmid_contexts_per_iteration', 'pmid_changes_per_iteration']].loc[0]"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 18,
   "id": "0f88f2e2-7ef8-46f5-8974-1ad482cdb365",
   "metadata": {
    "execution": {
     "iopub.execute_input": "2025-01-20T20:24:28.856376Z",
     "iopub.status.busy": "2025-01-20T20:24:28.855898Z",
     "iopub.status.idle": "2025-01-20T20:24:28.868023Z",
     "shell.execute_reply": "2025-01-20T20:24:28.866974Z",
     "shell.execute_reply.started": "2025-01-20T20:24:28.856338Z"
    }
   },
   "outputs": [
    {
     "data": {
      "text/plain": [
       "respond_llm                    Based on the provided abstracts, an indirect relationship between temozolomide and IRF1 protein, human, can be proposed as follows:\\n\\n1. **Temozolomide's mechanism of action**: Temozolomide is a DNA alkylating agent that works by damaging the DNA of cancer cells, thereby inhibiting their growth and proliferation. The effectiveness of temozolomide is influenced by the activity of the O6-methylguanine-DNA methyltransferase (MGMT) enzyme, which can repair the DNA damage caused by temozolomide.\\n\\n2. **MGMT and IRF1 connection**: The abstract \"Methionine-stress: a pleiotropic approach in enhancing the efficacy of chemotherapy\" mentions that methionine stress can inhibit the growth of brain tumor xenografts and enhance the efficacy of DNA alkylating chemotherapeutic agents, including temozolomide. This is associated with the upregulation of IRF-1 (Interferon Regulatory Factor 1) among other factors. IRF-1 is a transcription factor involved in the regulation of various cellular processes, including cell growth, differentiation, and apoptosis.\\n\\n3. **Indirect relationship**: While there is no direct mention of temozolomide inducing IRF1 expression, the connection between temozolomide's mechanism of action and IRF1 can be inferred through the MGMT enzyme. Temozolomide's effectiveness is reduced by MGMT activity. Methionine stress, which can be induced by dietary restriction and administration of methioninase, inhibits MGMT expression and enhances temozolomide's efficacy. This methionine stress also upregulates IRF-1, suggesting that the conditions under which temozolomide is more effective (i.e., low MGMT activity) are also conditions under which IRF-1 is upregulated.\\n\\n4. **Potential intermediate processes**: The upregulation of IRF-1 in response to methionine stress and its association with enhanced efficacy of temozolomide suggests that IRF-1 could play a role in sensitizing cancer cells to temozolomide. This could occur through various intermediate processes, such as modulation of cell cycle checkpoints, induction of apoptosis, or alteration of DNA repair mechanisms, which are all influenced by IRF-1.\\n\\nIn summary, the indirect relationship between temozolomide and IRF1 protein, human, is proposed through the common pathway of MGMT modulation and the effects of methionine stress on both temozolomide efficacy and IRF-1 expression. This relationship suggests that conditions or interventions that upregulate IRF-1 could potentially enhance the effectiveness of temozolomide in cancer treatment.\n",
       "pmid_contexts_per_iteration                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             {('C0076080', 'C0069197'): ['19514084', '32901889', '20706757', '4300795', '21066565'], ('C0069197', 'C1530270'): ['16520149', '34932098', '33992628', '7199054', '2418942']}\n",
       "pmid_changes_per_iteration                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             {'edge': ('C0076080', 'C0069197'), 'dropped': '20706757', 'added': '17097370'}\n",
       "Name: 1, dtype: object"
      ]
     },
     "execution_count": 18,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "exploded_res_df_mini_sample_3_pair_k_5_max_itr4_llama33_70B[[ 'respond_llm','pmid_contexts_per_iteration', 'pmid_changes_per_iteration']].loc[1]"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "ed83d3cd-aac1-4064-80c5-0f3c2c8bb6b9",
   "metadata": {
    "execution": {
     "iopub.status.busy": "2025-01-20T15:35:56.804281Z",
     "iopub.status.idle": "2025-01-20T15:35:56.804508Z",
     "shell.execute_reply": "2025-01-20T15:35:56.804398Z",
     "shell.execute_reply.started": "2025-01-20T15:35:56.804388Z"
    }
   },
   "outputs": [],
   "source": [
    "# output_file = process_and_save_dataframe_with_llm(\n",
    "#     df=df,\n",
    "#     sents_db=sents_db,\n",
    "#     max_iterations=3,\n",
    "#     k=3,\n",
    "#     output_dir=\"./all_pkl_files\"\n",
    "# )\n",
    "# print(f\"Output saved at: {output_file}\")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "fd9b48ed-e272-4d95-a838-b7423e9da837",
   "metadata": {},
   "outputs": [],
   "source": [
    "res_df_774 = pd.read_pickle('./all_pkl_files/proc_774_samp_6.pkl')\n",
    "res_df_774"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 5,
   "id": "41a053d1-7159-4762-b21b-7b7f30f8140a",
   "metadata": {
    "execution": {
     "iopub.execute_input": "2025-01-20T14:40:00.406641Z",
     "iopub.status.busy": "2025-01-20T14:40:00.406189Z",
     "iopub.status.idle": "2025-01-20T14:40:00.436032Z",
     "shell.execute_reply": "2025-01-20T14:40:00.435205Z",
     "shell.execute_reply.started": "2025-01-20T14:40:00.406604Z"
    },
    "scrolled": true
   },
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>pair</th>\n",
       "      <th>subj_name</th>\n",
       "      <th>obj_name</th>\n",
       "      <th>pmid</th>\n",
       "      <th>pmid_text</th>\n",
       "      <th>source</th>\n",
       "      <th>first_year</th>\n",
       "      <th>label</th>\n",
       "      <th>context_pmids</th>\n",
       "      <th>path</th>\n",
       "      <th>context_pmids_space_edge</th>\n",
       "      <th>sorted_context_pmids</th>\n",
       "      <th>final_context_pmids</th>\n",
       "      <th>respond_llm</th>\n",
       "      <th>respond_time_llm</th>\n",
       "      <th>prompts_per_iteration</th>\n",
       "      <th>pmid_contexts_per_iteration</th>\n",
       "      <th>pmid_changes_per_iteration</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>774</th>\n",
       "      <td>C0076080 C1530270</td>\n",
       "      <td>temozolomide</td>\n",
       "      <td>IRF1 protein, human</td>\n",
       "      <td>35274103</td>\n",
       "      <td>XAF1 directs glioma response to temozolomide t...</td>\n",
       "      <td>sr_pred_sent_7</td>\n",
       "      <td>2022</td>\n",
       "      <td>1</td>\n",
       "      <td>{('C0076080', 'C0069197'): ['19514084', '32901...</td>\n",
       "      <td>[C0076080, C0069197, C1530270]</td>\n",
       "      <td>{('C0076080', 'C0069197'): ['4300795', '210665...</td>\n",
       "      <td>{('C0076080', 'C0069197'): ['19514084', '32901...</td>\n",
       "      <td>{('C0076080', 'C0069197'): ['19514084', '32901...</td>\n",
       "      <td>[{'iteration': 1, 'response': 'Based on the pr...</td>\n",
       "      <td>[28.262667179107666, 40.4062659740448, 32.7980...</td>\n",
       "      <td>[Based on the following scientific abstracts, ...</td>\n",
       "      <td>[{('C0076080', 'C0069197'): ['19514084', '3290...</td>\n",
       "      <td>[{'edge': ('C0069197', 'C1530270'), 'dropped':...</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "                  pair     subj_name             obj_name      pmid  \\\n",
       "774  C0076080 C1530270  temozolomide  IRF1 protein, human  35274103   \n",
       "\n",
       "                                             pmid_text          source  \\\n",
       "774  XAF1 directs glioma response to temozolomide t...  sr_pred_sent_7   \n",
       "\n",
       "    first_year  label                                      context_pmids  \\\n",
       "774       2022      1  {('C0076080', 'C0069197'): ['19514084', '32901...   \n",
       "\n",
       "                               path  \\\n",
       "774  [C0076080, C0069197, C1530270]   \n",
       "\n",
       "                              context_pmids_space_edge  \\\n",
       "774  {('C0076080', 'C0069197'): ['4300795', '210665...   \n",
       "\n",
       "                                  sorted_context_pmids  \\\n",
       "774  {('C0076080', 'C0069197'): ['19514084', '32901...   \n",
       "\n",
       "                                   final_context_pmids  \\\n",
       "774  {('C0076080', 'C0069197'): ['19514084', '32901...   \n",
       "\n",
       "                                           respond_llm  \\\n",
       "774  [{'iteration': 1, 'response': 'Based on the pr...   \n",
       "\n",
       "                                      respond_time_llm  \\\n",
       "774  [28.262667179107666, 40.4062659740448, 32.7980...   \n",
       "\n",
       "                                 prompts_per_iteration  \\\n",
       "774  [Based on the following scientific abstracts, ...   \n",
       "\n",
       "                           pmid_contexts_per_iteration  \\\n",
       "774  [{('C0076080', 'C0069197'): ['19514084', '3290...   \n",
       "\n",
       "                            pmid_changes_per_iteration  \n",
       "774  [{'edge': ('C0069197', 'C1530270'), 'dropped':...  "
      ]
     },
     "execution_count": 5,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "res_df_774 = pd.read_pickle('./all_pkl_files/proc_774_samp_6.pkl')\n",
    "res_df_774"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 8,
   "id": "6f5312f0-9110-4fbf-b09a-fca548dc3652",
   "metadata": {
    "execution": {
     "iopub.execute_input": "2025-01-20T14:40:09.330383Z",
     "iopub.status.busy": "2025-01-20T14:40:09.329917Z",
     "iopub.status.idle": "2025-01-20T14:40:09.356880Z",
     "shell.execute_reply": "2025-01-20T14:40:09.355926Z",
     "shell.execute_reply.started": "2025-01-20T14:40:09.330347Z"
    },
    "scrolled": true
   },
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>respond_llm</th>\n",
       "      <th>respond_time_llm</th>\n",
       "      <th>prompts_per_iteration</th>\n",
       "      <th>pmid_contexts_per_iteration</th>\n",
       "      <th>pmid_changes_per_iteration</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>774</th>\n",
       "      <td>[{'iteration': 1, 'response': 'Based on the provided scientific abstracts, an indirect relationship between temozolomide and IRF1 protein, human, can be proposed as follows:\n",
       "\n",
       "1. **Temozolomide's mechanism of action**: Temozolomide is a DNA alkylating agent that works by damaging the DNA of cancer cells, thereby inhibiting their growth and proliferation. The effectiveness of temozolomide is influenced by the activity of the O6-methylguanine-DNA methyltransferase (MGMT) enzyme, which can repair the DNA damage caused by temozolomide.\n",
       "\n",
       "2. **MGMT and IRF1 connection**: The abstract \"Methionine-stress: a pleiotropic approach in enhancing the efficacy of chemotherapy\" mentions that methionine stress (MET-stress) can inhibit the growth of brain tumor xenografts and enhance the efficacy of DNA alkylating chemotherapeutic agents, including temozolomide. MET-stress is associated with the upregulation of IRF-1, among other genes. IRF-1 is a transcription factor that plays a role in regulating cell growth, differentiation, and apoptosis.\n",
       "\n",
       "3. **MET-stress and MGMT**: The same abstract states that MET-stress is associated with the marked inhibition of MGMT expression. As MGMT is a key enzyme involved in repairing DNA damage caused by temozolomide, its inhibition can enhance the effectiveness of temozolomide.\n",
       "\n",
       "4. **Temozolomide and IRF1 indirect relationship**: Given that MET-stress can upregulate IRF-1 and inhibit MGMT, it is possible that temozolomide treatment can indirectly influence IRF-1 expression through the MET-stress pathway. If temozolomide treatment induces MET-stress in cancer cells, this could lead to the upregulation of IRF-1, which in turn could contribute to the anticancer effects of temozolomide.\n",
       "\n",
       "In summary, the indirect relationship between temozolomide and IRF1 protein, human, can be proposed as follows: temozolomide → MET-stress → MGMT inhibition → IRF-1 upregulation. This relationship suggests that temozolomide treatment can indirectly influence IRF-1 expression through the MET-stress pathway, which may contribute to its anticancer effects. However, further research is needed to fully elucidate the mechanisms underlying this relationship.'}, {'iteration': 2, 'response': 'To describe an indirect relationship between temozolomide and IRF1 protein, human, we must consider the key findings and mechanisms mentioned in the provided abstracts, even though none directly mention IRF1. IRF1 (Interferon Regulatory Factor 1) is a protein involved in the regulation of the immune system, cell growth, and differentiation, and it plays a role in the response to viral infections and in the regulation of apoptosis.\n",
       "\n",
       "1. **Temozolomide's Mechanism and Resistance**: Temozolomide is an alkylating agent used in the treatment of glioblastoma. It works by methylating DNA, which leads to DNA damage and subsequently triggers cell death. However, its efficacy can be limited by the activity of the DNA repair enzyme O6-methylguanine-DNA methyltransferase (MGMT), which can repair the DNA damage induced by temozolomide. The first abstract discusses the correlation between MGMT promoter methylation status and the survival benefit of temozolomide treatment in elderly patients with glioblastoma.\n",
       "\n",
       "2. **PARP-1 Inhibition and Temozolomide Sensitivity**: The second abstract explores how PARP-1 (Poly (ADP-ribose) polymerase 1) inhibition can sensitize glioblastoma cells to temozolomide, independent of MGMT activity. PARP-1 is involved in DNA repair, and its inhibition can lead to an accumulation of DNA damage, making cells more susceptible to the effects of temozolomide.\n",
       "\n",
       "3. **Multimodal Treatment Approaches**: The third abstract discusses a multimodal treatment approach combining local chemotherapy with carmustine wafers and concomitant radiochemotherapy with temozolomide for newly diagnosed glioblastoma patients. This approach aims to utilize the sensitizing effects of temozolomide on MGMT and potentially other pathways to overcome drug resistance.\n",
       "\n",
       "Given these points, an indirect relationship between temozolomide and IRF1 protein could be hypothesized through several potential pathways:\n",
       "\n",
       "- **DNA Damage Response**: Temozolomide induces DNA damage, which could potentially activate pathways involving IRF1, given IRF1's role in regulating responses to cellular stress and damage. Activation of IRF1 could influence the expression of genes involved in DNA repair, apoptosis, or cell cycle regulation, indirectly affecting the efficacy of temozolomide.\n",
       "\n",
       "- **Immune System Modulation**: IRF1 plays a role in the regulation of the immune system. Temozolomide, by inducing cell death, could lead to the release of tumor antigens, potentially stimulating an immune response. IRF1 could be involved in modulating this immune response, thereby indirectly influencing the outcome of temozolomide treatment.\n",
       "\n",
       "- **Cell Cycle and Apoptosis Regulation**: IRF1 is involved in the regulation of cell cycle and apoptosis. Temozolomide's ability to induce cell death could be influenced by the cell's ability to undergo apoptosis, a process in which IRF1 might play a regulatory role. Thus, the expression or activity level of IRF1 could indirectly affect the sensitivity of cancer cells to temozolomide.\n",
       "\n",
       "While these abstracts do not directly address the relationship between temozolomide and IRF1, they provide a framework for understanding how temozolomide works and how its efficacy can be influenced by various cellular mechanisms. The potential indirect relationship between temozolomide and IRF1 highlights the complexity of cancer treatment and the need for further research into the molecular mechanisms underlying drug resistance and sensitivity.'}, {'iteration': 3, 'response': 'To describe an indirect relationship between temozolomide and IRF1 protein, human, we must consider the information provided in the abstracts and connect the key findings, underlying mechanisms, and intermediate entities or processes to form a coherent narrative.\n",
       "\n",
       "First, let's establish the context. Temozolomide (TMZ) is a chemotherapeutic agent used in the treatment of glioblastoma, a type of brain cancer. The abstracts discuss the efficacy of combining TMZ with other treatments, such as PARP-1 inhibition, to overcome resistance and improve treatment outcomes.\n",
       "\n",
       "Now, let's introduce IRF1 (Interferon Regulatory Factor 1), a protein involved in the regulation of immune responses and cell growth. While IRF1 is not directly mentioned in the abstracts, we can infer a potential indirect relationship between TMZ and IRF1 through the following mechanisms:\n",
       "\n",
       "1. **DNA damage and repair**: TMZ works by inducing DNA damage in cancer cells, which triggers cell death. IRF1 is involved in the regulation of DNA repair pathways, including those that respond to DNA damage induced by chemotherapeutic agents like TMZ. Therefore, IRF1 might play a role in the cellular response to TMZ-induced DNA damage.\n",
       "2. **Cell cycle regulation**: TMZ can cause cell cycle arrest, particularly in the G2/M phase, which is a common mechanism of action for many chemotherapeutic agents. IRF1 has been shown to regulate cell cycle progression and can induce cell cycle arrest in response to DNA damage. This suggests that IRF1 might be involved in the cellular response to TMZ-induced cell cycle arrest.\n",
       "3. **Apoptosis and immune response**: TMZ can induce apoptosis (programmed cell death) in cancer cells, which can also trigger an immune response. IRF1 is involved in the regulation of apoptosis and immune responses, including the activation of interferons, which are cytokines that play a crucial role in the immune response to cancer. Therefore, IRF1 might be involved in the immune response to TMZ-treated cancer cells.\n",
       "4. **PARP-1 inhibition**: The first abstract discusses the combination of TMZ with PARP-1 inhibition, which can enhance the efficacy of TMZ. IRF1 has been shown to interact with PARP-1, and this interaction can regulate the activity of both proteins. Therefore, the combination of TMZ with PARP-1 inhibition might indirectly affect IRF1 activity, leading to an enhanced therapeutic response.\n",
       "\n",
       "In summary, while there is no direct mention of IRF1 in the abstracts, we can infer an indirect relationship between TMZ and IRF1 through the mechanisms of DNA damage and repair, cell cycle regulation, apoptosis, and immune response. The combination of TMZ with other treatments, such as PARP-1 inhibition, might also indirectly affect IRF1 activity, leading to an enhanced therapeutic response. Further research is needed to fully understand the relationship between TMZ and IRF1 and to explore the potential therapeutic implications of this interaction.'}]</td>\n",
       "      <td>[28.262667179107666, 40.4062659740448, 32.79805064201355]</td>\n",
       "      <td>[Based on the following scientific abstracts, please describe how an indirect relationship between temozolomide and IRF1 protein, human might exist. Consider the key findings, underlying mechanisms, and any intermediate entities or processes mentioned in the abstracts. Your explanation should connect these elements to form a coherent narrative that illustrates the possible indirect linkage between temozolomide and IRF1 protein, human.\\n\\nTemozolomide concomitant and adjuvant to radiotherapy in elderly patients with glioblastoma: correlation with MGMT promoter methylation status. A recent randomized study conducted on newly diagnosed glioblastoma (GBM) patients demonstrated that concomitant and adjuvant temozolomide added to standard radiotherapy had a survival advantage compared with radiotherapy alone. The overall survival benefit of this aggressive treatment, however, was attenuated in older or poor performance status patients. The aim of the present study was to verify the activity and the toxicity of temozolomide administration concurrent and adjuvant to radiotherapy as first-line treatment for elderly GBM patients, and to explore correlations between clinical outcome and O6 methylguanine-DNA methyltransferase (MGMT) promoter methylation status. Newly diagnosed GBM patients&gt;or=65 years were considered eligible. Treatment comprised radiotherapy (60 Gy in 30 fractions over 6 weeks) plus continuous daily temozolomide (75 mg/m2/day), followed by 12 maintenance temozolomide cycles (150 mg/m2 once a day for 5 consecutive days every 28 days) if MRI showed no enhancement suggesting a tumor; otherwise, chemotherapy was delivered until complete response or unequivocal progression. A total of 58 patients (34 males; median age, 68 years; range, 65-82 years) were enrolled. Sixteen patients (43%) presented MGMT promoter methylated and 21 unmethylated (57%) status. The median progression-free survival and median survival time (MST) were 9.5 months (95% confidence interval [CI], 8.6-10.5) and 13.7 months (95% CI, 10-17.3 months), respectively. Mental status deterioration grade 3-4 was detected in 25% of patients. Leukoencephalopathy was diagnosed in 10% of patients. The overall and progression-free survival of patients given concomitant and adjuvant temozolomide are greater than in those given radiotherapy alone; however, this regimen incurs a greater deterioration in mental status. Further randomized trials should, therefore, be conducted to investigate the efficacy and against the toxicity of this regimen as first-line therapy in patients with GBM.\\n\\nPARP-1 inhibition sensitizes temozolomide-treated glioblastoma cell lines and decreases drug resistance independent of MGMT activity and PTEN proficiency. Information on the mechanisms that are associated with tumor resistance has the potential to provide the fundamental basis for novel therapeutic strategies. In glioblastoma (GBM), predictive biomarkers of cellular responses to temozolomide (TMZ) combined with poly-ADP-ribose polymerase inhibitor (PARPi) remain largely unidentified. In this context, the influence of MGMT (O6-methylguanine DNA methyltransferase) and PTEN (phosphatase and tensin homologue deleted on chromosome ten) has been studied in addition to the occurrence of synthetic lethality involving PTEN and PARPi. The present study investigated whether PARP-1 inhibition by NU1025 may increase the cytotoxicity of TMZ-induced lesions in GBM cells, and whether these mechanisms can be influenced by MGMT and PTEN status. The impact of PTEN deficiency in repair pathways, and the effects of PARP-1 inhibition and PTEN silencing, in terms of synthetic lethality, were also assessed. NU1025 combined with TMZ effectively sensitized TMZ-resistant cells (T98G PTEN-mutated and LN18 PTEN-wild-type) and TMZ-sensitive cells (U251MG PTEN-mutated), in contrast to NU1025 alone. However, the sensitizing effects were not observed in U87MG (PTEN-mutated) cells, suggesting that specific genetic alterations may influence the response to drug treatment. The sensitizing effects occurred independently of MGMT activity, which was evaluated in O6-BG-treated cells. PTEN silencing using small interfering (si)RNA did not sensitize PTEN-proficient cells to TMZ + NU1025, or NU1025 alone, indicating an absence of synthetic lethality. The responses to TMZ + NU1025 involved antiproliferative activity, G2/M arrest, double strand breaks and the induction of apoptosis. Following 20 days of recovery after three consecutive days of TMZ treatment, TMZ-resistant cells were observed. However, when TMZ was combined with NU1025, the viability of T98G and LN18 cells was extremely decreased, indicating a lethal drug combination. Therefore, independently of MGMT proficiency and PTEN status, TMZ combined with PARPi may be a promising strategy that can be used to overcome TMZ acquired resistance in GBM cells.\\n\\nFirst-line treatment of malignant glioma with carmustine implants followed by concomitant radiochemotherapy: a multicenter experience. Randomized phase III trials have shown significant improvement of survival 1, 2, and 3 years after implantation of 1,3-bis (2-chloroethyl)-1-nitrosourea (BCNU) wafers for patients with newly diagnosed malignant glioma. But these studies and subsequent non-phase III studies have also shown risks associated with local chemotherapy within the central nervous system. The introduction of concomitant radiochemotherapy with temozolomide (TMZ) has later demonstrated a survival benefit in a phase III trial and has become the current treatment standard for newly diagnosed malignant glioma patients. Lately, this has resulted in clinical protocols combining local chemotherapy with BCNU wafers and concomitant radiochemotherapy with TMZ although this may carry the risk of increased toxicity. We have compiled the treatment experience of seven neurosurgical centers using implantation of carmustine wafers at primary surgery followed by 6 weeks of radiation therapy (59-60 Gy) and 75 mg/m(2)/day TMZ in patients with newly diagnosed glioblastoma followed by TMZ monochemotherapy. We have retrospectively analyzed the postoperative clinical course, occurrence and severity of adverse events, progression-free interval, and overall survival in 44 patients with newly diagnosed glioblastoma multiforme. All patients received multimodal treatment including tumor resection, BCNU wafer implantation, and concomitant radiochemotherapy. Of 44 patients (mean age 59 +/- 10.8 years) with glioblastoma who received Gliadel wafer at primary surgery, 28 patients (64%) had died, 16 patients (36%) were alive, and 15 patients showed no evidence of clinical or radiographic progression after a median follow-up of 15.6 months. At time of analysis of adverse events in this patient population, the median overall survival was 12.7 months and median progression-free survival was 7.0 months. Surgical, neurological, and medical adverse events were analyzed. Twenty-three patients (52%) experienced adverse events of any kind including complications that did not require treatment. Nineteen patients (43%) experienced grade 3 or grade 4 adverse events. Surgical complications included cerebral edema, healing abnormalities, cerebral spinal fluid leakage, meningitis, intracranial abscess, and hydrocephalus. Neurological adverse events included newly diagnosed seizures, alteration of mental status, and new neurological deficits. Medical complications were thromboembolic events (thrombosis, pulmonary embolism) and hematotoxicity. Combination of both treatment strategies, local chemotherapy with BCNU wafer and concomitant radiochemotherapy, appears attractive in aggressive multimodal treatment schedules and may utilize the sensitizing effect of TMZ and carmustine on MGMT and AGT on their respective drug resistance genes. Our data demonstrate that combination of local chemotherapy and concomitant radiochemotherapy carries a significant risk of toxicity that currently appears underestimated. Adverse events observed in this study appear similar to complication rates published in the phase III trials for BCNU wafer implantation followed by radiation therapy alone, but further add the toxicity of concomitant radiochemotherapy with systemic TMZ. Save use of a combined approach will require specific prevention strategies for multimodal treatments.\\n\\nMethionine-stress: a pleiotropic approach in enhancing the efficacy of chemotherapy. Malignant cells fail to utilize homocysteine (HCYS) in place of methionine (MET) and they are dependent on exogenous MET for growth. In animals, reduction of plasma MET to &lt;5 microM can be induced by combined dietary restriction of MET and administration of L-methionine-alpha-deamino-gamma-lyase (methioninase). This treatment, termed as MET-stress, inhibits the growth of brain tumor xenografts in athymic mice and enhances the efficacy of DNA alkylating chemotherapeutic agents. The response of tumors to MET-stress depends on their mutational status, however, it always involves inhibition of CDK1 and in most cases the upregulation of p21, p27, GADDs and 14-3-3sigma in response to upregulation of TGF-beta, IRF-1, TNF-alpha, Rb and/or MDA-7 and the downregulation of PI3K, RAS and NF-kappaB. Although inhibition of the cell cycle and mitosis is not necessarily dependent on the tumor's p53 status, the expression of p21, GADD45 and apoptosis related genes (BAX, BCL-2) are regulated by wt-p53, in addition to their regulation by TGF-beta or MDA-7 in mutated p53 tumors. Mutational variability determines the mode of death (mitotic catastrophe versus apoptosis) in tumor cells subjected to MET-stress. The increase of the efficacy of alkylating agents is related to marked inhibition of O6-methylguanine-DNA methyltransferase (MGMT) expression, the induction of cell cycle check points and the inhibition of pro-survival pathways by MET-stress.\\n\\nIncorrect Recommendation Wording in Figure. \\n\\nCTV-to-PTV margin assessment for esophageal cancer radiotherapy based on an accumulated dose analysis. This study aimed to assess the smallest clinical target volume (CTV) to planned target volume (PTV) margins for esophageal cancer radiotherapy using daily online registration to the bony anatomy that yield full dosimetric coverage over the course of treatment. 29 esophageal cancer patients underwent six T2-weighted MRI scans at weekly intervals. An online bone-match image-guided radiotherapy treatment of five fractions was simulated for each patient. Multiple conformal treatment plans with increasing margins around the CTV were created for each patient. Then, the dose was warped to obtain an accumulated dose per simulated fraction. Full target coverage by 95% of the prescribed dose was assessed as a function of margin expansion in six directions. If target coverage in a single direction was accomplished, then the respective margin remained fixed for the subsequent dose plans. Margins in uncovered directions were increased in a new dose plan until full target coverage was achieved. The smallest set of CTV-to-PTV margins that yielded full dosimetric CTV coverage was 8 mm in posterior and right direction, 9 mm in anterior and cranial direction and 10 mm in left and caudal direction for 27 out of 29 patients. In two patients the curvature of the esophagus considerably changed between fractions, which required a 17 and 23 mm margin in right direction. Accumulated dose analysis revealed that CTV-to-PTV treatment margins of 8, 9 and 10 mm in posterior &amp; right, anterior &amp; cranial and left &amp; caudal direction, respectively, are sufficient to account for interfraction tumor variations over the course of treatment when applying a daily online bone match. However, two patients with extreme esophageal interfraction motion were insufficiently covered with these margins and were identified as patients requiring replanning to achieve full target coverage., Based on the following scientific abstracts, please describe how an indirect relationship between temozolomide and IRF1 protein, human might exist. Consider the key findings, underlying mechanisms, and any intermediate entities or processes mentioned in the abstracts. Your explanation should connect these elements to form a coherent narrative that illustrates the possible indirect linkage between temozolomide and IRF1 protein, human.\\n\\nTemozolomide concomitant and adjuvant to radiotherapy in elderly patients with glioblastoma: correlation with MGMT promoter methylation status. A recent randomized study conducted on newly diagnosed glioblastoma (GBM) patients demonstrated that concomitant and adjuvant temozolomide added to standard radiotherapy had a survival advantage compared with radiotherapy alone. The overall survival benefit of this aggressive treatment, however, was attenuated in older or poor performance status patients. The aim of the present study was to verify the activity and the toxicity of temozolomide administration concurrent and adjuvant to radiotherapy as first-line treatment for elderly GBM patients, and to explore correlations between clinical outcome and O6 methylguanine-DNA methyltransferase (MGMT) promoter methylation status. Newly diagnosed GBM patients&gt;or=65 years were considered eligible. Treatment comprised radiotherapy (60 Gy in 30 fractions over 6 weeks) plus continuous daily temozolomide (75 mg/m2/day), followed by 12 maintenance temozolomide cycles (150 mg/m2 once a day for 5 consecutive days every 28 days) if MRI showed no enhancement suggesting a tumor; otherwise, chemotherapy was delivered until complete response or unequivocal progression. A total of 58 patients (34 males; median age, 68 years; range, 65-82 years) were enrolled. Sixteen patients (43%) presented MGMT promoter methylated and 21 unmethylated (57%) status. The median progression-free survival and median survival time (MST) were 9.5 months (95% confidence interval [CI], 8.6-10.5) and 13.7 months (95% CI, 10-17.3 months), respectively. Mental status deterioration grade 3-4 was detected in 25% of patients. Leukoencephalopathy was diagnosed in 10% of patients. The overall and progression-free survival of patients given concomitant and adjuvant temozolomide are greater than in those given radiotherapy alone; however, this regimen incurs a greater deterioration in mental status. Further randomized trials should, therefore, be conducted to investigate the efficacy and against the toxicity of this regimen as first-line therapy in patients with GBM.\\n\\nPARP-1 inhibition sensitizes temozolomide-treated glioblastoma cell lines and decreases drug resistance independent of MGMT activity and PTEN proficiency. Information on the mechanisms that are associated with tumor resistance has the potential to provide the fundamental basis for novel therapeutic strategies. In glioblastoma (GBM), predictive biomarkers of cellular responses to temozolomide (TMZ) combined with poly-ADP-ribose polymerase inhibitor (PARPi) remain largely unidentified. In this context, the influence of MGMT (O6-methylguanine DNA methyltransferase) and PTEN (phosphatase and tensin homologue deleted on chromosome ten) has been studied in addition to the occurrence of synthetic lethality involving PTEN and PARPi. The present study investigated whether PARP-1 inhibition by NU1025 may increase the cytotoxicity of TMZ-induced lesions in GBM cells, and whether these mechanisms can be influenced by MGMT and PTEN status. The impact of PTEN deficiency in repair pathways, and the effects of PARP-1 inhibition and PTEN silencing, in terms of synthetic lethality, were also assessed. NU1025 combined with TMZ effectively sensitized TMZ-resistant cells (T98G PTEN-mutated and LN18 PTEN-wild-type) and TMZ-sensitive cells (U251MG PTEN-mutated), in contrast to NU1025 alone. However, the sensitizing effects were not observed in U87MG (PTEN-mutated) cells, suggesting that specific genetic alterations may influence the response to drug treatment. The sensitizing effects occurred independently of MGMT activity, which was evaluated in O6-BG-treated cells. PTEN silencing using small interfering (si)RNA did not sensitize PTEN-proficient cells to TMZ + NU1025, or NU1025 alone, indicating an absence of synthetic lethality. The responses to TMZ + NU1025 involved antiproliferative activity, G2/M arrest, double strand breaks and the induction of apoptosis. Following 20 days of recovery after three consecutive days of TMZ treatment, TMZ-resistant cells were observed. However, when TMZ was combined with NU1025, the viability of T98G and LN18 cells was extremely decreased, indicating a lethal drug combination. Therefore, independently of MGMT proficiency and PTEN status, TMZ combined with PARPi may be a promising strategy that can be used to overcome TMZ acquired resistance in GBM cells.\\n\\nFirst-line treatment of malignant glioma with carmustine implants followed by concomitant radiochemotherapy: a multicenter experience. Randomized phase III trials have shown significant improvement of survival 1, 2, and 3 years after implantation of 1,3-bis (2-chloroethyl)-1-nitrosourea (BCNU) wafers for patients with newly diagnosed malignant glioma. But these studies and subsequent non-phase III studies have also shown risks associated with local chemotherapy within the central nervous system. The introduction of concomitant radiochemotherapy with temozolomide (TMZ) has later demonstrated a survival benefit in a phase III trial and has become the current treatment standard for newly diagnosed malignant glioma patients. Lately, this has resulted in clinical protocols combining local chemotherapy with BCNU wafers and concomitant radiochemotherapy with TMZ although this may carry the risk of increased toxicity. We have compiled the treatment experience of seven neurosurgical centers using implantation of carmustine wafers at primary surgery followed by 6 weeks of radiation therapy (59-60 Gy) and 75 mg/m(2)/day TMZ in patients with newly diagnosed glioblastoma followed by TMZ monochemotherapy. We have retrospectively analyzed the postoperative clinical course, occurrence and severity of adverse events, progression-free interval, and overall survival in 44 patients with newly diagnosed glioblastoma multiforme. All patients received multimodal treatment including tumor resection, BCNU wafer implantation, and concomitant radiochemotherapy. Of 44 patients (mean age 59 +/- 10.8 years) with glioblastoma who received Gliadel wafer at primary surgery, 28 patients (64%) had died, 16 patients (36%) were alive, and 15 patients showed no evidence of clinical or radiographic progression after a median follow-up of 15.6 months. At time of analysis of adverse events in this patient population, the median overall survival was 12.7 months and median progression-free survival was 7.0 months. Surgical, neurological, and medical adverse events were analyzed. Twenty-three patients (52%) experienced adverse events of any kind including complications that did not require treatment. Nineteen patients (43%) experienced grade 3 or grade 4 adverse events. Surgical complications included cerebral edema, healing abnormalities, cerebral spinal fluid leakage, meningitis, intracranial abscess, and hydrocephalus. Neurological adverse events included newly diagnosed seizures, alteration of mental status, and new neurological deficits. Medical complications were thromboembolic events (thrombosis, pulmonary embolism) and hematotoxicity. Combination of both treatment strategies, local chemotherapy with BCNU wafer and concomitant radiochemotherapy, appears attractive in aggressive multimodal treatment schedules and may utilize the sensitizing effect of TMZ and carmustine on MGMT and AGT on their respective drug resistance genes. Our data demonstrate that combination of local chemotherapy and concomitant radiochemotherapy carries a significant risk of toxicity that currently appears underestimated. Adverse events observed in this study appear similar to complication rates published in the phase III trials for BCNU wafer implantation followed by radiation therapy alone, but further add the toxicity of concomitant radiochemotherapy with systemic TMZ. Save use of a combined approach will require specific prevention strategies for multimodal treatments.\\n\\nIncorrect Recommendation Wording in Figure. \\n\\nCTV-to-PTV margin assessment for esophageal cancer radiotherapy based on an accumulated dose analysis. This study aimed to assess the smallest clinical target volume (CTV) to planned target volume (PTV) margins for esophageal cancer radiotherapy using daily online registration to the bony anatomy that yield full dosimetric coverage over the course of treatment. 29 esophageal cancer patients underwent six T2-weighted MRI scans at weekly intervals. An online bone-match image-guided radiotherapy treatment of five fractions was simulated for each patient. Multiple conformal treatment plans with increasing margins around the CTV were created for each patient. Then, the dose was warped to obtain an accumulated dose per simulated fraction. Full target coverage by 95% of the prescribed dose was assessed as a function of margin expansion in six directions. If target coverage in a single direction was accomplished, then the respective margin remained fixed for the subsequent dose plans. Margins in uncovered directions were increased in a new dose plan until full target coverage was achieved. The smallest set of CTV-to-PTV margins that yielded full dosimetric CTV coverage was 8 mm in posterior and right direction, 9 mm in anterior and cranial direction and 10 mm in left and caudal direction for 27 out of 29 patients. In two patients the curvature of the esophagus considerably changed between fractions, which required a 17 and 23 mm margin in right direction. Accumulated dose analysis revealed that CTV-to-PTV treatment margins of 8, 9 and 10 mm in posterior &amp; right, anterior &amp; cranial and left &amp; caudal direction, respectively, are sufficient to account for interfraction tumor variations over the course of treatment when applying a daily online bone match. However, two patients with extreme esophageal interfraction motion were insufficiently covered with these margins and were identified as patients requiring replanning to achieve full target coverage.\\n\\nImpact of new legislation on presumed consent on organ donation on liver transplant in Singapore: a preliminary analysis. Demand for the liver organ for transplantation vastly exceeded the availability of deceased donor organs. A new law, the revised Human Organ Transplant Act (HOTA), was implemented in Singapore in July 2004, which allowed for recovering four organs, including liver, for transplant unless the deceased give objection prior to their demise. We set to study the impact of the revised legislation by comparing the number of potential suitable donors, liver recovery surgery, and liver transplants two years before and one year after the implementation. There was no change in the number of suitable donors, but there was an increase in the number of liver recovery surgeries and liver transplantation, and a lower refusal rate among suitable donors. Although the revised legislation helped improve the availability of deceased donor organs moderately, other nonlegislative, supplementary measures are needed to further improve the low organ donation rate., Based on the following scientific abstracts, please describe how an indirect relationship between temozolomide and IRF1 protein, human might exist. Consider the key findings, underlying mechanisms, and any intermediate entities or processes mentioned in the abstracts. Your explanation should connect these elements to form a coherent narrative that illustrates the possible indirect linkage between temozolomide and IRF1 protein, human.\\n\\nPARP-1 inhibition sensitizes temozolomide-treated glioblastoma cell lines and decreases drug resistance independent of MGMT activity and PTEN proficiency. Information on the mechanisms that are associated with tumor resistance has the potential to provide the fundamental basis for novel therapeutic strategies. In glioblastoma (GBM), predictive biomarkers of cellular responses to temozolomide (TMZ) combined with poly-ADP-ribose polymerase inhibitor (PARPi) remain largely unidentified. In this context, the influence of MGMT (O6-methylguanine DNA methyltransferase) and PTEN (phosphatase and tensin homologue deleted on chromosome ten) has been studied in addition to the occurrence of synthetic lethality involving PTEN and PARPi. The present study investigated whether PARP-1 inhibition by NU1025 may increase the cytotoxicity of TMZ-induced lesions in GBM cells, and whether these mechanisms can be influenced by MGMT and PTEN status. The impact of PTEN deficiency in repair pathways, and the effects of PARP-1 inhibition and PTEN silencing, in terms of synthetic lethality, were also assessed. NU1025 combined with TMZ effectively sensitized TMZ-resistant cells (T98G PTEN-mutated and LN18 PTEN-wild-type) and TMZ-sensitive cells (U251MG PTEN-mutated), in contrast to NU1025 alone. However, the sensitizing effects were not observed in U87MG (PTEN-mutated) cells, suggesting that specific genetic alterations may influence the response to drug treatment. The sensitizing effects occurred independently of MGMT activity, which was evaluated in O6-BG-treated cells. PTEN silencing using small interfering (si)RNA did not sensitize PTEN-proficient cells to TMZ + NU1025, or NU1025 alone, indicating an absence of synthetic lethality. The responses to TMZ + NU1025 involved antiproliferative activity, G2/M arrest, double strand breaks and the induction of apoptosis. Following 20 days of recovery after three consecutive days of TMZ treatment, TMZ-resistant cells were observed. However, when TMZ was combined with NU1025, the viability of T98G and LN18 cells was extremely decreased, indicating a lethal drug combination. Therefore, independently of MGMT proficiency and PTEN status, TMZ combined with PARPi may be a promising strategy that can be used to overcome TMZ acquired resistance in GBM cells.\\n\\nFirst-line treatment of malignant glioma with carmustine implants followed by concomitant radiochemotherapy: a multicenter experience. Randomized phase III trials have shown significant improvement of survival 1, 2, and 3 years after implantation of 1,3-bis (2-chloroethyl)-1-nitrosourea (BCNU) wafers for patients with newly diagnosed malignant glioma. But these studies and subsequent non-phase III studies have also shown risks associated with local chemotherapy within the central nervous system. The introduction of concomitant radiochemotherapy with temozolomide (TMZ) has later demonstrated a survival benefit in a phase III trial and has become the current treatment standard for newly diagnosed malignant glioma patients. Lately, this has resulted in clinical protocols combining local chemotherapy with BCNU wafers and concomitant radiochemotherapy with TMZ although this may carry the risk of increased toxicity. We have compiled the treatment experience of seven neurosurgical centers using implantation of carmustine wafers at primary surgery followed by 6 weeks of radiation therapy (59-60 Gy) and 75 mg/m(2)/day TMZ in patients with newly diagnosed glioblastoma followed by TMZ monochemotherapy. We have retrospectively analyzed the postoperative clinical course, occurrence and severity of adverse events, progression-free interval, and overall survival in 44 patients with newly diagnosed glioblastoma multiforme. All patients received multimodal treatment including tumor resection, BCNU wafer implantation, and concomitant radiochemotherapy. Of 44 patients (mean age 59 +/- 10.8 years) with glioblastoma who received Gliadel wafer at primary surgery, 28 patients (64%) had died, 16 patients (36%) were alive, and 15 patients showed no evidence of clinical or radiographic progression after a median follow-up of 15.6 months. At time of analysis of adverse events in this patient population, the median overall survival was 12.7 months and median progression-free survival was 7.0 months. Surgical, neurological, and medical adverse events were analyzed. Twenty-three patients (52%) experienced adverse events of any kind including complications that did not require treatment. Nineteen patients (43%) experienced grade 3 or grade 4 adverse events. Surgical complications included cerebral edema, healing abnormalities, cerebral spinal fluid leakage, meningitis, intracranial abscess, and hydrocephalus. Neurological adverse events included newly diagnosed seizures, alteration of mental status, and new neurological deficits. Medical complications were thromboembolic events (thrombosis, pulmonary embolism) and hematotoxicity. Combination of both treatment strategies, local chemotherapy with BCNU wafer and concomitant radiochemotherapy, appears attractive in aggressive multimodal treatment schedules and may utilize the sensitizing effect of TMZ and carmustine on MGMT and AGT on their respective drug resistance genes. Our data demonstrate that combination of local chemotherapy and concomitant radiochemotherapy carries a significant risk of toxicity that currently appears underestimated. Adverse events observed in this study appear similar to complication rates published in the phase III trials for BCNU wafer implantation followed by radiation therapy alone, but further add the toxicity of concomitant radiochemotherapy with systemic TMZ. Save use of a combined approach will require specific prevention strategies for multimodal treatments.\\n\\nIn vitro uptake of ascorbic acid-1-14-C by adrenal glands of different species of animals.\\n\\nIncorrect Recommendation Wording in Figure. \\n\\nCTV-to-PTV margin assessment for esophageal cancer radiotherapy based on an accumulated dose analysis. This study aimed to assess the smallest clinical target volume (CTV) to planned target volume (PTV) margins for esophageal cancer radiotherapy using daily online registration to the bony anatomy that yield full dosimetric coverage over the course of treatment. 29 esophageal cancer patients underwent six T2-weighted MRI scans at weekly intervals. An online bone-match image-guided radiotherapy treatment of five fractions was simulated for each patient. Multiple conformal treatment plans with increasing margins around the CTV were created for each patient. Then, the dose was warped to obtain an accumulated dose per simulated fraction. Full target coverage by 95% of the prescribed dose was assessed as a function of margin expansion in six directions. If target coverage in a single direction was accomplished, then the respective margin remained fixed for the subsequent dose plans. Margins in uncovered directions were increased in a new dose plan until full target coverage was achieved. The smallest set of CTV-to-PTV margins that yielded full dosimetric CTV coverage was 8 mm in posterior and right direction, 9 mm in anterior and cranial direction and 10 mm in left and caudal direction for 27 out of 29 patients. In two patients the curvature of the esophagus considerably changed between fractions, which required a 17 and 23 mm margin in right direction. Accumulated dose analysis revealed that CTV-to-PTV treatment margins of 8, 9 and 10 mm in posterior &amp; right, anterior &amp; cranial and left &amp; caudal direction, respectively, are sufficient to account for interfraction tumor variations over the course of treatment when applying a daily online bone match. However, two patients with extreme esophageal interfraction motion were insufficiently covered with these margins and were identified as patients requiring replanning to achieve full target coverage.\\n\\nImpact of new legislation on presumed consent on organ donation on liver transplant in Singapore: a preliminary analysis. Demand for the liver organ for transplantation vastly exceeded the availability of deceased donor organs. A new law, the revised Human Organ Transplant Act (HOTA), was implemented in Singapore in July 2004, which allowed for recovering four organs, including liver, for transplant unless the deceased give objection prior to their demise. We set to study the impact of the revised legislation by comparing the number of potential suitable donors, liver recovery surgery, and liver transplants two years before and one year after the implementation. There was no change in the number of suitable donors, but there was an increase in the number of liver recovery surgeries and liver transplantation, and a lower refusal rate among suitable donors. Although the revised legislation helped improve the availability of deceased donor organs moderately, other nonlegislative, supplementary measures are needed to further improve the low organ donation rate.]</td>\n",
       "      <td>[{('C0076080', 'C0069197'): ['19514084', '32901889', '20706757'], ('C0069197', 'C1530270'): ['16520149', '34932098', '33992628']}, {('C0076080', 'C0069197'): ['19514084', '32901889', '20706757'], ('C0069197', 'C1530270'): ['34932098', '33992628', '17102778']}, {('C0076080', 'C0069197'): ['32901889', '20706757', '4300795'], ('C0069197', 'C1530270'): ['34932098', '33992628', '17102778']}]</td>\n",
       "      <td>[{'edge': ('C0069197', 'C1530270'), 'dropped': '16520149', 'added': '17102778'}, {'edge': ('C0076080', 'C0069197'), 'dropped': '19514084', 'added': '4300795'}, {'edge': None, 'dropped': None, 'added': None}]</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               respond_llm  \\\n",
       "774  [{'iteration': 1, 'response': 'Based on the provided scientific abstracts, an indirect relationship between temozolomide and IRF1 protein, human, can be proposed as follows:\n",
       "\n",
       "1. **Temozolomide's mechanism of action**: Temozolomide is a DNA alkylating agent that works by damaging the DNA of cancer cells, thereby inhibiting their growth and proliferation. The effectiveness of temozolomide is influenced by the activity of the O6-methylguanine-DNA methyltransferase (MGMT) enzyme, which can repair the DNA damage caused by temozolomide.\n",
       "\n",
       "2. **MGMT and IRF1 connection**: The abstract \"Methionine-stress: a pleiotropic approach in enhancing the efficacy of chemotherapy\" mentions that methionine stress (MET-stress) can inhibit the growth of brain tumor xenografts and enhance the efficacy of DNA alkylating chemotherapeutic agents, including temozolomide. MET-stress is associated with the upregulation of IRF-1, among other genes. IRF-1 is a transcription factor that plays a role in regulating cell growth, differentiation, and apoptosis.\n",
       "\n",
       "3. **MET-stress and MGMT**: The same abstract states that MET-stress is associated with the marked inhibition of MGMT expression. As MGMT is a key enzyme involved in repairing DNA damage caused by temozolomide, its inhibition can enhance the effectiveness of temozolomide.\n",
       "\n",
       "4. **Temozolomide and IRF1 indirect relationship**: Given that MET-stress can upregulate IRF-1 and inhibit MGMT, it is possible that temozolomide treatment can indirectly influence IRF-1 expression through the MET-stress pathway. If temozolomide treatment induces MET-stress in cancer cells, this could lead to the upregulation of IRF-1, which in turn could contribute to the anticancer effects of temozolomide.\n",
       "\n",
       "In summary, the indirect relationship between temozolomide and IRF1 protein, human, can be proposed as follows: temozolomide → MET-stress → MGMT inhibition → IRF-1 upregulation. This relationship suggests that temozolomide treatment can indirectly influence IRF-1 expression through the MET-stress pathway, which may contribute to its anticancer effects. However, further research is needed to fully elucidate the mechanisms underlying this relationship.'}, {'iteration': 2, 'response': 'To describe an indirect relationship between temozolomide and IRF1 protein, human, we must consider the key findings and mechanisms mentioned in the provided abstracts, even though none directly mention IRF1. IRF1 (Interferon Regulatory Factor 1) is a protein involved in the regulation of the immune system, cell growth, and differentiation, and it plays a role in the response to viral infections and in the regulation of apoptosis.\n",
       "\n",
       "1. **Temozolomide's Mechanism and Resistance**: Temozolomide is an alkylating agent used in the treatment of glioblastoma. It works by methylating DNA, which leads to DNA damage and subsequently triggers cell death. However, its efficacy can be limited by the activity of the DNA repair enzyme O6-methylguanine-DNA methyltransferase (MGMT), which can repair the DNA damage induced by temozolomide. The first abstract discusses the correlation between MGMT promoter methylation status and the survival benefit of temozolomide treatment in elderly patients with glioblastoma.\n",
       "\n",
       "2. **PARP-1 Inhibition and Temozolomide Sensitivity**: The second abstract explores how PARP-1 (Poly (ADP-ribose) polymerase 1) inhibition can sensitize glioblastoma cells to temozolomide, independent of MGMT activity. PARP-1 is involved in DNA repair, and its inhibition can lead to an accumulation of DNA damage, making cells more susceptible to the effects of temozolomide.\n",
       "\n",
       "3. **Multimodal Treatment Approaches**: The third abstract discusses a multimodal treatment approach combining local chemotherapy with carmustine wafers and concomitant radiochemotherapy with temozolomide for newly diagnosed glioblastoma patients. This approach aims to utilize the sensitizing effects of temozolomide on MGMT and potentially other pathways to overcome drug resistance.\n",
       "\n",
       "Given these points, an indirect relationship between temozolomide and IRF1 protein could be hypothesized through several potential pathways:\n",
       "\n",
       "- **DNA Damage Response**: Temozolomide induces DNA damage, which could potentially activate pathways involving IRF1, given IRF1's role in regulating responses to cellular stress and damage. Activation of IRF1 could influence the expression of genes involved in DNA repair, apoptosis, or cell cycle regulation, indirectly affecting the efficacy of temozolomide.\n",
       "\n",
       "- **Immune System Modulation**: IRF1 plays a role in the regulation of the immune system. Temozolomide, by inducing cell death, could lead to the release of tumor antigens, potentially stimulating an immune response. IRF1 could be involved in modulating this immune response, thereby indirectly influencing the outcome of temozolomide treatment.\n",
       "\n",
       "- **Cell Cycle and Apoptosis Regulation**: IRF1 is involved in the regulation of cell cycle and apoptosis. Temozolomide's ability to induce cell death could be influenced by the cell's ability to undergo apoptosis, a process in which IRF1 might play a regulatory role. Thus, the expression or activity level of IRF1 could indirectly affect the sensitivity of cancer cells to temozolomide.\n",
       "\n",
       "While these abstracts do not directly address the relationship between temozolomide and IRF1, they provide a framework for understanding how temozolomide works and how its efficacy can be influenced by various cellular mechanisms. The potential indirect relationship between temozolomide and IRF1 highlights the complexity of cancer treatment and the need for further research into the molecular mechanisms underlying drug resistance and sensitivity.'}, {'iteration': 3, 'response': 'To describe an indirect relationship between temozolomide and IRF1 protein, human, we must consider the information provided in the abstracts and connect the key findings, underlying mechanisms, and intermediate entities or processes to form a coherent narrative.\n",
       "\n",
       "First, let's establish the context. Temozolomide (TMZ) is a chemotherapeutic agent used in the treatment of glioblastoma, a type of brain cancer. The abstracts discuss the efficacy of combining TMZ with other treatments, such as PARP-1 inhibition, to overcome resistance and improve treatment outcomes.\n",
       "\n",
       "Now, let's introduce IRF1 (Interferon Regulatory Factor 1), a protein involved in the regulation of immune responses and cell growth. While IRF1 is not directly mentioned in the abstracts, we can infer a potential indirect relationship between TMZ and IRF1 through the following mechanisms:\n",
       "\n",
       "1. **DNA damage and repair**: TMZ works by inducing DNA damage in cancer cells, which triggers cell death. IRF1 is involved in the regulation of DNA repair pathways, including those that respond to DNA damage induced by chemotherapeutic agents like TMZ. Therefore, IRF1 might play a role in the cellular response to TMZ-induced DNA damage.\n",
       "2. **Cell cycle regulation**: TMZ can cause cell cycle arrest, particularly in the G2/M phase, which is a common mechanism of action for many chemotherapeutic agents. IRF1 has been shown to regulate cell cycle progression and can induce cell cycle arrest in response to DNA damage. This suggests that IRF1 might be involved in the cellular response to TMZ-induced cell cycle arrest.\n",
       "3. **Apoptosis and immune response**: TMZ can induce apoptosis (programmed cell death) in cancer cells, which can also trigger an immune response. IRF1 is involved in the regulation of apoptosis and immune responses, including the activation of interferons, which are cytokines that play a crucial role in the immune response to cancer. Therefore, IRF1 might be involved in the immune response to TMZ-treated cancer cells.\n",
       "4. **PARP-1 inhibition**: The first abstract discusses the combination of TMZ with PARP-1 inhibition, which can enhance the efficacy of TMZ. IRF1 has been shown to interact with PARP-1, and this interaction can regulate the activity of both proteins. Therefore, the combination of TMZ with PARP-1 inhibition might indirectly affect IRF1 activity, leading to an enhanced therapeutic response.\n",
       "\n",
       "In summary, while there is no direct mention of IRF1 in the abstracts, we can infer an indirect relationship between TMZ and IRF1 through the mechanisms of DNA damage and repair, cell cycle regulation, apoptosis, and immune response. The combination of TMZ with other treatments, such as PARP-1 inhibition, might also indirectly affect IRF1 activity, leading to an enhanced therapeutic response. Further research is needed to fully understand the relationship between TMZ and IRF1 and to explore the potential therapeutic implications of this interaction.'}]   \n",
       "\n",
       "                                              respond_time_llm  \\\n",
       "774  [28.262667179107666, 40.4062659740448, 32.79805064201355]   \n",
       "\n",
       "                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               prompts_per_iteration  \\\n",
       "774  [Based on the following scientific abstracts, please describe how an indirect relationship between temozolomide and IRF1 protein, human might exist. Consider the key findings, underlying mechanisms, and any intermediate entities or processes mentioned in the abstracts. Your explanation should connect these elements to form a coherent narrative that illustrates the possible indirect linkage between temozolomide and IRF1 protein, human.\\n\\nTemozolomide concomitant and adjuvant to radiotherapy in elderly patients with glioblastoma: correlation with MGMT promoter methylation status. A recent randomized study conducted on newly diagnosed glioblastoma (GBM) patients demonstrated that concomitant and adjuvant temozolomide added to standard radiotherapy had a survival advantage compared with radiotherapy alone. The overall survival benefit of this aggressive treatment, however, was attenuated in older or poor performance status patients. The aim of the present study was to verify the activity and the toxicity of temozolomide administration concurrent and adjuvant to radiotherapy as first-line treatment for elderly GBM patients, and to explore correlations between clinical outcome and O6 methylguanine-DNA methyltransferase (MGMT) promoter methylation status. Newly diagnosed GBM patients>or=65 years were considered eligible. Treatment comprised radiotherapy (60 Gy in 30 fractions over 6 weeks) plus continuous daily temozolomide (75 mg/m2/day), followed by 12 maintenance temozolomide cycles (150 mg/m2 once a day for 5 consecutive days every 28 days) if MRI showed no enhancement suggesting a tumor; otherwise, chemotherapy was delivered until complete response or unequivocal progression. A total of 58 patients (34 males; median age, 68 years; range, 65-82 years) were enrolled. Sixteen patients (43%) presented MGMT promoter methylated and 21 unmethylated (57%) status. The median progression-free survival and median survival time (MST) were 9.5 months (95% confidence interval [CI], 8.6-10.5) and 13.7 months (95% CI, 10-17.3 months), respectively. Mental status deterioration grade 3-4 was detected in 25% of patients. Leukoencephalopathy was diagnosed in 10% of patients. The overall and progression-free survival of patients given concomitant and adjuvant temozolomide are greater than in those given radiotherapy alone; however, this regimen incurs a greater deterioration in mental status. Further randomized trials should, therefore, be conducted to investigate the efficacy and against the toxicity of this regimen as first-line therapy in patients with GBM.\\n\\nPARP-1 inhibition sensitizes temozolomide-treated glioblastoma cell lines and decreases drug resistance independent of MGMT activity and PTEN proficiency. Information on the mechanisms that are associated with tumor resistance has the potential to provide the fundamental basis for novel therapeutic strategies. In glioblastoma (GBM), predictive biomarkers of cellular responses to temozolomide (TMZ) combined with poly-ADP-ribose polymerase inhibitor (PARPi) remain largely unidentified. In this context, the influence of MGMT (O6-methylguanine DNA methyltransferase) and PTEN (phosphatase and tensin homologue deleted on chromosome ten) has been studied in addition to the occurrence of synthetic lethality involving PTEN and PARPi. The present study investigated whether PARP-1 inhibition by NU1025 may increase the cytotoxicity of TMZ-induced lesions in GBM cells, and whether these mechanisms can be influenced by MGMT and PTEN status. The impact of PTEN deficiency in repair pathways, and the effects of PARP-1 inhibition and PTEN silencing, in terms of synthetic lethality, were also assessed. NU1025 combined with TMZ effectively sensitized TMZ-resistant cells (T98G PTEN-mutated and LN18 PTEN-wild-type) and TMZ-sensitive cells (U251MG PTEN-mutated), in contrast to NU1025 alone. However, the sensitizing effects were not observed in U87MG (PTEN-mutated) cells, suggesting that specific genetic alterations may influence the response to drug treatment. The sensitizing effects occurred independently of MGMT activity, which was evaluated in O6-BG-treated cells. PTEN silencing using small interfering (si)RNA did not sensitize PTEN-proficient cells to TMZ + NU1025, or NU1025 alone, indicating an absence of synthetic lethality. The responses to TMZ + NU1025 involved antiproliferative activity, G2/M arrest, double strand breaks and the induction of apoptosis. Following 20 days of recovery after three consecutive days of TMZ treatment, TMZ-resistant cells were observed. However, when TMZ was combined with NU1025, the viability of T98G and LN18 cells was extremely decreased, indicating a lethal drug combination. Therefore, independently of MGMT proficiency and PTEN status, TMZ combined with PARPi may be a promising strategy that can be used to overcome TMZ acquired resistance in GBM cells.\\n\\nFirst-line treatment of malignant glioma with carmustine implants followed by concomitant radiochemotherapy: a multicenter experience. Randomized phase III trials have shown significant improvement of survival 1, 2, and 3 years after implantation of 1,3-bis (2-chloroethyl)-1-nitrosourea (BCNU) wafers for patients with newly diagnosed malignant glioma. But these studies and subsequent non-phase III studies have also shown risks associated with local chemotherapy within the central nervous system. The introduction of concomitant radiochemotherapy with temozolomide (TMZ) has later demonstrated a survival benefit in a phase III trial and has become the current treatment standard for newly diagnosed malignant glioma patients. Lately, this has resulted in clinical protocols combining local chemotherapy with BCNU wafers and concomitant radiochemotherapy with TMZ although this may carry the risk of increased toxicity. We have compiled the treatment experience of seven neurosurgical centers using implantation of carmustine wafers at primary surgery followed by 6 weeks of radiation therapy (59-60 Gy) and 75 mg/m(2)/day TMZ in patients with newly diagnosed glioblastoma followed by TMZ monochemotherapy. We have retrospectively analyzed the postoperative clinical course, occurrence and severity of adverse events, progression-free interval, and overall survival in 44 patients with newly diagnosed glioblastoma multiforme. All patients received multimodal treatment including tumor resection, BCNU wafer implantation, and concomitant radiochemotherapy. Of 44 patients (mean age 59 +/- 10.8 years) with glioblastoma who received Gliadel wafer at primary surgery, 28 patients (64%) had died, 16 patients (36%) were alive, and 15 patients showed no evidence of clinical or radiographic progression after a median follow-up of 15.6 months. At time of analysis of adverse events in this patient population, the median overall survival was 12.7 months and median progression-free survival was 7.0 months. Surgical, neurological, and medical adverse events were analyzed. Twenty-three patients (52%) experienced adverse events of any kind including complications that did not require treatment. Nineteen patients (43%) experienced grade 3 or grade 4 adverse events. Surgical complications included cerebral edema, healing abnormalities, cerebral spinal fluid leakage, meningitis, intracranial abscess, and hydrocephalus. Neurological adverse events included newly diagnosed seizures, alteration of mental status, and new neurological deficits. Medical complications were thromboembolic events (thrombosis, pulmonary embolism) and hematotoxicity. Combination of both treatment strategies, local chemotherapy with BCNU wafer and concomitant radiochemotherapy, appears attractive in aggressive multimodal treatment schedules and may utilize the sensitizing effect of TMZ and carmustine on MGMT and AGT on their respective drug resistance genes. Our data demonstrate that combination of local chemotherapy and concomitant radiochemotherapy carries a significant risk of toxicity that currently appears underestimated. Adverse events observed in this study appear similar to complication rates published in the phase III trials for BCNU wafer implantation followed by radiation therapy alone, but further add the toxicity of concomitant radiochemotherapy with systemic TMZ. Save use of a combined approach will require specific prevention strategies for multimodal treatments.\\n\\nMethionine-stress: a pleiotropic approach in enhancing the efficacy of chemotherapy. Malignant cells fail to utilize homocysteine (HCYS) in place of methionine (MET) and they are dependent on exogenous MET for growth. In animals, reduction of plasma MET to <5 microM can be induced by combined dietary restriction of MET and administration of L-methionine-alpha-deamino-gamma-lyase (methioninase). This treatment, termed as MET-stress, inhibits the growth of brain tumor xenografts in athymic mice and enhances the efficacy of DNA alkylating chemotherapeutic agents. The response of tumors to MET-stress depends on their mutational status, however, it always involves inhibition of CDK1 and in most cases the upregulation of p21, p27, GADDs and 14-3-3sigma in response to upregulation of TGF-beta, IRF-1, TNF-alpha, Rb and/or MDA-7 and the downregulation of PI3K, RAS and NF-kappaB. Although inhibition of the cell cycle and mitosis is not necessarily dependent on the tumor's p53 status, the expression of p21, GADD45 and apoptosis related genes (BAX, BCL-2) are regulated by wt-p53, in addition to their regulation by TGF-beta or MDA-7 in mutated p53 tumors. Mutational variability determines the mode of death (mitotic catastrophe versus apoptosis) in tumor cells subjected to MET-stress. The increase of the efficacy of alkylating agents is related to marked inhibition of O6-methylguanine-DNA methyltransferase (MGMT) expression, the induction of cell cycle check points and the inhibition of pro-survival pathways by MET-stress.\\n\\nIncorrect Recommendation Wording in Figure. \\n\\nCTV-to-PTV margin assessment for esophageal cancer radiotherapy based on an accumulated dose analysis. This study aimed to assess the smallest clinical target volume (CTV) to planned target volume (PTV) margins for esophageal cancer radiotherapy using daily online registration to the bony anatomy that yield full dosimetric coverage over the course of treatment. 29 esophageal cancer patients underwent six T2-weighted MRI scans at weekly intervals. An online bone-match image-guided radiotherapy treatment of five fractions was simulated for each patient. Multiple conformal treatment plans with increasing margins around the CTV were created for each patient. Then, the dose was warped to obtain an accumulated dose per simulated fraction. Full target coverage by 95% of the prescribed dose was assessed as a function of margin expansion in six directions. If target coverage in a single direction was accomplished, then the respective margin remained fixed for the subsequent dose plans. Margins in uncovered directions were increased in a new dose plan until full target coverage was achieved. The smallest set of CTV-to-PTV margins that yielded full dosimetric CTV coverage was 8 mm in posterior and right direction, 9 mm in anterior and cranial direction and 10 mm in left and caudal direction for 27 out of 29 patients. In two patients the curvature of the esophagus considerably changed between fractions, which required a 17 and 23 mm margin in right direction. Accumulated dose analysis revealed that CTV-to-PTV treatment margins of 8, 9 and 10 mm in posterior & right, anterior & cranial and left & caudal direction, respectively, are sufficient to account for interfraction tumor variations over the course of treatment when applying a daily online bone match. However, two patients with extreme esophageal interfraction motion were insufficiently covered with these margins and were identified as patients requiring replanning to achieve full target coverage., Based on the following scientific abstracts, please describe how an indirect relationship between temozolomide and IRF1 protein, human might exist. Consider the key findings, underlying mechanisms, and any intermediate entities or processes mentioned in the abstracts. Your explanation should connect these elements to form a coherent narrative that illustrates the possible indirect linkage between temozolomide and IRF1 protein, human.\\n\\nTemozolomide concomitant and adjuvant to radiotherapy in elderly patients with glioblastoma: correlation with MGMT promoter methylation status. A recent randomized study conducted on newly diagnosed glioblastoma (GBM) patients demonstrated that concomitant and adjuvant temozolomide added to standard radiotherapy had a survival advantage compared with radiotherapy alone. The overall survival benefit of this aggressive treatment, however, was attenuated in older or poor performance status patients. The aim of the present study was to verify the activity and the toxicity of temozolomide administration concurrent and adjuvant to radiotherapy as first-line treatment for elderly GBM patients, and to explore correlations between clinical outcome and O6 methylguanine-DNA methyltransferase (MGMT) promoter methylation status. Newly diagnosed GBM patients>or=65 years were considered eligible. Treatment comprised radiotherapy (60 Gy in 30 fractions over 6 weeks) plus continuous daily temozolomide (75 mg/m2/day), followed by 12 maintenance temozolomide cycles (150 mg/m2 once a day for 5 consecutive days every 28 days) if MRI showed no enhancement suggesting a tumor; otherwise, chemotherapy was delivered until complete response or unequivocal progression. A total of 58 patients (34 males; median age, 68 years; range, 65-82 years) were enrolled. Sixteen patients (43%) presented MGMT promoter methylated and 21 unmethylated (57%) status. The median progression-free survival and median survival time (MST) were 9.5 months (95% confidence interval [CI], 8.6-10.5) and 13.7 months (95% CI, 10-17.3 months), respectively. Mental status deterioration grade 3-4 was detected in 25% of patients. Leukoencephalopathy was diagnosed in 10% of patients. The overall and progression-free survival of patients given concomitant and adjuvant temozolomide are greater than in those given radiotherapy alone; however, this regimen incurs a greater deterioration in mental status. Further randomized trials should, therefore, be conducted to investigate the efficacy and against the toxicity of this regimen as first-line therapy in patients with GBM.\\n\\nPARP-1 inhibition sensitizes temozolomide-treated glioblastoma cell lines and decreases drug resistance independent of MGMT activity and PTEN proficiency. Information on the mechanisms that are associated with tumor resistance has the potential to provide the fundamental basis for novel therapeutic strategies. In glioblastoma (GBM), predictive biomarkers of cellular responses to temozolomide (TMZ) combined with poly-ADP-ribose polymerase inhibitor (PARPi) remain largely unidentified. In this context, the influence of MGMT (O6-methylguanine DNA methyltransferase) and PTEN (phosphatase and tensin homologue deleted on chromosome ten) has been studied in addition to the occurrence of synthetic lethality involving PTEN and PARPi. The present study investigated whether PARP-1 inhibition by NU1025 may increase the cytotoxicity of TMZ-induced lesions in GBM cells, and whether these mechanisms can be influenced by MGMT and PTEN status. The impact of PTEN deficiency in repair pathways, and the effects of PARP-1 inhibition and PTEN silencing, in terms of synthetic lethality, were also assessed. NU1025 combined with TMZ effectively sensitized TMZ-resistant cells (T98G PTEN-mutated and LN18 PTEN-wild-type) and TMZ-sensitive cells (U251MG PTEN-mutated), in contrast to NU1025 alone. However, the sensitizing effects were not observed in U87MG (PTEN-mutated) cells, suggesting that specific genetic alterations may influence the response to drug treatment. The sensitizing effects occurred independently of MGMT activity, which was evaluated in O6-BG-treated cells. PTEN silencing using small interfering (si)RNA did not sensitize PTEN-proficient cells to TMZ + NU1025, or NU1025 alone, indicating an absence of synthetic lethality. The responses to TMZ + NU1025 involved antiproliferative activity, G2/M arrest, double strand breaks and the induction of apoptosis. Following 20 days of recovery after three consecutive days of TMZ treatment, TMZ-resistant cells were observed. However, when TMZ was combined with NU1025, the viability of T98G and LN18 cells was extremely decreased, indicating a lethal drug combination. Therefore, independently of MGMT proficiency and PTEN status, TMZ combined with PARPi may be a promising strategy that can be used to overcome TMZ acquired resistance in GBM cells.\\n\\nFirst-line treatment of malignant glioma with carmustine implants followed by concomitant radiochemotherapy: a multicenter experience. Randomized phase III trials have shown significant improvement of survival 1, 2, and 3 years after implantation of 1,3-bis (2-chloroethyl)-1-nitrosourea (BCNU) wafers for patients with newly diagnosed malignant glioma. But these studies and subsequent non-phase III studies have also shown risks associated with local chemotherapy within the central nervous system. The introduction of concomitant radiochemotherapy with temozolomide (TMZ) has later demonstrated a survival benefit in a phase III trial and has become the current treatment standard for newly diagnosed malignant glioma patients. Lately, this has resulted in clinical protocols combining local chemotherapy with BCNU wafers and concomitant radiochemotherapy with TMZ although this may carry the risk of increased toxicity. We have compiled the treatment experience of seven neurosurgical centers using implantation of carmustine wafers at primary surgery followed by 6 weeks of radiation therapy (59-60 Gy) and 75 mg/m(2)/day TMZ in patients with newly diagnosed glioblastoma followed by TMZ monochemotherapy. We have retrospectively analyzed the postoperative clinical course, occurrence and severity of adverse events, progression-free interval, and overall survival in 44 patients with newly diagnosed glioblastoma multiforme. All patients received multimodal treatment including tumor resection, BCNU wafer implantation, and concomitant radiochemotherapy. Of 44 patients (mean age 59 +/- 10.8 years) with glioblastoma who received Gliadel wafer at primary surgery, 28 patients (64%) had died, 16 patients (36%) were alive, and 15 patients showed no evidence of clinical or radiographic progression after a median follow-up of 15.6 months. At time of analysis of adverse events in this patient population, the median overall survival was 12.7 months and median progression-free survival was 7.0 months. Surgical, neurological, and medical adverse events were analyzed. Twenty-three patients (52%) experienced adverse events of any kind including complications that did not require treatment. Nineteen patients (43%) experienced grade 3 or grade 4 adverse events. Surgical complications included cerebral edema, healing abnormalities, cerebral spinal fluid leakage, meningitis, intracranial abscess, and hydrocephalus. Neurological adverse events included newly diagnosed seizures, alteration of mental status, and new neurological deficits. Medical complications were thromboembolic events (thrombosis, pulmonary embolism) and hematotoxicity. Combination of both treatment strategies, local chemotherapy with BCNU wafer and concomitant radiochemotherapy, appears attractive in aggressive multimodal treatment schedules and may utilize the sensitizing effect of TMZ and carmustine on MGMT and AGT on their respective drug resistance genes. Our data demonstrate that combination of local chemotherapy and concomitant radiochemotherapy carries a significant risk of toxicity that currently appears underestimated. Adverse events observed in this study appear similar to complication rates published in the phase III trials for BCNU wafer implantation followed by radiation therapy alone, but further add the toxicity of concomitant radiochemotherapy with systemic TMZ. Save use of a combined approach will require specific prevention strategies for multimodal treatments.\\n\\nIncorrect Recommendation Wording in Figure. \\n\\nCTV-to-PTV margin assessment for esophageal cancer radiotherapy based on an accumulated dose analysis. This study aimed to assess the smallest clinical target volume (CTV) to planned target volume (PTV) margins for esophageal cancer radiotherapy using daily online registration to the bony anatomy that yield full dosimetric coverage over the course of treatment. 29 esophageal cancer patients underwent six T2-weighted MRI scans at weekly intervals. An online bone-match image-guided radiotherapy treatment of five fractions was simulated for each patient. Multiple conformal treatment plans with increasing margins around the CTV were created for each patient. Then, the dose was warped to obtain an accumulated dose per simulated fraction. Full target coverage by 95% of the prescribed dose was assessed as a function of margin expansion in six directions. If target coverage in a single direction was accomplished, then the respective margin remained fixed for the subsequent dose plans. Margins in uncovered directions were increased in a new dose plan until full target coverage was achieved. The smallest set of CTV-to-PTV margins that yielded full dosimetric CTV coverage was 8 mm in posterior and right direction, 9 mm in anterior and cranial direction and 10 mm in left and caudal direction for 27 out of 29 patients. In two patients the curvature of the esophagus considerably changed between fractions, which required a 17 and 23 mm margin in right direction. Accumulated dose analysis revealed that CTV-to-PTV treatment margins of 8, 9 and 10 mm in posterior & right, anterior & cranial and left & caudal direction, respectively, are sufficient to account for interfraction tumor variations over the course of treatment when applying a daily online bone match. However, two patients with extreme esophageal interfraction motion were insufficiently covered with these margins and were identified as patients requiring replanning to achieve full target coverage.\\n\\nImpact of new legislation on presumed consent on organ donation on liver transplant in Singapore: a preliminary analysis. Demand for the liver organ for transplantation vastly exceeded the availability of deceased donor organs. A new law, the revised Human Organ Transplant Act (HOTA), was implemented in Singapore in July 2004, which allowed for recovering four organs, including liver, for transplant unless the deceased give objection prior to their demise. We set to study the impact of the revised legislation by comparing the number of potential suitable donors, liver recovery surgery, and liver transplants two years before and one year after the implementation. There was no change in the number of suitable donors, but there was an increase in the number of liver recovery surgeries and liver transplantation, and a lower refusal rate among suitable donors. Although the revised legislation helped improve the availability of deceased donor organs moderately, other nonlegislative, supplementary measures are needed to further improve the low organ donation rate., Based on the following scientific abstracts, please describe how an indirect relationship between temozolomide and IRF1 protein, human might exist. Consider the key findings, underlying mechanisms, and any intermediate entities or processes mentioned in the abstracts. Your explanation should connect these elements to form a coherent narrative that illustrates the possible indirect linkage between temozolomide and IRF1 protein, human.\\n\\nPARP-1 inhibition sensitizes temozolomide-treated glioblastoma cell lines and decreases drug resistance independent of MGMT activity and PTEN proficiency. Information on the mechanisms that are associated with tumor resistance has the potential to provide the fundamental basis for novel therapeutic strategies. In glioblastoma (GBM), predictive biomarkers of cellular responses to temozolomide (TMZ) combined with poly-ADP-ribose polymerase inhibitor (PARPi) remain largely unidentified. In this context, the influence of MGMT (O6-methylguanine DNA methyltransferase) and PTEN (phosphatase and tensin homologue deleted on chromosome ten) has been studied in addition to the occurrence of synthetic lethality involving PTEN and PARPi. The present study investigated whether PARP-1 inhibition by NU1025 may increase the cytotoxicity of TMZ-induced lesions in GBM cells, and whether these mechanisms can be influenced by MGMT and PTEN status. The impact of PTEN deficiency in repair pathways, and the effects of PARP-1 inhibition and PTEN silencing, in terms of synthetic lethality, were also assessed. NU1025 combined with TMZ effectively sensitized TMZ-resistant cells (T98G PTEN-mutated and LN18 PTEN-wild-type) and TMZ-sensitive cells (U251MG PTEN-mutated), in contrast to NU1025 alone. However, the sensitizing effects were not observed in U87MG (PTEN-mutated) cells, suggesting that specific genetic alterations may influence the response to drug treatment. The sensitizing effects occurred independently of MGMT activity, which was evaluated in O6-BG-treated cells. PTEN silencing using small interfering (si)RNA did not sensitize PTEN-proficient cells to TMZ + NU1025, or NU1025 alone, indicating an absence of synthetic lethality. The responses to TMZ + NU1025 involved antiproliferative activity, G2/M arrest, double strand breaks and the induction of apoptosis. Following 20 days of recovery after three consecutive days of TMZ treatment, TMZ-resistant cells were observed. However, when TMZ was combined with NU1025, the viability of T98G and LN18 cells was extremely decreased, indicating a lethal drug combination. Therefore, independently of MGMT proficiency and PTEN status, TMZ combined with PARPi may be a promising strategy that can be used to overcome TMZ acquired resistance in GBM cells.\\n\\nFirst-line treatment of malignant glioma with carmustine implants followed by concomitant radiochemotherapy: a multicenter experience. Randomized phase III trials have shown significant improvement of survival 1, 2, and 3 years after implantation of 1,3-bis (2-chloroethyl)-1-nitrosourea (BCNU) wafers for patients with newly diagnosed malignant glioma. But these studies and subsequent non-phase III studies have also shown risks associated with local chemotherapy within the central nervous system. The introduction of concomitant radiochemotherapy with temozolomide (TMZ) has later demonstrated a survival benefit in a phase III trial and has become the current treatment standard for newly diagnosed malignant glioma patients. Lately, this has resulted in clinical protocols combining local chemotherapy with BCNU wafers and concomitant radiochemotherapy with TMZ although this may carry the risk of increased toxicity. We have compiled the treatment experience of seven neurosurgical centers using implantation of carmustine wafers at primary surgery followed by 6 weeks of radiation therapy (59-60 Gy) and 75 mg/m(2)/day TMZ in patients with newly diagnosed glioblastoma followed by TMZ monochemotherapy. We have retrospectively analyzed the postoperative clinical course, occurrence and severity of adverse events, progression-free interval, and overall survival in 44 patients with newly diagnosed glioblastoma multiforme. All patients received multimodal treatment including tumor resection, BCNU wafer implantation, and concomitant radiochemotherapy. Of 44 patients (mean age 59 +/- 10.8 years) with glioblastoma who received Gliadel wafer at primary surgery, 28 patients (64%) had died, 16 patients (36%) were alive, and 15 patients showed no evidence of clinical or radiographic progression after a median follow-up of 15.6 months. At time of analysis of adverse events in this patient population, the median overall survival was 12.7 months and median progression-free survival was 7.0 months. Surgical, neurological, and medical adverse events were analyzed. Twenty-three patients (52%) experienced adverse events of any kind including complications that did not require treatment. Nineteen patients (43%) experienced grade 3 or grade 4 adverse events. Surgical complications included cerebral edema, healing abnormalities, cerebral spinal fluid leakage, meningitis, intracranial abscess, and hydrocephalus. Neurological adverse events included newly diagnosed seizures, alteration of mental status, and new neurological deficits. Medical complications were thromboembolic events (thrombosis, pulmonary embolism) and hematotoxicity. Combination of both treatment strategies, local chemotherapy with BCNU wafer and concomitant radiochemotherapy, appears attractive in aggressive multimodal treatment schedules and may utilize the sensitizing effect of TMZ and carmustine on MGMT and AGT on their respective drug resistance genes. Our data demonstrate that combination of local chemotherapy and concomitant radiochemotherapy carries a significant risk of toxicity that currently appears underestimated. Adverse events observed in this study appear similar to complication rates published in the phase III trials for BCNU wafer implantation followed by radiation therapy alone, but further add the toxicity of concomitant radiochemotherapy with systemic TMZ. Save use of a combined approach will require specific prevention strategies for multimodal treatments.\\n\\nIn vitro uptake of ascorbic acid-1-14-C by adrenal glands of different species of animals.\\n\\nIncorrect Recommendation Wording in Figure. \\n\\nCTV-to-PTV margin assessment for esophageal cancer radiotherapy based on an accumulated dose analysis. This study aimed to assess the smallest clinical target volume (CTV) to planned target volume (PTV) margins for esophageal cancer radiotherapy using daily online registration to the bony anatomy that yield full dosimetric coverage over the course of treatment. 29 esophageal cancer patients underwent six T2-weighted MRI scans at weekly intervals. An online bone-match image-guided radiotherapy treatment of five fractions was simulated for each patient. Multiple conformal treatment plans with increasing margins around the CTV were created for each patient. Then, the dose was warped to obtain an accumulated dose per simulated fraction. Full target coverage by 95% of the prescribed dose was assessed as a function of margin expansion in six directions. If target coverage in a single direction was accomplished, then the respective margin remained fixed for the subsequent dose plans. Margins in uncovered directions were increased in a new dose plan until full target coverage was achieved. The smallest set of CTV-to-PTV margins that yielded full dosimetric CTV coverage was 8 mm in posterior and right direction, 9 mm in anterior and cranial direction and 10 mm in left and caudal direction for 27 out of 29 patients. In two patients the curvature of the esophagus considerably changed between fractions, which required a 17 and 23 mm margin in right direction. Accumulated dose analysis revealed that CTV-to-PTV treatment margins of 8, 9 and 10 mm in posterior & right, anterior & cranial and left & caudal direction, respectively, are sufficient to account for interfraction tumor variations over the course of treatment when applying a daily online bone match. However, two patients with extreme esophageal interfraction motion were insufficiently covered with these margins and were identified as patients requiring replanning to achieve full target coverage.\\n\\nImpact of new legislation on presumed consent on organ donation on liver transplant in Singapore: a preliminary analysis. Demand for the liver organ for transplantation vastly exceeded the availability of deceased donor organs. A new law, the revised Human Organ Transplant Act (HOTA), was implemented in Singapore in July 2004, which allowed for recovering four organs, including liver, for transplant unless the deceased give objection prior to their demise. We set to study the impact of the revised legislation by comparing the number of potential suitable donors, liver recovery surgery, and liver transplants two years before and one year after the implementation. There was no change in the number of suitable donors, but there was an increase in the number of liver recovery surgeries and liver transplantation, and a lower refusal rate among suitable donors. Although the revised legislation helped improve the availability of deceased donor organs moderately, other nonlegislative, supplementary measures are needed to further improve the low organ donation rate.]   \n",
       "\n",
       "                                                                                                                                                                                                                                                                                                                                                                               pmid_contexts_per_iteration  \\\n",
       "774  [{('C0076080', 'C0069197'): ['19514084', '32901889', '20706757'], ('C0069197', 'C1530270'): ['16520149', '34932098', '33992628']}, {('C0076080', 'C0069197'): ['19514084', '32901889', '20706757'], ('C0069197', 'C1530270'): ['34932098', '33992628', '17102778']}, {('C0076080', 'C0069197'): ['32901889', '20706757', '4300795'], ('C0069197', 'C1530270'): ['34932098', '33992628', '17102778']}]   \n",
       "\n",
       "                                                                                                                                                                                          pmid_changes_per_iteration  \n",
       "774  [{'edge': ('C0069197', 'C1530270'), 'dropped': '16520149', 'added': '17102778'}, {'edge': ('C0076080', 'C0069197'), 'dropped': '19514084', 'added': '4300795'}, {'edge': None, 'dropped': None, 'added': None}]  "
      ]
     },
     "execution_count": 8,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "res_df_774[['respond_llm',\t'respond_time_llm',\t'prompts_per_iteration',\t'pmid_contexts_per_iteration',\t'pmid_changes_per_iteration']]\n",
    "\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "d65e4e72-0255-443b-8094-c8f64904021c",
   "metadata": {},
   "outputs": [],
   "source": []
  }
 ],
 "metadata": {
  "kernelspec": {
   "display_name": "Python [conda env:agatha_0724]",
   "language": "python",
   "name": "conda-env-agatha_0724-py"
  },
  "language_info": {
   "codemirror_mode": {
    "name": "ipython",
    "version": 3
   },
   "file_extension": ".py",
   "mimetype": "text/x-python",
   "name": "python",
   "nbconvert_exporter": "python",
   "pygments_lexer": "ipython3",
   "version": "3.9.15"
  }
 },
 "nbformat": 4,
 "nbformat_minor": 5
}
